≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Atrial septal defect

EFO Endpoint Browser PheWeb

Q17_ASD

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q21.1
  • Hospital discharge: ICD-9 — 7455A|7456A
  • Hospital discharge: excluded ICD-10 — Q20|Q2111|Q2[2-5]|Q26[0-1]|Q26[5-9]
  • Cause of death: ICD-10 — Q21.1
  • Cause of death: ICD-9 — 7455A|7456A
  • Cause of death: excluded ICD-10 — Q20|Q2111|Q2[2-5]|Q26[0-1]|Q26[5-9]
  • Operations: NOMESCO codes — ^FFC00|^FFC02|^FFC22|^FFC50|^FFC96

3 out of 7 registries used, show all original rules.

1520

4. Check minimum number of events

None

1520

5. Include endpoints

None

1520

6. Filter based on genotype QC (FinnGen only)

1462

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_CIRCULATO_SYSTEM

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF6v3

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 13463 7684 5736
Only index persons 10427 6013 4414
Unadjusted period prevalence (%)
Whole population 0.19 0.22 0.16
Only index persons 0.20 0.22 0.17
Median age at first event (years)
Whole population 10.26 11.40 8.49
Only index persons 19.79 22.50 16.11

-FinnGen-

Key figures

All Female Male
Number of individuals 1462 899 563
Unadjusted period prevalence (%) 0.30 0.32 0.26
Median age at first event (years) 43.11 41.60 45.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1520
Matched controls
15097
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
6.9
311.1
773
1975
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
307.7
842
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
9.1
307.7
677
1230
XF620
NOMESCO Finland
Examination of circulation with color method
216.1
307.7
223
12
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
23.8
307.7
321
168
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
307.7
450
*
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
307.7
335
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
+∞
307.7
387
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
43.3
307.7
723
310
B01AA03
ATC
warfarin; systemic
7.8
287.8
509
918
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
41.3
239.8
147
39
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
+∞
218.6
205
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
11.5
194.2
215
213
XF400
NOMESCO Finland
ECG with 12 standard connections
5.3
188.5
503
1291
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
6.6
163.8
301
544
XF404
NOMESCO Finland
Ambulatory ECG
6.5
162.6
304
559
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
7.7
156.9
243
366
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
13.4
156.8
154
126
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
6.5
152.1
281
509
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
144.0
953
4560
I48
ICD-10 Finland
Atrial fibrillation and flutter
4.6
135.5
407
1121
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
126.6
120
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
+∞
125.5
119
*
C01AA05
ATC
digoxin; systemic
7.3
125.1
197
300
FM2CE, ,
NOMESCO Finland
10.1
121.2
143
153
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
121.2
115
*
31
HP
Congenital heart failure surgery
+∞
121.2
115
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
15.2
118.7
107
75
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
116.9
111
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
112.4
426
1373
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
112.1
239
490
WX872
NOMESCO Finland
Intensive care
7.5
109.8
167
244
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.8
106.0
421
1395
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
57.7
98.7
56
10
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
+∞
96.7
92
*
C03CA01
ATC
furosemide; systemic
3.3
95.5
484
1859
TFP20
NOMESCO Finland
Cardiodefibrillation
5.8
95.1
187
354
207
Kela drug reimbursment
Chronic arrhythmias
4.1
89.7
291
830
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
87.9
287
822
61
HP
Catheterization and pressure measurement of the left side of the heart
17.6
85.7
71
42
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
7.2
85.6
133
198
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
7.0
85.0
137
212
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
14.1
77.4
72
53
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
12.0
74.8
77
67
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
74.5
557
2601
5205
FHL
ASD blockage, secondary defect
+∞
73.3
70
*
5253
FHL
Cardiac lung machine
30.7
72.4
48
16
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
+∞
71.2
68
*
C03DA01
ATC
spironolactone; oral
3.8
71.1
252
758
XF402
NOMESCO Finland
ECG with work load test
4.1
70.8
220
603
74642
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium secundum
350.1
67.9
68
*
K78
ICPC
Atrial fibrillation/flutter
5.0
67.7
157
342
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.0
66.5
151
323
I34.1
ICD-10 Finland
Mitral (valve) prolapse
8.2
66.3
91
117
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
6.3
65.9
116
196
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
65.1
699
3837
Q21.1
ICD-10 Finland
Atrial septal defect
+∞
63.8
61
*
WX892
NOMESCO Finland
Monitored bed care
3.9
63.7
207
584
PA2AE
NOMESCO Finland
Ultrasound examination of brain artery
224.6
63.5
65
*
I50.9
ICD-10 Finland
Heart failure, unspecified
3.7
62.4
224
677
XFE00
NOMESCO Finland
Epicardial ultrasonography
10.5
61.6
69
68
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.0
60.9
138
294
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
11.0
60.8
66
62
C07AB07
ATC
bisoprolol; oral
2.4
59.6
694
3908
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
59.6
57
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
59.5
285
1030
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
59.3
455
2113
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
10.3
58.3
66
66
FFC50
NOMESCO Finland
Closure of ostium secundum type ASD using patch
+∞
57.5
55
*
XA800
NOMESCO Finland
Neuropsychological investigation
4.0
57.2
178
486
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.4
56.8
117
229
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
56.5
54
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
3.2
55.7
250
867
I50.0
ICD-10 Finland
Congestive heart failure
4.8
54.9
130
287
62
HP
Catheterization and pressure measurement of the right side of the heart
71.1
54.4
62
9
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
3.9
52.6
169
471
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
51.9
604
3352
Q23.11
ICD-10 Finland
Bicuspid aortic valve
267.7
51.3
52
*
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
19.4
50.7
40
21
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.3
50.7
210
692
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
6.1
49.5
89
153
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
20.3
49.2
38
19
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
15.9
48.4
42
27
B01AC04
ATC
clopidogrel; oral
3.0
48.3
245
908
XF622
NOMESCO Finland
Measurement of minute volume of heart
79.5
48.1
54
7
Q21.20
ICD-10 Finland
Atrial septal defect of primum type
+∞
48.1
46
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.6
48.0
50
44
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
3.1
47.5
221
779
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
47.0
45
*
APK
HP
ASD closure
+∞
47.0
45
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
4.1
46.5
135
349
AF1
HP
Surgery of congenital heart defect
+∞
46.0
44
*
R4110
NOMESCO Finland
Physiotherapy
2.2
44.6
520
2852
XF600
NOMESCO Finland
Bloodpressure measurement
3.4
44.1
177
570
Q21.12
ICD-10 Finland
Defective sinus venosus
+∞
43.9
42
*
Z2221
NOMESCO Finland
Medical doctor
2.2
43.1
502
2745
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
16.6
42.5
36
22
C07AA07
ATC
sotalol; systemic
5.9
41.2
76
134
APJ
HP
PFO closure
+∞
40.7
39
*
G04BE03
ATC
sildenafil; oral
10.4
39.4
44
43
C01BD01
ATC
amiodarone; systemic
6.4
38.9
66
107
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
38.6
37
*
XX3BT
NOMESCO Finland
Other labeling with X-ray guidance
8.5
38.4
50
60
XF640, ,
NOMESCO Finland
6.5
38.3
64
102
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
38.2
308
1431
I48.2
ICD-10 Finland
Chronic atrial fibrillation
4.6
36.7
89
200
7456A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[DEFECTUS SEPTI ATRIORUM NUD]
+∞
36.5
35
*
I49.5
ICD-10 Finland
Sick sinus syndrome
5.0
36.5
80
165
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
35.7
374
1937
FFC42
NOMESCO Finland
Percutaneous closure of patent foramen ovale
+∞
35.5
34
*
B01AF02
ATC
apixaban; oral
2.8
35.3
194
746
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
122.0
33.7
36
*
B01AB05
ATC
enoxaparin; parenteral
2.1
32.8
434
2449
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
+∞
32.3
31
*
WX882
NOMESCO Finland
High dependency care
3.3
31.4
128
414
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
12.6
31.3
31
25
Q21.0
ICD-10 Finland
Ventricular septal defect
+∞
31.3
30
*
AN1
HP
Coronary angiography
3.0
31.2
148
524
AA1AD
NOMESCO Finland
CT of head and brain
2.0
30.3
402
2261
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.2
30.0
125
410
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.8
29.7
93
253
ZXD05
NOMESCO Finland
Urgent procedure
1.9
28.3
464
2799
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
28.1
27
*
WX402
NOMESCO Finland
General anaesthesia
2.0
28.0
420
2456
AP2
HP
Catheterization of the right side of the heart
47.8
27.4
33
7
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
4.3
27.2
71
169
Q20.48
ICD-10 Finland
Single ventricle
+∞
27.1
26
*
I44.2
ICD-10 Finland
Atrioventricular block, complete
5.5
27.0
53
99
R4120
NOMESCO Finland
Occupational therapy
2.7
26.7
152
592
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
273.9
26.7
27
*
I48.1
ICD-10 Finland
Persistent atrial fibrillation
4.3
26.3
70
169
TFP34
NOMESCO Finland
Electrophysiological investigation
4.1
26.1
73
183
K90
ICPC
Stroke/cerebrovascular accident
4.9
26.1
58
121
Q26.3
ICD-10 Finland
Partial anomalous pulmonary venous connection
+∞
26.0
25
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
9.5
26.0
31
33
K84
ICPC
Heart disease other
5.0
25.2
55
113
RS224, ,
NOMESCO Finland
7.7
24.9
35
46
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.3
24.9
51
99
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
70.6
24.8
28
*
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
91.0
24.6
27
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
24.3
375
2200
FFC96
NOMESCO Finland
Other closure of isolated atrial septal defect
+∞
24.0
23
*
PD5BD
NOMESCO Finland
Extensive CT of aorta
7.5
23.6
34
46
I50.1
ICD-10 Finland
Left ventricular failure
3.9
23.3
70
185
ZXE00
NOMESCO Finland
One hour or less
1.7
23.3
612
4211
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
22.9
22
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
22.9
22
*
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
22.9
22
*
C01BC04
ATC
flecainide; systemic
3.9
22.4
66
172
TFP35
NOMESCO Finland
Electroanatomical mapping
5.7
22.0
41
73
C07AB02
ATC
metoprolol; systemic
2.1
21.9
242
1258
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
7.0
21.5
33
48
I35.0
ICD-10 Finland
Aortic (valve) stenosis
3.4
21.4
79
240
AP3
HP
Catheterization of the right and left side of the heart
43.7
21.4
26
6
Z98.8
ICD-10 Finland
Other specified postsurgical states
5.8
21.3
39
68
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
23.4
21.2
30
13
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.2
21.0
57
140
7454B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]
+∞
20.8
20
*
Q21.30
ICD-10 Finland
Tetralogy of Fallot
+∞
20.8
20
*
Z3231
NOMESCO Finland
Registered nurse
1.7
20.8
469
3068
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.2
20.7
56
137
C09AA05
ATC
ramipril; oral
1.9
20.5
291
1651
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
20.4
183
876
I48.4
ICD-10 Finland
Atypical atrial flutter
18.5
20.4
31
17
R06.0
ICD-10 Finland
Dyspnoea
1.8
20.3
387
2409
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
4.9
20.2
45
94
R04.0
ICD-10 Finland
Epistaxis
2.6
20.2
122
489
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.0
20.1
58
149
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
19.9
204
1030
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.7
19.8
115
452
Q21.29
ICD-10 Finland
Atrioventricular septal defect UNS
+∞
19.8
19
*
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
+∞
19.8
19
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.1
19.6
41
81
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
105.7
19.5
21
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.8
19.2
60
163
Z3226
NOMESCO Finland
Physiotherapist
1.8
19.2
323
1931
I42.0
ICD-10 Finland
Dilated cardiomyopathy
4.7
19.0
44
95
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
22.7
19.0
27
12
81
HP
Angiography of the heart and coronary arteries
3.3
18.9
73
228
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
+∞
18.7
18
*
I37.0
ICD-10 Finland
Pulmonary valve stenosis
+∞
18.7
18
*
74646
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium primum
+∞
18.7
18
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
18.6
217
1148
250, ,
Kela drug reimbursment
5.2
18.5
38
74
WX704
NOMESCO Finland
Intubation
2.4
18.5
137
604
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
19.5
18.1
27
14
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.3
18.0
69
215
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.7
17.9
58
162
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
17.8
377
2406
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
+∞
17.7
17
*
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
17.7
17
*
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
17.7
17
*
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
180.8
17.5
18
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
5.8
17.5
32
56
I47.1
ICD-10 Finland
Supraventricular tachycardia
2.8
16.8
86
317
Q22.5
ICD-10 Finland
Ebstein anomaly
+∞
16.7
16
*
FFC32
NOMESCO Finland
Percutaneous transluminal closure of sinus venosus type ASD
+∞
16.7
16
*
Q90.9
ICD-10 Finland
Down syndrome, unspecified
90.5
16.5
18
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
6.0
16.4
29
49
K83
ICPC
Heart valve disease NOS
12.2
16.3
29
24
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
16.3
255
1485
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
16.2
157
774
I47.2
ICD-10 Finland
Ventricular tachycardia
4.5
15.8
38
85
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
+∞
15.6
15
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
15.6
15
*
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
+∞
15.6
15
*
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
15.6
15
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.2
15.6
147
716
FM1CD
NOMESCO Finland
Very extensive CT of heart
26.4
15.5
21
8
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
22.1
15.5
22
10
602
Kela drug reimbursment
Children's severe malnutrition
3.8
15.4
47
126
K80
ICPC
Cardiac arrhythmia NOS
2.3
15.2
125
576
ZXY02
NOMESCO Finland
Neuropsychologist
6.7
15.2
24
36
B01AE07
ATC
dabigatran etexilate; oral
3.5
14.9
51
148
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
6.5
14.8
24
37
I27.0
ICD-10 Finland
Primary pulmonary hypertension
31.8
14.8
19
6
74663
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae pulmonalis
56.9
14.8
17
*
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
4.4
14.6
37
86
51
HP
Other heart surgery
+∞
14.6
14
*
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
+∞
14.6
14
*
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
+∞
14.6
14
*
I97.0
ICD-10 Finland
Postcardiotomy syndrome
36.2
14.4
18
5
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
14.4
93
385
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
6.6
14.4
23
35
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.8
14.1
43
115
Q87.14
ICD-10 Finland
Noonan's syndrome
53.5
13.8
16
*
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
+∞
13.5
13
*
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
+∞
13.5
13
*
I44.1
ICD-10 Finland
Atrioventricular block, second degree
4.7
13.4
31
67
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.3
13.3
34
80
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
4.1
13.2
36
89
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
13.1
335
2226
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
16.8
12.9
20
12
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
28.4
12.9
17
6
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
13.0
12.9
22
17
WX002
NOMESCO Finland
Sedation and analgesia
1.7
12.8
243
1492
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
12.7
206
1208
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
70.0
12.6
14
*
I48.3
ICD-10 Finland
Typical atrial flutter
6.0
12.5
22
37
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
+∞
12.5
12
*
Q21.2
ICD-10 Finland
Atrioventricular septal defect
+∞
12.5
12
*
7460C
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]
+∞
12.5
12
*
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
+∞
12.5
12
*
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
130.2
12.4
13
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
12.3
439
3148
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
11.7
12.3
22
19
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
12.2
642
4990
K99
ICPC
Cardiovascular disease other
4.0
12.1
34
86
Z31.5
ICD-10 Finland
Genetic counselling
2.1
12.0
118
583
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
4.5
12.0
29
65
AC4
HP
MVP
26.7
12.0
16
6
C10AA05
ATC
atorvastatin; oral
1.5
12.0
445
3214
I63
ICD-10 Finland
Cerebral infarction
10.1
11.9
23
23
FPD00
NOMESCO Finland
Maze procedure for atrial fibrillation
46.7
11.8
14
*
J01CA04
ATC
amoxicillin; systemic
1.7
11.8
1284
11542
R01.1
ICD-10 Finland
Cardiac murmur, unspecified
2.9
11.7
56
199
AD1
HP
TVP
65.0
11.6
13
*
FPD96
NOMESCO Finland
Other operation for atrial fibrillation
65.0
11.6
13
*
R50.9
ICD-10 Finland
Fever, unspecified
1.6
11.5
273
1775
K77
ICPC
Heart failure
4.1
11.5
31
76
I44.0
ICD-10 Finland
Atrioventricular block, first degree
5.3
11.4
23
44
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
11.4
11
*
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
11.4
11
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
+∞
11.4
11
*
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
11.4
11
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
11.4
11
*
I51.0
ICD-10 Finland
Cardiac septal defect, acquired
+∞
11.4
11
*
Q25.78
ICD-10 Finland
Other congenital malformations of pulmonary artery
+∞
11.4
11
*
AH3
HP
Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery
+∞
11.4
11
*
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
11.4
11
*
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
120.1
11.4
12
*
74699
ICD-8 Finland
Congenital anomalies of heart, Unspecified anomalies of heart
120.1
11.4
12
*
R62.0
ICD-10 Finland
Delayed milestone
2.8
11.4
57
208
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
4.7
11.3
26
56
Z2445
NOMESCO Finland
Psychologist
2.0
11.1
115
580
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
10.9
102
495
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.7
10.9
25
54
7AX01, ,
NOMESCO Finland
15.5
10.8
17
11
TFP45
NOMESCO Finland
Ablation treatment of non-typical atrial flutter
28.0
10.7
14
5
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
4.3
10.7
27
63
H53.4
ICD-10 Finland
Visual field defects
3.6
10.5
34
95
342
Kela drug reimbursment
Dronedarone
8.5
10.5
22
26
Q90
ICD-10 Finland
Down syndrome
+∞
10.4
10
*
Q24.6
ICD-10 Finland
Congenital heart block
+∞
10.4
10
*
7454A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]
+∞
10.4
10
*
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
+∞
10.4
10
*
APX
HP
Other cardiac catheter operation
+∞
10.4
10
*
Q25.3
ICD-10 Finland
Stenosis of aorta
110.0
10.4
11
*
R1260
NOMESCO Finland
Evaluation of communicative skills
3.3
10.3
39
121
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
32.5
10.3
13
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
10.3
80
361
3A064, ,
NOMESCO Finland
18.8
10.2
15
8
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
7.5
10.1
23
31
FM1AD
NOMESCO Finland
CT of heart
13.1
10.1
17
13
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.1
10.1
42
138
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
9.9
119
633
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
9.8
91
441
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
9.8
103
523
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
26.0
9.8
13
5
WW502
NOMESCO Finland
Autotransfusion
10.6
9.7
18
17
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
2.8
9.7
49
180
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.0
9.7
43
147
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
7.8
9.6
21
27
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.6
9.6
31
87
I21.19
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
5.3
9.6
19
36
FM1BD
NOMESCO Finland
Extensive CT of heart
11.4
9.5
17
15
L04AD02
ATC
tacrolimus; systemic
3.4
9.5
33
97
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
9.1
9.5
19
21
C01BD07
ATC
dronedarone; oral
9.1
9.5
19
21
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
10.0
9.5
18
18
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.6
9.5
55
217
R42
ICD-10 Finland
Dizziness and giddiness
1.6
9.4
281
1922
7471A
ICD-9 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]
100.0
9.4
10
*
FDE10
NOMESCO Finland
Ligature of patent ductus arteriosus
+∞
9.4
9
*
Q20.5
ICD-10 Finland
Discordant atrioventricular connection
+∞
9.4
9
*
AE1
HP
Pulmonary artery thrombendarterectomy
+∞
9.4
9
*
Q24.0
ICD-10 Finland
Dextrocardia
+∞
9.4
9
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
+∞
9.4
9
*
FM2FN
NOMESCO Finland
Intra cardiac shunt isotope imaging
+∞
9.4
9
*
5207
FHL
VSD closure
+∞
9.4
9
*
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
21.7
9.3
13
6
I49.1
ICD-10 Finland
Atrial premature depolarization
2.6
9.3
54
213
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.6
9.3
54
213
ZX199
NOMESCO Finland
Other rote
6.9
9.3
22
32
F83
ICD-10 Finland
Mixed specific developmental disorders
2.8
9.2
45
163
73
HP
Initial pacemaker installation
13.7
9.1
15
11
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.4
9.0
63
271
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.5
9.0
30
86
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
4.1
8.9
24
59
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.5
8.9
56
230
UGC02
NOMESCO Finland
Rigid bronchoscopy
7.4
8.9
20
27
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
8.8
81
392
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
4.9
8.8
19
39
Z94.1
ICD-10 Finland
Heart transplant status
8.6
8.8
18
21
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.0
8.5
24
61
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
8.5
407
3058
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
8.5
72
337
C02KX01
ATC
bosentan; oral
27.5
8.5
11
*
FPD10
NOMESCO Finland
Surgical ablation of atrial fibrillation
27.5
8.5
11
*
AB2
HP
AVR bio, stent
20.0
8.4
12
6
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
8.4
1036
11337
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.5
8.3
49
195
1EA01, ,
NOMESCO Finland
+∞
8.3
8
*
I37.2
ICD-10 Finland
Pulmonary valve stenosis with insufficiency
+∞
8.3
8
*
Q25.48
ICD-10 Finland
Other congenital malformations of the aorta
+∞
8.3
8
*
7456C
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[ASD CANALIS ATRIOVENTRICULARIS COMMUNIS]
+∞
8.3
8
*
FGD00
NOMESCO Finland
Repair of tricuspid valve using suture
+∞
8.3
8
*
Q20.8
ICD-10 Finland
Other congenital malformations of cardiac chambers and connections
+∞
8.3
8
*
FLE96
NOMESCO Finland
Other repair of outlet obstruction of left ventricle
+∞
8.3
8
*
FFF96
NOMESCO Finland
Other operation for partially anomalous pulmonary veins
+∞
8.3
8
*
Q21.80
ICD-10 Finland
Communication from left ventricle to right atrium
+∞
8.3
8
*
GD1LA
NOMESCO Finland
GD
3.8
8.3
25
67
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
14.5
8.2
13
9
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
3.5
8.2
27
77
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.9
8.1
38
134
AP1
HP
Catheterization of the left side of the heart
3.9
8.1
23
59
FFW96
NOMESCO Finland
Other operation on atria
33.3
8.1
10
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
8.1
113
633
Z2446
NOMESCO Finland
Social worker
1.7
8.1
153
936
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
4.7
8.0
18
38
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
4.7
8.0
18
38
C09AA02
ATC
enalapril; systemic
1.6
8.0
185
1189
127
Kela drug reimbursment
Transplant complication
2.8
8.0
38
135
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
6.8
8.0
19
28
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
8.0
267
1867
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
10.0
8.0
15
15
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.1
7.9
32
104
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
7.9
65
301
FKC60
NOMESCO Finland
Resection and reconstruction of leaflet of mitral valve for insufficiency
13.0
7.8
13
10
RS221, ,
NOMESCO Finland
2.8
7.8
37
132
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.4
7.8
51
214
RK260, ,
NOMESCO Finland
10.8
7.8
14
13
3810A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media
10.8
7.8
14
13
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
7.7
64
298
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
7.7
164
1035
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.9
7.6
22
57
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
7.6
88
463
B01AF01
ATC
rivaroxaban; oral
1.7
7.6
132
788
FN1AD
NOMESCO Finland
CT of coronary arteries
3.2
7.6
29
91
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
7.6
220
1492
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
8.0
7.6
16
20
742, ,
NOMESCO Finland
25.0
7.5
10
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
25.0
7.5
10
*
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
10.0
7.5
14
14
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.4
7.5
52
224
FFC40
NOMESCO Finland
Closure of Patent Foramen Ovale
79.9
7.4
8
*
90492, ,
NOMESCO Finland
79.9
7.4
8
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
6.0
7.3
19
32
WX870
NOMESCO Finland
Other postsurgical intensive care
8.3
7.3
15
18
74719
ICD-8 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta
+∞
7.3
7
*
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
+∞
7.3
7
*
FJE42
NOMESCO Finland
Percutaneous transluminal expansion of pulmonary valve
+∞
7.3
7
*
Q21
ICD-10 Finland
Congenital malformations of cardiac septa
+∞
7.3
7
*
FFF20
NOMESCO Finland
Anastomosis to left atrium from partially anomalous pulmonary veins
+∞
7.3
7
*
FK1AC
NOMESCO Finland
Right cardioangiography
+∞
7.3
7
*
74689
ICD-8 Finland
Congenital anomalies of heart, Aliae definitae
+∞
7.3
7
*
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
7.3
7
*
Q21.31
ICD-10 Finland
Tetralogy of Fallot and double outlet right ventricle
+∞
7.3
7
*
Q20.60
ICD-10 Finland
Left isomerism of atrial appendages
+∞
7.3
7
*
FHB00
NOMESCO Finland
Transatrial suture of VSD
+∞
7.3
7
*
1CX08, ,
NOMESCO Finland
10.8
7.3
13
12
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.5
7.3
44
178
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
7.2
215
1465
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
7.2
99
552
3AC01, ,
NOMESCO Finland
4.3
7.1
18
42
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
4.3
7.1
18
42
ZX120
NOMESCO Finland
Intravenous
1.7
7.1
122
725
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.4
7.1
48
204
7470A
ICD-9 Finland
Other congenital anomalies of circulatory system, Patent ductus arteriosus
30.0
7.1
9
*
C10AA01
ATC
simvastatin; oral
1.4
7.1
371
2820
ZX108
NOMESCO Finland
Inhalation
3.9
7.1
20
51
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
6.6
7.1
17
26
I50
ICD-10 Finland
Heart failure
2.8
7.0
33
117
R47.0
ICD-10 Finland
Dysphasia and aphasia
5.6
7.0
19
34
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.5
7.0
41
163
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.7
6.9
36
135
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.2
6.9
26
81
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
6.8
123
744
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
40.0
6.7
8
*
I36.0
ICD-10 Finland
Nonrheumatic tricuspid (valve) stenosis
40.0
6.7
8
*
Z95.9
ICD-10 Finland
Presence of cardiac and vascular implant and graft, unspecified
16.7
6.7
10
6
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.6
6.7
38
149
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
6.7
337
2542
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
6.7
293
2158
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
6.6
58
276
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.6
477
3815
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
3.7
6.6
20
54
K91
ICPC
Cerebrovascular disease
4.0
6.6
18
45
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
6.5
90
502
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.9
6.5
84
459
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.9
6.5
78
416
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
6.5
525
4267
P07.3
ICD-10 Finland
Other preterm infants
2.7
6.4
33
123
R07.2
ICD-10 Finland
Precordial pain
3.0
6.4
27
90
FGE10
NOMESCO Finland
Replacement of tricuspid valve using biological prosthesis
69.7
6.4
7
*
FXA13
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion
69.7
6.4
7
*
Q90.1
ICD-10 Finland
Trisomy 21, mosaicism (mitotic nondisjunction)
69.7
6.4
7
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.9
6.4
79
426
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
14.3
6.4
10
7
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
14.3
6.4
10
7
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
3.3
6.3
23
70
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
3.3
6.3
23
70
A02BC02
ATC
pantoprazole; systemic
1.3
6.3
805
6969
C08DA01
ATC
verapamil; systemic
2.2
6.3
51
235
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.2
6.3
18
35
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
18.0
6.2
9
5
Q21.81
ICD-10 Finland
Eisenmenger's syndrome
+∞
6.2
6
*
7456B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[DEFECTUS SEPTI ATRIORUM, OSTII PRIMII]
+∞
6.2
6
*
FHE30
NOMESCO Finland
Repair of tetralogy of Fallot with transannular patch
+∞
6.2
6
*
FMC96
NOMESCO Finland
Other operation on aortic valve for insufficiency
+∞
6.2
6
*
ZF61V, ,
NOMESCO Finland
+∞
6.2
6
*
Q25.21
ICD-10 Finland
Interrupted aortic arch
+∞
6.2
6
*
3AE00, ,
NOMESCO Finland
+∞
6.2
6
*
Q21.15
ICD-10 Finland
Common atrium
+∞
6.2
6
*
Q21.88
ICD-10 Finland
Other congenital malformations of cardiac septa
+∞
6.2
6
*
0034, ,
NOMESCO Finland
+∞
6.2
6
*
Q89.30
ICD-10 Finland
Situs inversus with dextrocardia
+∞
6.2
6
*
Q21.8
ICD-10 Finland
Other congenital malformations of cardiac septa
+∞
6.2
6
*
FDE32
NOMESCO Finland
Percutaneous transluminal closure of patent ductus arteriosus
+∞
6.2
6
*
K73
ICPC
Congenital anomaly cardiovascular
+∞
6.2
6
*
M41.9
ICD-10 Finland
Scoliosis, unspecified
3.3
6.2
23
71
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
6.1
544
4473
A12BA01
ATC
potassium chloride; oral
2.4
6.1
40
168
J96.1
ICD-10 Finland
Chronic respiratory failure
3.1
6.1
24
77
R00.2
ICD-10 Finland
Palpitations
1.7
6.1
111
672
D68.8
ICD-10 Finland
Other specified coagulation defects
3.5
6.1
20
57
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
2.8
6.1
29
104
P85
ICPC
Mental retardation
3.2
6.1
23
72
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.2
6.1
23
72
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
6.1
117
719
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
12.5
6.1
10
8
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
6.0
18
48
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
8.6
6.0
12
14
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
10.0
6.0
11
11
FPJ04
NOMESCO Finland
Revision of pacemaker generator with atrial and ventricular electrodes
10.0
6.0
11
11

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Cerebral infarction, unspecified
I63.9 [45596216]
1.6e+00
4.1e+00
4.4e+00
—
3.7e+00
3.1e+00
1.9e+00
cases:3.02%
controls:0.63%
cases:12.00%
controls:0.23%
cases:3.23%
controls:0.04%
—
—
cases:2.59%
controls:0.07%
cases:5.80%
controls:0.29%
cases:5.96%
controls:0.97%
36
75
1157
11751
145
27
1063
11919
39
5
1169
11941
—
31
8
1168
11924
69
34
1121
11758
67
107
1057
10927
Standard cardiac ultrasound examination
FM1AE [2001303278]
1.6e+00
2.9e+00
3.2e+00
1.0e+50
3.6e+00
3.6e+00
2.4e+00
cases:8.97%
controls:2.00%
cases:15.23%
controls:0.98%
cases:2.65%
controls:0.11%
cases:18.63%
controls:0.00%
cases:3.59%
controls:0.10%
cases:22.02%
controls:0.78%
cases:20.46%
controls:2.18%
107
237
1086
11589
184
117
1024
11829
32
13
1176
11933
225
0
983
11946
43
12
1156
11920
262
92
928
11700
230
240
894
10794
Cardiology
6 [38004451]
1.2e+00
2.7e+00
3.1e+00
—
3.5e+00
3.6e+00
2.5e+00
cases:19.36%
controls:6.66%
cases:32.53%
controls:3.08%
cases:9.02%
controls:0.46%
—
—
cases:13.68%
controls:0.46%
cases:54.29%
controls:3.03%
cases:52.58%
controls:8.28%
231
788
962
11038
393
368
815
11578
109
55
1099
11891
—
164
55
1035
11877
646
357
544
11435
591
914
533
10120
Sequelae of cerebral infarction
I69.3 [45533476]
1.4e+00
2.8e+00
3.0e+00
1.0e+50
3.3e+00
3.2e+00
2.6e+00
cases:2.01%
controls:0.48%
cases:4.47%
controls:0.29%
cases:1.49%
controls:0.08%
cases:3.23%
controls:0.00%
cases:1.92%
controls:0.08%
cases:6.81%
controls:0.31%
cases:10.32%
controls:0.87%
24
57
1169
11769
54
35
1154
11911
18
9
1190
11937
39
0
1169
11946
23
9
1176
11923
81
36
1109
11756
116
96
1008
10938
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
2.4e+00
4.5e+00
—
1.0e+50
1.0e+50
5.1e+00
3.1e+00
cases:3.94%
controls:0.39%
cases:14.82%
controls:0.18%
—
—
cases:17.05%
controls:0.00%
cases:2.50%
controls:0.00%
cases:13.45%
controls:0.09%
cases:7.21%
controls:0.35%
47
46
1146
11780
179
22
1029
11924
—
206
0
1002
11946
30
0
1169
11932
160
11
1030
11781
81
39
1043
10995
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
5.1e-01
1.9e+00
3.8e+00
1.0e+50
4.1e+00
3.5e+00
1.7e+00
cases:1.34%
controls:0.81%
cases:2.57%
controls:0.39%
cases:3.48%
controls:0.08%
cases:7.45%
controls:0.00%
cases:2.42%
controls:0.04%
cases:7.90%
controls:0.25%
cases:3.74%
controls:0.73%
16
96
1177
11730
31
46
1177
11900
42
10
1166
11936
90
0
1118
11946
29
5
1170
11927
94
29
1096
11763
42
81
1082
10953
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
1.2e+00
2.4e+00
2.8e+00
—
3.2e+00
2.8e+00
2.0e+00
cases:6.96%
controls:2.27%
cases:10.60%
controls:1.05%
cases:1.99%
controls:0.12%
—
—
cases:2.09%
controls:0.08%
cases:14.79%
controls:1.02%
cases:22.24%
controls:3.56%
83
269
1110
11557
128
125
1080
11821
24
14
1184
11932
—
25
10
1174
11922
176
120
1014
11672
250
393
874
10641
INR in Blood by Coagulation assay
34714-6 [3032080]
6.3e-01
1.7e+00
2.7e+00
4.0e+00
2.5e+00
1.9e+00
1.0e+00
cases:9.47%
controls:5.29%
cases:16.72%
controls:3.54%
cases:15.23%
controls:1.25%
cases:4.30%
controls:0.08%
cases:11.59%
controls:1.11%
cases:20.67%
controls:3.67%
cases:23.75%
controls:9.98%
113
626
1080
11200
202
423
1006
11523
184
149
1024
11797
52
10
1156
11936
139
132
1060
11800
246
433
944
11359
267
1101
857
9933
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
2.2e+00
4.6e+00
—
1.0e+50
—
4.3e+00
2.9e+00
cases:0.92%
controls:0.10%
cases:6.95%
controls:0.08%
—
—
cases:2.57%
controls:0.00%
—
—
cases:4.29%
controls:0.06%
cases:3.47%
controls:0.19%
11
12
1182
11814
84
9
1124
11937
—
31
0
1177
11946
—
51
7
1139
11785
39
21
1085
11013
Internal Medicine
11 [38004456]
4.8e-01
1.4e+00
1.7e+00
5.9e+00
2.2e+00
1.4e+00
8.7e-01
cases:25.90%
controls:17.83%
cases:23.76%
controls:7.16%
cases:6.71%
controls:1.24%
cases:20.03%
controls:0.07%
cases:10.01%
controls:1.24%
cases:23.87%
controls:7.00%
cases:32.30%
controls:16.62%
309
2108
884
9718
287
855
921
11091
81
148
1127
11798
242
8
966
11938
120
148
1079
11784
284
826
906
10966
363
1834
761
9200
warfarin; oral, parenteral
B01AA03 [21600965]
1.6e+00
2.2e+00
2.1e+00
—
3.0e+00
2.6e+00
2.0e+00
cases:13.50%
controls:2.99%
cases:19.12%
controls:2.49%
cases:5.30%
controls:0.66%
—
—
cases:10.51%
controls:0.56%
cases:24.37%
controls:2.42%
cases:20.73%
controls:3.27%
161
354
1032
11472
231
298
977
11648
64
79
1144
11867
—
126
67
1073
11865
290
285
900
11507
233
361
891
10673
Atrial fibrillation and flutter
I48 [45596206]
1.6e+00
2.1e+00
2.5e+00
—
3.1e+00
2.3e+00
1.8e+00
cases:12.41%
controls:2.85%
cases:13.49%
controls:1.80%
cases:4.47%
controls:0.37%
—
—
cases:7.09%
controls:0.34%
cases:15.21%
controls:1.70%
cases:18.42%
controls:3.72%
148
337
1045
11489
163
215
1045
11731
54
44
1154
11902
—
85
40
1114
11892
181
200
1009
11592
207
410
917
10624
Inpatient Hospital
21 [8717]
2.2e-01
1.3e+00
1.4e+00
6.4e+00
2.0e+00
1.3e+00
6.0e-01
cases:34.62%
controls:29.87%
cases:28.73%
controls:10.20%
cases:5.55%
controls:1.36%
cases:25.99%
controls:0.06%
cases:9.67%
controls:1.50%
cases:26.39%
controls:8.97%
cases:33.19%
controls:21.47%
413
3533
780
8293
347
1219
861
10727
67
163
1141
11783
314
7
894
11939
116
179
1083
11753
314
1058
876
10734
373
2369
751
8665
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
9.2e-01
3.2e+00
2.6e+00
1.0e+50
3.4e+00
2.1e+00
1.5e+00
cases:1.34%
controls:0.54%
cases:8.36%
controls:0.38%
cases:0.66%
controls:0.05%
cases:0.58%
controls:0.00%
cases:2.00%
controls:0.07%
cases:2.10%
controls:0.25%
cases:3.02%
controls:0.67%
16
64
1177
11762
101
45
1107
11901
8
6
1200
11940
7
0
1201
11946
24
8
1175
11924
25
30
1165
11762
34
74
1090
10960
12 lead EKG panel
34534-8 [3044889]
2.9e-01
1.3e+00
2.9e+00
3.4e+00
2.8e+00
1.4e+00
7.6e-01
cases:14.42%
controls:11.20%
cases:18.71%
controls:6.12%
cases:13.82%
controls:0.88%
cases:2.24%
controls:0.08%
cases:10.76%
controls:0.75%
cases:21.68%
controls:6.25%
cases:33.36%
controls:18.97%
172
1325
1021
10501
226
731
982
11215
167
105
1041
11841
27
9
1181
11937
129
90
1070
11842
258
737
932
11055
375
2093
749
8941
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-4.5e-01
7.7e-01
2.6e+00
4.5e+00
3.0e+00
2.8e+00
cases:9.56%
controls:24.78%
cases:6.71%
controls:10.11%
cases:2.65%
controls:1.25%
cases:0.58%
controls:0.04%
cases:3.67%
controls:0.04%
cases:10.25%
controls:0.56%
cases:15.30%
controls:1.06%
114
2931
1079
8895
81
1208
1127
10738
32
149
1176
11797
7
5
1201
11941
44
5
1155
11927
122
66
1068
11726
172
117
952
10917
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
4.6e-01
2.5e+00
3.1e+00
1.0e+50
3.0e+00
2.1e+00
1.0e+00
cases:2.60%
controls:1.65%
cases:10.68%
controls:0.93%
cases:3.31%
controls:0.15%
cases:2.73%
controls:0.00%
cases:2.42%
controls:0.12%
cases:5.88%
controls:0.75%
cases:7.30%
controls:2.76%
31
195
1162
11631
129
111
1079
11835
40
18
1168
11928
33
0
1175
11946
29
14
1170
11918
70
89
1120
11703
82
304
1042
10730
Angiography of heart and/or coronary arteries
FN1AC [2001302996]
5.1e-01
2.2e+00
3.6e+00
—
2.7e+00
2.5e+00
7.9e-01
cases:3.60%
controls:2.20%
cases:5.63%
controls:0.65%
cases:1.49%
controls:0.04%
—
—
cases:0.75%
controls:0.05%
cases:6.05%
controls:0.53%
cases:4.80%
controls:2.25%
43
260
1150
11566
68
78
1140
11868
18
5
1190
11941
—
9
6
1190
11926
72
62
1118
11730
54
248
1070
10786
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
1.0e+00
2.0e+00
3.3e+00
1.0e+50
2.5e+00
1.7e+00
1.2e+00
cases:6.20%
controls:2.30%
cases:9.19%
controls:1.39%
cases:4.64%
controls:0.18%
cases:1.32%
controls:0.00%
cases:2.75%
controls:0.23%
cases:8.49%
controls:1.70%
cases:16.99%
controls:5.72%
74
272
1119
11554
111
166
1097
11780
56
22
1152
11924
16
0
1192
11946
33
28
1166
11904
101
200
1089
11592
191
631
933
10403
digoxin; oral, parenteral
C01AA05 [21600234]
1.7e+00
2.0e+00
1.7e+00
—
2.2e+00
2.1e+00
1.9e+00
cases:3.86%
controls:0.70%
cases:4.47%
controls:0.60%
cases:0.91%
controls:0.17%
—
—
cases:1.08%
controls:0.13%
cases:5.04%
controls:0.62%
cases:5.78%
controls:0.94%
46
83
1147
11743
54
72
1154
11874
11
20
1197
11926
—
13
15
1186
11917
60
73
1130
11719
65
104
1059
10930
Thorax X-ray examination
GD1AA [2001303617]
6.5e-01
1.8e+00
2.6e+00
—
3.1e+00
2.4e+00
1.2e+00
cases:11.15%
controls:6.12%
cases:12.75%
controls:2.47%
cases:4.06%
controls:0.32%
—
—
cases:5.42%
controls:0.25%
cases:19.24%
controls:2.16%
cases:20.37%
controls:7.46%
133
724
1060
11102
154
295
1054
11651
49
38
1159
11908
—
65
30
1134
11902
229
255
961
11537
229
823
895
10211
Mitral (valve) prolapse
I34.1 [45552788]
2.5e+00
3.2e+00
—
1.0e+50
—
3.4e+00
2.5e+00
cases:2.43%
controls:0.20%
cases:2.57%
controls:0.11%
—
—
cases:2.57%
controls:0.00%
—
—
cases:2.69%
controls:0.09%
cases:3.20%
controls:0.26%
29
24
1164
11802
31
13
1177
11933
—
31
0
1177
11946
—
32
11
1158
11781
36
29
1088
11005
Emergency Room Visit
ER [9203]
3.8e-01
1.5e+00
1.6e+00
4.7e+00
1.4e+00
9.3e-01
5.4e-01
cases:41.49%
controls:32.65%
cases:36.34%
controls:11.48%
cases:7.04%
controls:1.44%
cases:4.47%
controls:0.04%
cases:5.84%
controls:1.49%
cases:22.52%
controls:10.24%
cases:38.61%
controls:26.81%
495
3861
698
7965
439
1371
769
10575
85
172
1123
11774
54
5
1154
11941
70
178
1129
11754
268
1208
922
10584
434
2958
690
8076
clopidogrel; oral
B01AC04 [21600989]
5.5e-01
2.2e+00
2.2e+00
—
2.8e+00
2.4e+00
1.5e+00
cases:2.60%
controls:1.51%
cases:7.12%
controls:0.88%
cases:2.07%
controls:0.23%
—
—
cases:4.09%
controls:0.27%
cases:10.25%
controls:1.03%
cases:9.25%
controls:2.13%
31
179
1162
11647
86
105
1122
11841
25
28
1183
11918
—
49
32
1150
11900
122
122
1068
11670
104
235
1020
10799
Heart failure, unspecified
I50.9 [45576879]
1.3e+00
2.1e+00
2.2e+00
—
1.9e+00
2.1e+00
1.4e+00
cases:2.85%
controls:0.82%
cases:3.48%
controls:0.44%
cases:0.99%
controls:0.11%
—
—
cases:0.83%
controls:0.13%
cases:3.45%
controls:0.43%
cases:5.60%
controls:1.38%
34
97
1159
11729
42
52
1166
11894
12
13
1196
11933
—
10
15
1189
11917
41
51
1149
11741
63
152
1061
10882
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
FXA00 [2001303347]
1.5e+00
2.1e+00
—
1.0e+50
1.0e+50
4.7e+00
2.7e+00
cases:0.92%
controls:0.20%
cases:0.91%
controls:0.11%
—
—
cases:4.72%
controls:0.00%
cases:0.92%
controls:0.00%
cases:5.13%
controls:0.05%
cases:2.67%
controls:0.18%
11
24
1182
11802
11
13
1197
11933
—
57
0
1151
11946
11
0
1188
11932
61
6
1129
11786
30
20
1094
11014
Outpatient Visit
OP [9202]
3.4e-01
8.4e-01
9.0e-01
5.2e+00
1.1e+00
1.5e+00
1.1e+00
cases:72.76%
controls:65.53%
cases:65.40%
controls:45.02%
cases:22.10%
controls:10.39%
cases:51.82%
controls:0.59%
cases:26.61%
controls:10.75%
cases:78.74%
controls:44.88%
cases:91.01%
controls:76.29%
868
7750
325
4076
790
5378
418
6568
267
1241
941
10705
626
71
582
11875
319
1283
880
10649
937
5292
253
6500
1023
8418
101
2616
ECG with 12 standard connections
XF400 [2001303368]
1.2e+00
2.4e+00
2.4e+00
1.0e+50
—
2.9e+00
1.9e+00
cases:5.53%
controls:1.69%
cases:6.87%
controls:0.69%
cases:0.99%
controls:0.09%
cases:2.48%
controls:0.00%
—
—
cases:5.97%
controls:0.35%
cases:7.74%
controls:1.26%
66
200
1127
11626
83
82
1125
11864
12
11
1196
11935
30
0
1178
11946
—
71
41
1119
11751
87
139
1037
10895
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-4.2e-02
1.3e+00
1.8e+00
4.3e+00
1.8e+00
1.2e+00
4.1e-01
cases:7.38%
controls:7.67%
cases:16.23%
controls:4.97%
cases:4.47%
controls:0.80%
cases:4.06%
controls:0.06%
cases:4.34%
controls:0.75%
cases:13.03%
controls:4.46%
cases:20.20%
controls:14.40%
88
907
1105
10919
196
594
1012
11352
54
95
1154
11851
49
7
1159
11939
52
89
1147
11843
155
526
1035
11266
227
1589
897
9445
Psychologist
Z2445 [2001311558]
-9.5e-02
2.1e+00
2.5e+00
—
2.3e+00
2.1e+00
1.6e+00
cases:0.75%
controls:0.83%
cases:2.48%
controls:0.31%
cases:0.75%
controls:0.06%
—
—
cases:0.58%
controls:0.06%
cases:1.34%
controls:0.17%
cases:1.07%
controls:0.23%
9
98
1184
11728
30
37
1178
11909
9
7
1199
11939
—
7
7
1192
11925
16
20
1174
11772
12
25
1112
11009
Aortic (valve) stenosis
I35.0 [45576869]
1.0e+00
1.8e+00
2.8e+00
—
2.7e+00
1.8e+00
1.1e+00
cases:1.09%
controls:0.39%
cases:1.57%
controls:0.25%
cases:0.83%
controls:0.05%
—
—
cases:1.00%
controls:0.07%
cases:1.76%
controls:0.29%
cases:1.60%
controls:0.53%
13
46
1180
11780
19
30
1189
11916
10
6
1198
11940
—
12
8
1187
11924
21
34
1169
11758
18
58
1106
10976
Pediatric Cardiology
OMOP4821938 [45756805]
1.9e+00
1.6e+00
—
1.0e+50
—
3.9e+00
2.7e+00
cases:2.77%
controls:0.41%
cases:1.57%
controls:0.31%
—
—
cases:3.97%
controls:0.00%
—
—
cases:5.38%
controls:0.12%
cases:6.67%
controls:0.46%
33
48
1160
11778
19
37
1189
11909
—
48
0
1160
11946
—
64
14
1126
11778
75
51
1049
10983
Thrombin time
3243-3 [3036489]
7.2e-01
3.2e+00
2.6e+00
1.0e+50
3.1e+00
1.1e+00
1.3e+00
cases:1.17%
controls:0.58%
cases:8.69%
controls:0.39%
cases:0.66%
controls:0.05%
cases:0.66%
controls:0.00%
cases:1.67%
controls:0.08%
cases:1.01%
controls:0.32%
cases:2.67%
controls:0.77%
14
68
1179
11758
105
46
1103
11900
8
6
1200
11940
8
0
1200
11946
20
9
1179
11923
12
38
1178
11754
30
85
1094
10949
Congestive heart failure
I50.0 [45567179]
1.6e+00
2.3e+00
2.6e+00
1.0e+50
—
2.2e+00
1.4e+00
cases:1.51%
controls:0.31%
cases:1.57%
controls:0.16%
cases:0.58%
controls:0.04%
cases:0.83%
controls:0.00%
—
—
cases:1.51%
controls:0.17%
cases:2.22%
controls:0.57%
18
37
1175
11789
19
19
1189
11927
7
5
1201
11941
10
0
1198
11946
—
18
20
1172
11772
25
63
1099
10971
Neurology
13 [38004458]
3.9e-01
2.1e+00
2.5e+00
—
2.3e+00
1.7e+00
9.2e-01
cases:10.90%
controls:7.65%
cases:22.35%
controls:3.46%
cases:7.04%
controls:0.60%
—
—
cases:6.17%
controls:0.65%
cases:16.47%
controls:3.41%
cases:18.86%
controls:8.46%
130
905
1063
10921
270
413
938
11533
85
72
1123
11874
—
74
77
1125
11855
196
402
994
11390
212
933
912
10101
Dyspnoea
R06.0 [45558449]
8.8e-01
1.7e+00
2.5e+00
1.0e+50
2.5e+00
1.6e+00
6.7e-01
cases:5.45%
controls:2.34%
cases:4.06%
controls:0.80%
cases:0.83%
controls:0.07%
cases:0.99%
controls:0.00%
cases:1.08%
controls:0.09%
cases:3.87%
controls:0.79%
cases:6.58%
controls:3.48%
65
277
1128
11549
49
95
1159
11851
10
8
1198
11938
12
0
1196
11946
13
11
1186
11921
46
93
1144
11699
74
384
1050
10650
Ambulatory ECG
XF404 [2001303370]
1.7e+00
3.3e+00
—
1.0e+50
—
2.7e+00
2.1e+00
cases:4.19%
controls:0.79%
cases:4.72%
controls:0.18%
—
—
cases:1.41%
controls:0.00%
—
—
cases:3.53%
controls:0.25%
cases:5.96%
controls:0.77%
50
93
1143
11733
57
22
1151
11924
—
17
0
1191
11946
—
42
30
1148
11762
67
85
1057
10949
sotalol; oral, parenteral
C07AA07 [21601672]
1.8e+00
1.5e+00
—
—
2.5e+00
1.9e+00
2.0e+00
cases:1.26%
controls:0.22%
cases:0.75%
controls:0.16%
—
—
—
—
cases:0.58%
controls:0.05%
cases:1.18%
controls:0.18%
cases:1.78%
controls:0.24%
15
26
1178
11800
9
19
1199
11927
—
—
7
6
1192
11926
14
21
1176
11771
20
26
1104
11008
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
8.2e-01
2.1e+00
1.5e+00
—
3.2e+00
2.1e+00
1.5e+00
cases:2.26%
controls:1.01%
cases:4.39%
controls:0.57%
cases:0.41%
controls:0.09%
—
—
cases:1.17%
controls:0.05%
cases:3.03%
controls:0.37%
cases:4.63%
controls:1.10%
27
119
1166
11707
53
68
1155
11878
5
11
1203
11935
—
14
6
1185
11926
36
44
1154
11748
52
121
1072
10913
Medical doctor
Z2221 [2001311556]
5.9e-01
1.5e+00
1.8e+00
1.0e+50
2.2e+00
2.0e+00
1.5e+00
cases:8.97%
controls:5.19%
cases:7.04%
controls:1.70%
cases:1.66%
controls:0.28%
cases:8.61%
controls:0.00%
cases:2.42%
controls:0.28%
cases:8.49%
controls:1.26%
cases:10.41%
controls:2.41%
107
614
1086
11212
85
203
1123
11743
20
34
1188
11912
104
0
1104
11946
29
33
1170
11899
101
149
1089
11643
117
266
1007
10768
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
9.9e-01
2.0e+00
2.1e+00
—
1.6e+00
1.6e+00
1.3e+00
cases:1.93%
controls:0.73%
cases:4.72%
controls:0.64%
cases:1.74%
controls:0.23%
—
—
cases:1.25%
controls:0.26%
cases:3.36%
controls:0.71%
cases:3.56%
controls:0.99%
23
86
1170
11740
57
76
1151
11870
21
27
1187
11919
—
15
31
1184
11901
40
84
1150
11708
40
109
1084
10925
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
9.9e-01
2.0e+00
2.1e+00
—
1.6e+00
1.6e+00
1.3e+00
cases:1.93%
controls:0.73%
cases:4.72%
controls:0.64%
cases:1.74%
controls:0.23%
—
—
cases:1.25%
controls:0.26%
cases:3.36%
controls:0.71%
cases:3.56%
controls:0.99%
23
86
1170
11740
57
76
1151
11870
21
27
1187
11919
—
15
31
1184
11901
40
84
1150
11708
40
109
1084
10925
Chronic arrhythmias
207 [2001600205]
1.8e+00
2.3e+00
2.5e+00
—
—
1.9e+00
1.1e+00
cases:3.52%
controls:0.61%
cases:2.73%
controls:0.27%
cases:0.58%
controls:0.05%
—
—
—
—
cases:2.02%
controls:0.31%
cases:3.02%
controls:1.04%
42
72
1151
11754
33
32
1175
11914
7
6
1201
11940
—
—
24
37
1166
11755
34
115
1090
10919
Cardiodefibrillation
TFP20 [2001303224]
2.1e+00
2.6e+00
—
1.0e+50
—
2.9e+00
1.8e+00
cases:3.69%
controls:0.47%
cases:2.65%
controls:0.19%
—
—
cases:1.08%
controls:0.00%
—
—
cases:2.86%
controls:0.16%
cases:3.29%
controls:0.54%
44
55
1149
11771
32
23
1176
11923
—
13
0
1195
11946
—
34
19
1156
11773
37
60
1087
10974
spironolactone; oral
C03DA01 [21601534]
1.2e+00
1.4e+00
1.6e+00
—
2.0e+00
1.7e+00
1.5e+00
cases:3.60%
controls:1.07%
cases:3.56%
controls:0.90%
cases:1.32%
controls:0.27%
—
—
cases:1.67%
controls:0.23%
cases:5.29%
controls:1.02%
cases:7.03%
controls:1.65%
43
126
1150
11700
43
107
1165
11839
16
32
1192
11914
—
20
28
1179
11904
63
120
1127
11672
79
182
1045
10852
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
-9.6e-02
5.9e-01
3.9e+00
—
2.6e+00
1.9e+00
8.9e-01
cases:2.18%
controls:2.39%
cases:2.48%
controls:1.39%
cases:9.02%
controls:0.21%
—
—
cases:2.50%
controls:0.18%
cases:8.15%
controls:1.30%
cases:9.61%
controls:4.19%
26
283
1167
11543
30
166
1178
11780
109
25
1099
11921
—
30
22
1169
11910
97
153
1093
11639
108
462
1016
10572
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
2.7e-01
1.7e+00
1.7e+00
—
3.2e+00
1.7e+00
9.1e-01
cases:2.35%
controls:1.80%
cases:6.29%
controls:1.21%
cases:0.99%
controls:0.18%
—
—
cases:4.25%
controls:0.18%
cases:5.88%
controls:1.09%
cases:8.99%
controls:3.81%
28
213
1165
11613
76
144
1132
11802
12
22
1196
11924
—
51
22
1148
11910
70
129
1120
11663
101
420
1023
10614
rivaroxaban; oral
B01AF01 [43534761]
8.3e-01
1.6e+00
2.0e+00
—
2.4e+00
1.4e+00
1.1e+00
cases:2.60%
controls:1.15%
cases:3.23%
controls:0.69%
cases:1.41%
controls:0.20%
—
—
cases:1.50%
controls:0.14%
cases:3.28%
controls:0.83%
cases:5.07%
controls:1.77%
31
136
1162
11690
39
82
1169
11864
17
24
1191
11922
—
18
17
1181
11915
39
98
1151
11694
57
195
1067
10839
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.3e-01
7.4e-01
2.0e+00
3.2e+00
1.9e+00
8.0e-01
4.4e-01
cases:24.39%
controls:22.04%
cases:30.96%
controls:17.56%
cases:20.61%
controls:3.34%
cases:7.62%
controls:0.33%
cases:18.85%
controls:3.34%
cases:32.61%
controls:17.89%
cases:49.11%
controls:38.35%
291
2606
902
9220
374
2098
834
9848
249
399
959
11547
92
39
1116
11907
226
399
973
11533
388
2110
802
9682
552
4232
572
6802
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
5.5e-02
9.6e-01
2.2e+00
3.4e+00
1.7e+00
5.9e-01
3.5e-01
cases:13.41%
controls:12.79%
cases:17.38%
controls:7.46%
cases:9.27%
controls:1.16%
cases:1.24%
controls:0.04%
cases:4.84%
controls:0.96%
cases:12.69%
controls:7.46%
cases:27.31%
controls:20.87%
160
1512
1033
10314
210
891
998
11055
112
138
1096
11808
15
5
1193
11941
58
115
1141
11817
151
880
1039
10912
307
2303
817
8731
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.2e-01
7.2e-01
2.0e+00
3.2e+00
1.9e+00
8.0e-01
4.2e-01
cases:24.39%
controls:22.24%
cases:30.79%
controls:17.77%
cases:20.70%
controls:3.36%
cases:7.28%
controls:0.33%
cases:19.10%
controls:3.40%
cases:33.03%
controls:18.08%
cases:49.02%
controls:38.65%
291
2630
902
9196
372
2123
836
9823
250
401
958
11545
88
39
1120
11907
229
406
970
11526
393
2132
797
9660
551
4265
573
6769
apixaban; oral
B01AF02 [43534762]
1.2e+00
1.6e+00
1.9e+00
—
1.8e+00
1.5e+00
1.0e+00
cases:1.68%
controls:0.51%
cases:3.39%
controls:0.70%
cases:2.48%
controls:0.38%
—
—
cases:2.42%
controls:0.42%
cases:4.12%
controls:0.92%
cases:4.80%
controls:1.79%
20
60
1173
11766
41
84
1167
11862
30
45
1178
11901
—
29
50
1170
11882
49
109
1141
11683
54
198
1070
10836
bisoprolol; oral
C07AB07 [21601689]
7.6e-01
1.1e+00
1.1e+00
2.5e+00
1.4e+00
1.3e+00
1.0e+00
cases:20.87%
controls:11.00%
cases:23.59%
controls:9.62%
cases:7.78%
controls:2.78%
cases:1.32%
controls:0.11%
cases:9.92%
controls:2.77%
cases:28.91%
controls:10.37%
cases:31.32%
controls:14.41%
249
1301
944
10525
285
1149
923
10797
94
332
1114
11614
16
13
1192
11933
119
331
1080
11601
344
1223
846
10569
352
1590
772
9444
Paroxysmal atrial fibrillation
I48.0 [45581776]
2.5e+00
2.4e+00
—
1.0e+50
—
2.6e+00
1.5e+00
cases:1.09%
controls:0.09%
cases:1.16%
controls:0.11%
—
—
cases:1.08%
controls:0.00%
—
—
cases:2.61%
controls:0.20%
cases:3.83%
controls:0.92%
13
11
1180
11815
14
13
1194
11933
—
13
0
1195
11946
—
31
24
1159
11768
43
102
1081
10932
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
2.5e-01
1.8e+00
2.3e+00
—
2.4e+00
1.5e+00
8.5e-01
cases:4.69%
controls:3.70%
cases:12.83%
controls:2.27%
cases:3.81%
controls:0.39%
—
—
cases:3.42%
controls:0.32%
cases:7.73%
controls:1.91%
cases:11.74%
controls:5.38%
56
438
1137
11388
155
271
1053
11675
46
47
1162
11899
—
41
38
1158
11894
92
225
1098
11567
132
594
992
10440
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.3e-01
8.0e-01
1.8e+00
3.0e+00
2.0e+00
8.6e-01
3.5e-01
cases:23.97%
controls:21.67%
cases:27.90%
controls:14.77%
cases:16.72%
controls:3.07%
cases:4.97%
controls:0.27%
cases:17.26%
controls:2.88%
cases:29.58%
controls:15.04%
cases:43.77%
controls:35.34%
286
2563
907
9263
337
1764
871
10182
202
367
1006
11579
60
32
1148
11914
207
344
992
11588
352
1774
838
10018
492
3899
632
7135
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-5.6e-02
6.3e-01
3.6e+00
—
2.4e+00
1.6e+00
5.2e-01
cases:4.78%
controls:5.04%
cases:5.30%
controls:2.88%
cases:11.67%
controls:0.36%
—
—
cases:3.17%
controls:0.29%
cases:11.76%
controls:2.57%
cases:14.59%
controls:9.21%
57
596
1136
11230
64
344
1144
11602
141
43
1067
11903
—
38
35
1161
11897
140
303
1050
11489
164
1016
960
10018
Scheduled procedure
ZXD10 [2001311387]
4.6e-01
9.3e-01
1.4e+00
—
2.5e+00
2.1e+00
1.3e+00
cases:9.89%
controls:6.47%
cases:5.22%
controls:2.13%
cases:0.83%
controls:0.20%
—
—
cases:2.34%
controls:0.19%
cases:9.75%
controls:1.31%
cases:10.23%
controls:2.93%
118
765
1075
11061
63
255
1145
11691
10
24
1198
11922
—
28
23
1171
11909
116
154
1074
11638
115
323
1009
10711
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
6.6e-01
3.0e+00
—
1.0e+50
3.0e+00
1.5e+00
1.2e+00
cases:1.01%
controls:0.52%
cases:6.87%
controls:0.37%
—
—
cases:0.58%
controls:0.00%
cases:1.33%
controls:0.07%
cases:1.09%
controls:0.24%
cases:2.05%
controls:0.63%
12
62
1181
11764
83
44
1125
11902
—
7
0
1201
11946
16
8
1183
11924
13
28
1177
11764
23
69
1101
10965
Extensive angiography of hear and/or coronary arteries
FN1BC [2001303000]
1.5e+00
2.6e+00
—
1.0e+50
—
3.1e+00
1.6e+00
cases:2.10%
controls:0.47%
cases:1.08%
controls:0.08%
—
—
cases:0.91%
controls:0.00%
—
—
cases:0.92%
controls:0.04%
cases:1.42%
controls:0.30%
25
56
1168
11770
13
10
1195
11936
—
11
0
1197
11946
—
11
5
1179
11787
16
33
1108
11001
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 [45562366]
1.7e+00
3.2e+00
—
—
—
2.5e+00
1.3e+00
cases:0.75%
controls:0.14%
cases:2.15%
controls:0.09%
—
—
—
—
—
—
cases:1.26%
controls:0.10%
cases:1.25%
controls:0.33%
9
17
1184
11809
26
11
1182
11935
—
—
—
15
12
1175
11780
14
36
1110
10998
Essential (primary) hypertension
I10 [45591453]
1.4e-02
7.3e-01
8.7e-01
5.1e+00
1.3e+00
6.3e-01
2.3e-01
cases:11.40%
controls:11.26%
cases:11.01%
controls:5.63%
cases:2.32%
controls:0.99%
cases:7.45%
controls:0.05%
cases:3.42%
controls:0.91%
cases:10.42%
controls:5.81%
cases:20.46%
controls:16.90%
136
1332
1057
10494
133
673
1075
11273
28
118
1180
11828
90
6
1118
11940
41
109
1158
11823
124
685
1066
11107
230
1865
894
9169
ramipril; oral
C09AA05 [21601789]
5.9e-01
1.0e+00
1.1e+00
2.1e+00
1.5e+00
1.2e+00
9.4e-01
cases:7.46%
controls:4.27%
cases:9.27%
controls:3.46%
cases:3.06%
controls:1.00%
cases:0.50%
controls:0.06%
cases:4.42%
controls:1.06%
cases:11.43%
controls:3.61%
cases:12.46%
controls:5.25%
89
505
1104
11321
112
413
1096
11533
37
120
1171
11826
6
7
1202
11939
53
127
1146
11805
136
426
1054
11366
140
579
984
10455
Neuropsychological investigation
XA800 [2001300412]
4.0e-01
3.2e+00
3.2e+00
—
—
2.1e+00
6.0e-01
cases:0.92%
controls:0.62%
cases:6.95%
controls:0.29%
cases:0.99%
controls:0.04%
—
—
—
—
cases:1.93%
controls:0.24%
cases:1.07%
controls:0.59%
11
73
1182
11753
84
35
1124
11911
12
5
1196
11941
—
—
23
28
1167
11764
12
65
1112
10969
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
-2.2e-01
4.5e-01
3.5e+00
—
2.6e+00
1.7e+00
7.4e-01
cases:3.02%
controls:3.75%
cases:3.31%
controls:2.13%
cases:9.44%
controls:0.31%
—
—
cases:2.75%
controls:0.21%
cases:9.16%
controls:1.87%
cases:10.85%
controls:5.50%
36
443
1157
11383
40
255
1168
11691
114
37
1094
11909
—
33
25
1166
11907
109
220
1081
11572
122
607
1002
10427
CBC panel - Blood by Automated count
58410-2 [40761511]
5.8e-02
6.4e-01
1.6e+00
3.3e+00
1.9e+00
7.1e-01
3.4e-01
cases:24.48%
controls:23.42%
cases:27.81%
controls:16.92%
cases:14.07%
controls:3.11%
cases:5.79%
controls:0.23%
cases:15.93%
controls:2.87%
cases:29.75%
controls:17.21%
cases:45.82%
controls:37.51%
292
2770
901
9056
336
2021
872
9925
170
371
1038
11575
70
27
1138
11919
191
342
1008
11590
354
2029
836
9763
515
4139
609
6895
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
1.1e+00
5.0e+00
—
—
—
2.1e+00
1.3e+00
cases:0.84%
controls:0.27%
cases:7.04%
controls:0.05%
—
—
—
—
—
—
cases:0.76%
controls:0.09%
cases:1.07%
controls:0.28%
10
32
1183
11794
85
6
1123
11940
—
—
—
9
11
1181
11781
12
31
1112
11003
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.0e-01
1.6e+00
2.4e+00
—
2.2e+00
1.0e+00
5.0e-01
cases:6.37%
controls:3.97%
cases:9.85%
controls:2.07%
cases:2.90%
controls:0.26%
—
—
cases:2.59%
controls:0.29%
cases:6.22%
controls:2.28%
cases:12.72%
controls:8.16%
76
470
1117
11356
119
247
1089
11699
35
31
1173
11915
—
31
35
1168
11897
74
269
1116
11523
143
900
981
10134
Mitral (valve) insufficiency
I34.09 [2000502484]
1.6e+00
2.5e+00
—
—
—
1.9e+00
2.2e+00
cases:1.59%
controls:0.32%
cases:1.82%
controls:0.15%
—
—
—
—
—
—
cases:1.26%
controls:0.19%
cases:3.56%
controls:0.39%
19
38
1174
11788
22
18
1186
11928
—
—
—
15
22
1175
11770
40
43
1084
10991
Doppler ultrasound examination of heart
FM1DE [2001303299]
1.2e+00
2.0e+00
—
1.0e+50
—
2.9e+00
2.2e+00
cases:3.35%
controls:1.01%
cases:2.57%
controls:0.35%
—
—
cases:3.73%
controls:0.00%
—
—
cases:5.29%
controls:0.31%
cases:8.01%
controls:0.98%
40
120
1153
11706
31
42
1177
11904
—
45
0
1163
11946
—
63
37
1127
11755
90
108
1034
10926
furosemide; oral, parenteral
C03CA01 [21601518]
9.1e-01
1.4e+00
1.5e+00
—
1.7e+00
1.6e+00
1.1e+00
cases:8.63%
controls:3.65%
cases:11.09%
controls:3.02%
cases:3.73%
controls:0.84%
—
—
cases:4.92%
controls:0.90%
cases:13.45%
controls:3.10%
cases:14.59%
controls:5.24%
103
432
1090
11394
134
361
1074
11585
45
100
1163
11846
—
59
107
1140
11825
160
366
1030
11426
164
578
960
10456
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
1.0e+00
1.7e+00
—
1.0e+50
2.6e+00
1.7e+00
1.2e+00
cases:2.01%
controls:0.73%
cases:1.57%
controls:0.30%
—
—
cases:0.41%
controls:0.00%
cases:0.58%
controls:0.04%
cases:1.68%
controls:0.31%
cases:3.20%
controls:0.97%
24
86
1169
11740
19
36
1189
11910
—
5
0
1203
11946
7
5
1192
11927
20
36
1170
11756
36
107
1088
10927
Monitored bed care
WX892 [2001310850]
6.5e-01
2.3e+00
2.6e+00
1.0e+50
—
2.0e+00
1.3e+00
cases:1.42%
controls:0.75%
cases:2.65%
controls:0.28%
cases:0.58%
controls:0.04%
cases:0.50%
controls:0.00%
—
—
cases:1.93%
controls:0.25%
cases:2.49%
controls:0.69%
17
89
1176
11737
32
33
1176
11913
7
5
1201
11941
6
0
1202
11946
—
23
30
1167
11762
28
76
1096
10958
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
5.6e-02
6.6e-01
1.8e+00
2.9e+00
1.9e+00
6.5e-01
3.2e-01
cases:15.17%
controls:14.47%
cases:22.19%
controls:12.87%
cases:15.15%
controls:2.74%
cases:3.48%
controls:0.19%
cases:14.76%
controls:2.65%
cases:23.03%
controls:13.48%
cases:37.28%
controls:30.17%
181
1711
1012
10115
268
1538
940
10408
183
327
1025
11619
42
23
1166
11923
177
316
1022
11616
274
1590
916
10202
419
3329
705
7705
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
7.3e-02
6.2e-01
1.9e+00
3.0e+00
1.8e+00
6.7e-01
3.4e-01
cases:25.90%
controls:24.52%
cases:32.37%
controls:20.48%
cases:22.43%
controls:4.30%
cases:6.21%
controls:0.34%
cases:20.02%
controls:4.16%
cases:34.71%
controls:21.36%
cases:51.33%
controls:42.94%
309
2900
884
8926
391
2447
817
9499
271
514
937
11432
75
41
1133
11905
240
496
959
11436
413
2519
777
9273
577
4738
547
6296
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
3.1e-01
2.2e+00
2.0e+00
—
2.8e+00
1.2e+00
3.5e-01
cases:4.19%
controls:3.09%
cases:12.25%
controls:1.57%
cases:1.57%
controls:0.21%
—
—
cases:3.42%
controls:0.21%
cases:5.21%
controls:1.69%
cases:8.45%
controls:6.08%
50
366
1143
11460
148
188
1060
11758
19
25
1189
11921
—
41
25
1158
11907
62
199
1128
11593
95
671
1029
10363
One hour or less
ZXE00 [2001311394]
3.7e-01
1.2e+00
2.0e+00
—
1.8e+00
1.7e+00
1.0e+00
cases:9.89%
controls:7.04%
cases:6.46%
controls:2.08%
cases:1.16%
controls:0.15%
—
—
cases:1.50%
controls:0.24%
cases:7.31%
controls:1.47%
cases:9.25%
controls:3.59%
118
832
1075
10994
78
248
1130
11698
14
18
1194
11928
—
18
29
1181
11903
87
173
1103
11619
104
396
1020
10638
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.6e-02
5.3e-01
1.7e+00
3.2e+00
1.7e+00
6.3e-01
3.0e-01
cases:17.52%
controls:17.15%
cases:23.76%
controls:15.49%
cases:16.56%
controls:3.44%
cases:5.22%
controls:0.23%
cases:16.18%
controls:3.26%
cases:25.63%
controls:15.54%
cases:39.06%
controls:32.29%
209
2028
984
9798
287
1851
921
10095
200
411
1008
11535
63
27
1145
11919
194
389
1005
11543
305
1833
885
9959
439
3563
685
7471
Nonrheumatic tricuspid (valve) insufficiency
I36.1 [45576870]
2.3e+00
2.8e+00
—
1.0e+50
1.0e+50
—
3.0e+00
cases:0.75%
controls:0.08%
cases:0.83%
controls:0.05%
—
—
cases:1.32%
controls:0.00%
cases:0.58%
controls:0.00%
—
—
cases:1.60%
controls:0.08%
9
9
1184
11817
10
6
1198
11940
—
16
0
1192
11946
7
0
1192
11932
—
18
9
1106
11025
dabigatran etexilate; oral
B01AE07 [21601026]
1.1e+00
1.4e+00
1.8e+00
—
1.9e+00
1.5e+00
1.4e+00
cases:0.92%
controls:0.31%
cases:0.99%
controls:0.24%
cases:0.66%
controls:0.11%
—
—
cases:0.75%
controls:0.12%
cases:1.26%
controls:0.29%
cases:2.05%
controls:0.49%
11
37
1182
11789
12
29
1196
11917
8
13
1200
11933
—
9
14
1190
11918
15
34
1175
11758
23
54
1101
10980
Cathetrisation of artery
TPH07 [2001309747]
9.7e-03
1.3e+00
—
1.0e+50
3.0e+00
2.4e+00
1.3e+00
cases:0.92%
controls:0.91%
cases:1.32%
controls:0.38%
—
—
cases:1.82%
controls:0.00%
cases:0.83%
controls:0.04%
cases:3.36%
controls:0.31%
cases:3.65%
controls:1.00%
11
108
1182
11718
16
45
1192
11901
—
22
0
1186
11946
10
5
1189
11927
40
36
1150
11756
41
110
1083
10924
Physiotherapist
Z3226 [2001311560]
1.4e-01
1.3e+00
1.7e+00
—
2.3e+00
1.5e+00
1.1e+00
cases:3.69%
controls:3.23%
cases:3.56%
controls:0.95%
cases:0.66%
controls:0.13%
—
—
cases:1.17%
controls:0.12%
cases:2.69%
controls:0.61%
cases:3.83%
controls:1.29%
44
382
1149
11444
43
114
1165
11832
8
15
1200
11931
—
14
14
1185
11918
32
72
1158
11720
43
142
1081
10892
Intensive care
WX872 [2001310844]
—
2.6e+00
—
1.0e+50
1.0e+50
3.7e+00
1.6e+00
—
—
cases:0.91%
controls:0.07%
—
—
cases:4.55%
controls:0.00%
cases:0.92%
controls:0.00%
cases:3.53%
controls:0.09%
cases:1.60%
controls:0.32%
—
11
8
1197
11938
—
55
0
1153
11946
11
0
1188
11932
42
11
1148
11781
18
35
1106
10999
enoxaparin; parenteral
B01AB05 [21600976]
4.5e-01
1.3e+00
1.4e+00
—
2.9e+00
1.4e+00
7.5e-01
cases:5.62%
controls:3.65%
cases:4.88%
controls:1.39%
cases:0.91%
controls:0.22%
—
—
cases:2.75%
controls:0.15%
cases:4.79%
controls:1.20%
cases:8.36%
controls:4.15%
67
432
1126
11394
59
166
1149
11780
11
26
1197
11920
—
33
18
1166
11914
57
141
1133
11651
94
458
1030
10576
Occupational therapy
R4120 [2001310234]
9.0e-01
3.3e+00
2.6e+00
—
—
1.8e+00
1.9e-01
cases:1.34%
controls:0.55%
cases:6.13%
controls:0.25%
cases:0.58%
controls:0.04%
—
—
—
—
cases:1.26%
controls:0.20%
cases:1.07%
controls:0.89%
16
65
1177
11761
74
30
1134
11916
7
5
1201
11941
—
—
15
24
1175
11768
12
98
1112
10936
Outpatient Hospital
22 [8756]
3.1e-01
1.4e+00
1.5e+00
—
2.1e+00
1.7e+00
7.7e-01
cases:29.09%
controls:23.14%
cases:24.09%
controls:7.48%
cases:4.72%
controls:1.06%
—
—
cases:7.76%
controls:1.06%
cases:26.22%
controls:6.23%
cases:28.65%
controls:15.66%
347
2736
846
9090
291
894
917
11052
57
127
1151
11819
—
93
127
1106
11805
312
735
878
11057
322
1728
802
9306
Aortic (valve) insufficiency
I35.1 [45572087]
1.9e+00
2.3e+00
—
1.0e+50
—
1.7e+00
1.7e+00
cases:2.18%
controls:0.34%
cases:2.15%
controls:0.22%
—
—
cases:1.90%
controls:0.00%
—
—
cases:1.60%
controls:0.29%
cases:3.65%
controls:0.66%
26
40
1167
11786
26
26
1182
11920
—
23
0
1185
11946
—
19
34
1171
11758
41
73
1083
10961
FEV1 --post bronchodilation
20155-8 [3023550]
9.0e-01
1.4e+00
2.7e+00
—
—
1.4e+00
1.3e+00
cases:3.02%
controls:1.25%
cases:2.07%
controls:0.54%
cases:0.75%
controls:0.05%
—
—
—
—
cases:1.85%
controls:0.48%
cases:3.29%
controls:0.92%
36
148
1157
11678
25
64
1183
11882
9
6
1199
11940
—
—
22
57
1168
11735
37
101
1087
10933
FEV1/FVC --post bronchodilation
69970-2 [42868459]
9.0e-01
1.4e+00
2.7e+00
—
—
1.4e+00
1.3e+00
cases:3.02%
controls:1.25%
cases:2.07%
controls:0.54%
cases:0.75%
controls:0.05%
—
—
—
—
cases:1.85%
controls:0.48%
cases:3.29%
controls:0.92%
36
148
1157
11678
25
64
1183
11882
9
6
1199
11940
—
—
22
57
1168
11735
37
101
1087
10933
FEV1 percent change
69983-5 [42868472]
9.0e-01
1.4e+00
2.7e+00
—
—
1.4e+00
1.3e+00
cases:3.02%
controls:1.25%
cases:2.07%
controls:0.54%
cases:0.75%
controls:0.05%
—
—
—
—
cases:1.85%
controls:0.48%
cases:3.29%
controls:0.92%
36
148
1157
11678
25
64
1183
11882
9
6
1199
11940
—
—
22
57
1168
11735
37
101
1087
10933
FVC percent change Respiratory system
69982-7 [42868471]
9.0e-01
1.4e+00
2.7e+00
—
—
1.4e+00
1.3e+00
cases:3.02%
controls:1.25%
cases:2.07%
controls:0.54%
cases:0.75%
controls:0.05%
—
—
—
—
cases:1.85%
controls:0.48%
cases:3.29%
controls:0.92%
36
148
1157
11678
25
64
1183
11882
9
6
1199
11940
—
—
22
57
1168
11735
37
101
1087
10933
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
9.0e-01
1.4e+00
2.7e+00
—
—
1.4e+00
1.3e+00
cases:3.02%
controls:1.25%
cases:2.07%
controls:0.54%
cases:0.75%
controls:0.05%
—
—
—
—
cases:1.85%
controls:0.48%
cases:3.29%
controls:0.92%
36
148
1157
11678
25
64
1183
11882
9
6
1199
11940
—
—
22
57
1168
11735
37
101
1087
10933
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-1.4e-01
5.2e-01
1.9e+00
3.0e+00
1.4e+00
4.8e-01
3.0e-01
cases:7.04%
controls:8.02%
cases:9.44%
controls:5.82%
cases:7.37%
controls:1.19%
cases:0.83%
controls:0.04%
cases:4.75%
controls:1.17%
cases:8.91%
controls:5.72%
cases:16.99%
controls:13.18%
84
948
1109
10878
114
695
1094
11251
89
142
1119
11804
10
5
1198
11941
57
140
1142
11792
106
674
1084
11118
191
1454
933
9580
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
1.5e-01
1.9e+00
2.5e+00
—
—
2.1e+00
1.1e+00
cases:1.01%
controls:0.87%
cases:2.15%
controls:0.33%
cases:0.50%
controls:0.04%
—
—
—
—
cases:2.44%
controls:0.30%
cases:3.65%
controls:1.26%
12
103
1181
11723
26
39
1182
11907
6
5
1202
11941
—
—
29
35
1161
11757
41
139
1083
10895
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
3.3e-01
8.1e-01
1.7e+00
—
2.9e+00
1.3e+00
8.6e-01
cases:1.51%
controls:1.09%
cases:1.82%
controls:0.82%
cases:0.99%
controls:0.18%
—
—
cases:1.33%
controls:0.08%
cases:2.52%
controls:0.72%
cases:4.45%
controls:1.94%
18
129
1175
11697
22
98
1186
11848
12
21
1196
11925
—
16
9
1183
11923
30
85
1160
11707
50
214
1074
10820
Atrial fibrillation and atrial flutter, unspecified
I48.9 [45755409]
1.9e+00
2.4e+00
—
—
—
2.1e+00
1.2e+00
cases:0.59%
controls:0.08%
cases:1.24%
controls:0.12%
—
—
—
—
—
—
cases:0.92%
controls:0.12%
cases:2.05%
controls:0.64%
7
10
1186
11816
15
14
1193
11932
—
—
—
11
14
1179
11778
23
71
1101
10963
Normoblasts [#/volume] in Blood
715-3 [3021589]
-7.7e-02
2.5e-01
1.9e+00
3.5e+00
1.5e+00
6.0e-01
2.3e-01
cases:5.70%
controls:6.13%
cases:6.79%
controls:5.36%
cases:7.70%
controls:1.21%
cases:1.41%
controls:0.04%
cases:4.92%
controls:1.16%
cases:9.66%
controls:5.53%
cases:15.39%
controls:12.58%
68
725
1125
11101
82
640
1126
11306
93
145
1115
11801
17
5
1191
11941
59
138
1140
11794
115
652
1075
11140
173
1388
951
9646
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
4.4e-02
5.1e-01
1.6e+00
2.9e+00
1.7e+00
5.4e-01
2.1e-01
cases:22.72%
controls:21.96%
cases:26.82%
controls:18.08%
cases:17.30%
controls:3.91%
cases:5.88%
controls:0.33%
cases:16.68%
controls:3.60%
cases:27.98%
controls:18.39%
cases:41.90%
controls:36.79%
271
2597
922
9229
324
2160
884
9786
209
467
999
11479
71
39
1137
11907
200
429
999
11503
333
2169
857
9623
471
4059
653
6975
FEV1/FVC
19926-5 [3011505]
8.5e-01
1.4e+00
2.5e+00
—
2.3e+00
1.4e+00
1.4e+00
cases:3.27%
controls:1.43%
cases:2.40%
controls:0.63%
cases:0.91%
controls:0.08%
—
—
cases:0.42%
controls:0.04%
cases:2.27%
controls:0.56%
cases:4.18%
controls:1.06%
39
169
1154
11657
29
75
1179
11871
11
9
1197
11937
—
5
5
1194
11927
27
66
1163
11726
47
117
1077
10917
FEV1
20150-9 [3024653]
8.5e-01
1.4e+00
2.5e+00
—
2.3e+00
1.4e+00
1.4e+00
cases:3.27%
controls:1.43%
cases:2.40%
controls:0.63%
cases:0.91%
controls:0.08%
—
—
cases:0.42%
controls:0.04%
cases:2.27%
controls:0.56%
cases:4.18%
controls:1.06%
39
169
1154
11657
29
75
1179
11871
11
9
1197
11937
—
5
5
1194
11927
27
66
1163
11726
47
117
1077
10917
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
8.5e-01
1.4e+00
2.5e+00
—
2.3e+00
1.4e+00
1.4e+00
cases:3.27%
controls:1.43%
cases:2.40%
controls:0.63%
cases:0.91%
controls:0.08%
—
—
cases:0.42%
controls:0.04%
cases:2.27%
controls:0.56%
cases:4.18%
controls:1.06%
39
169
1154
11657
29
75
1179
11871
11
9
1197
11937
—
5
5
1194
11927
27
66
1163
11726
47
117
1077
10917
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
3.2e-02
5.1e-01
1.6e+00
3.1e+00
1.6e+00
5.3e-01
2.2e-01
cases:29.00%
controls:28.34%
cases:34.93%
controls:24.34%
cases:22.27%
controls:5.42%
cases:8.53%
controls:0.43%
cases:20.68%
controls:5.23%
cases:36.81%
controls:25.51%
cases:54.00%
controls:48.44%
346
3352
847
8474
422
2908
786
9038
269
648
939
11298
103
51
1105
11895
248
624
951
11308
438
3008
752
8784
607
5345
517
5689
Extensive CT of aorta
PD5BD [2001309001]
1.5e+00
2.8e+00
—
—
—
2.4e+00
2.3e+00
cases:0.42%
controls:0.09%
cases:0.66%
controls:0.04%
—
—
—
—
—
—
cases:0.67%
controls:0.06%
cases:0.80%
controls:0.08%
5
11
1188
11815
8
5
1200
11941
—
—
—
8
7
1182
11785
9
9
1115
11025
acetylsalicylic acid; oral
B01AC06 [21600991]
5.5e-01
1.6e+00
1.5e+00
—
1.6e+00
1.6e+00
1.1e+00
cases:3.19%
controls:1.86%
cases:6.21%
controls:1.26%
cases:2.07%
controls:0.46%
—
—
cases:2.25%
controls:0.46%
cases:7.31%
controls:1.50%
cases:7.74%
controls:2.82%
38
220
1155
11606
75
150
1133
11796
25
55
1183
11891
—
27
55
1172
11877
87
177
1103
11615
87
311
1037
10723
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.7e-01
1.8e+00
2.7e+00
1.0e+50
—
1.9e+00
1.1e+00
cases:2.01%
controls:1.70%
cases:3.48%
controls:0.60%
cases:1.08%
controls:0.08%
cases:4.47%
controls:0.00%
—
—
cases:3.61%
controls:0.54%
cases:4.72%
controls:1.64%
24
201
1169
11625
42
72
1166
11874
13
9
1195
11937
54
0
1154
11946
—
43
64
1147
11728
53
181
1071
10853
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
9.9e-01
2.0e+00
—
1.0e+50
2.6e+00
1.7e+00
1.3e+00
cases:0.59%
controls:0.22%
cases:1.24%
controls:0.18%
—
—
cases:0.58%
controls:0.00%
cases:0.75%
controls:0.06%
cases:0.92%
controls:0.18%
cases:1.78%
controls:0.50%
7
26
1186
11800
15
21
1193
11925
—
7
0
1201
11946
9
7
1190
11925
11
21
1179
11771
20
55
1104
10979
Physiotherapy
R4110 [2001310233]
1.7e-01
1.5e+00
1.6e+00
1.0e+50
2.0e+00
1.5e+00
9.3e-01
cases:5.11%
controls:4.36%
cases:8.20%
controls:2.05%
cases:1.41%
controls:0.28%
cases:4.97%
controls:0.00%
cases:2.09%
controls:0.29%
cases:6.72%
controls:1.65%
cases:9.61%
controls:4.02%
61
516
1132
11310
99
245
1109
11701
17
33
1191
11913
60
0
1148
11946
25
35
1174
11897
80
195
1110
11597
108
444
1016
10590
Platelets [#/volume] in Blood
26515-7 [3007461]
2.5e-02
5.1e-01
1.6e+00
3.0e+00
1.6e+00
5.4e-01
2.3e-01
cases:28.75%
controls:28.23%
cases:34.85%
controls:24.27%
cases:22.19%
controls:5.42%
cases:7.86%
controls:0.43%
cases:20.68%
controls:5.20%
cases:36.81%
controls:25.42%
cases:54.00%
controls:48.36%
343
3339
850
8487
421
2899
787
9047
268
647
940
11299
95
51
1113
11895
248
621
951
11311
438
2997
752
8795
607
5336
517
5698
MCH [Entitic mass]
28539-5 [3035941]
3.6e-02
5.2e-01
1.6e+00
3.0e+00
1.6e+00
5.3e-01
2.2e-01
cases:29.00%
controls:28.27%
cases:34.93%
controls:24.28%
cases:22.19%
controls:5.42%
cases:7.86%
controls:0.43%
cases:20.68%
controls:5.21%
cases:36.81%
controls:25.45%
cases:54.00%
controls:48.41%
346
3343
847
8483
422
2900
786
9046
268
647
940
11299
95
51
1113
11895
248
622
951
11310
438
3001
752
8791
607
5342
517
5692
amiodarone; oral, parenteral
C01BD01 [21600270]
1.4e+00
1.7e+00
—
—
—
2.6e+00
1.7e+00
cases:1.01%
controls:0.25%
cases:0.83%
controls:0.16%
—
—
—
—
—
—
cases:1.85%
controls:0.14%
cases:1.25%
controls:0.23%
12
29
1181
11797
10
19
1198
11927
—
—
—
22
16
1168
11776
14
25
1110
11009
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
3.3e-02
5.1e-01
1.6e+00
3.0e+00
1.6e+00
5.3e-01
2.2e-01
cases:29.00%
controls:28.34%
cases:34.93%
controls:24.34%
cases:22.19%
controls:5.42%
cases:7.86%
controls:0.43%
cases:20.68%
controls:5.22%
cases:36.81%
controls:25.49%
cases:54.00%
controls:48.41%
346
3351
847
8475
422
2908
786
9038
268
648
940
11298
95
51
1113
11895
248
623
951
11309
438
3006
752
8786
607
5342
517
5692
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
3.2e-02
5.1e-01
1.6e+00
3.0e+00
1.6e+00
5.3e-01
2.2e-01
cases:29.00%
controls:28.34%
cases:34.93%
controls:24.35%
cases:22.19%
controls:5.43%
cases:7.86%
controls:0.43%
cases:20.68%
controls:5.22%
cases:36.81%
controls:25.50%
cases:54.00%
controls:48.44%
346
3352
847
8474
422
2909
786
9037
268
649
940
11297
95
51
1113
11895
248
623
951
11309
438
3007
752
8785
607
5345
517
5689
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
3.3e-02
5.1e-01
1.6e+00
3.0e+00
1.5e+00
5.3e-01
2.2e-01
cases:29.09%
controls:28.40%
cases:35.02%
controls:24.39%
cases:22.19%
controls:5.44%
cases:7.86%
controls:0.43%
cases:20.68%
controls:5.25%
cases:36.89%
controls:25.56%
cases:54.00%
controls:48.52%
347
3359
846
8467
423
2914
785
9032
268
650
940
11296
95
51
1113
11895
248
626
951
11306
439
3014
751
8778
607
5354
517
5680
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.6e-02
5.1e-01
1.6e+00
3.0e+00
1.5e+00
5.3e-01
2.2e-01
cases:28.92%
controls:28.40%
cases:35.02%
controls:24.42%
cases:22.19%
controls:5.44%
cases:7.86%
controls:0.43%
cases:20.68%
controls:5.25%
cases:36.81%
controls:25.54%
cases:54.00%
controls:48.53%
345
3358
848
8468
423
2917
785
9029
268
650
940
11296
95
51
1113
11895
248
627
951
11305
438
3012
752
8780
607
5355
517
5679
Atherosclerotic heart disease
I25.1 [45596196]
2.3e-01
1.0e+00
2.0e+00
—
2.1e+00
1.4e+00
7.9e-01
cases:3.02%
controls:2.41%
cases:3.81%
controls:1.40%
cases:0.99%
controls:0.14%
—
—
cases:1.42%
controls:0.17%
cases:5.13%
controls:1.26%
cases:7.12%
controls:3.36%
36
285
1157
11541
46
167
1162
11779
12
17
1196
11929
—
17
20
1182
11912
61
148
1129
11644
80
371
1044
10663
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
—
1.6e+00
—
1.0e+50
2.7e+00
2.0e+00
9.6e-01
—
—
cases:1.08%
controls:0.21%
—
—
cases:1.49%
controls:0.00%
cases:1.17%
controls:0.08%
cases:1.85%
controls:0.25%
cases:2.76%
controls:1.08%
—
13
25
1195
11921
—
18
0
1190
11946
14
9
1185
11923
22
30
1168
11762
31
119
1093
10915
Pulmonary Disease
29 [38004472]
3.7e-01
7.3e-01
9.6e-01
2.8e+00
1.2e+00
7.4e-01
5.5e-01
cases:9.14%
controls:6.49%
cases:6.71%
controls:3.35%
cases:1.57%
controls:0.61%
cases:0.66%
controls:0.04%
cases:2.00%
controls:0.60%
cases:7.06%
controls:3.51%
cases:12.99%
controls:7.97%
109
767
1084
11059
81
400
1127
11546
19
73
1189
11873
8
5
1200
11941
24
71
1175
11861
84
414
1106
11378
146
879
978
10155
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
1.1e-02
1.5e+00
—
1.0e+50
2.9e+00
1.7e+00
1.3e+00
cases:0.42%
controls:0.41%
cases:1.57%
controls:0.37%
—
—
cases:0.66%
controls:0.00%
cases:1.17%
controls:0.07%
cases:1.26%
controls:0.24%
cases:1.96%
controls:0.54%
5
49
1188
11777
19
44
1189
11902
—
8
0
1200
11946
14
8
1185
11924
15
28
1175
11764
22
60
1102
10974
Emergency Medicine
93 [38004510]
1.3e-01
7.8e-01
1.2e+00
3.5e+00
9.8e-01
5.6e-01
2.6e-01
cases:9.22%
controls:8.19%
cases:10.84%
controls:5.29%
cases:2.57%
controls:0.80%
cases:1.90%
controls:0.06%
cases:1.83%
controls:0.70%
cases:10.17%
controls:6.05%
cases:24.38%
controls:19.86%
110
969
1083
10857
131
632
1077
11314
31
95
1177
11851
23
7
1185
11939
22
83
1177
11849
121
714
1069
11078
274
2191
850
8843
Stroke/cerebrovascular accident
K90 [2002000617]
—
2.9e+00
—
—
—
2.3e+00
2.0e+00
—
—
cases:1.24%
controls:0.07%
—
—
—
—
—
—
cases:0.76%
controls:0.08%
cases:1.33%
controls:0.19%
—
15
8
1193
11938
—
—
—
9
9
1181
11783
15
21
1109
11013
flecainide; oral, parenteral
C01BC04 [21600266]
1.8e+00
1.9e+00
—
—
1.8e+00
1.7e+00
1.7e+00
cases:1.59%
controls:0.26%
cases:1.08%
controls:0.16%
—
—
—
—
cases:0.42%
controls:0.07%
cases:1.01%
controls:0.18%
cases:1.96%
controls:0.37%
19
31
1174
11795
13
19
1195
11927
—
—
5
8
1194
11924
12
21
1178
11771
22
41
1102
10993
Short blood count panel - Blood
55429-5 [40758558]
-7.1e-02
3.1e-01
2.1e+00
2.6e+00
1.4e+00
5.9e-01
4.3e-01
cases:4.69%
controls:5.02%
cases:4.39%
controls:3.26%
cases:5.55%
controls:0.73%
cases:0.66%
controls:0.05%
cases:3.00%
controls:0.75%
cases:5.04%
controls:2.85%
cases:8.45%
controls:5.67%
56
594
1137
11232
53
389
1155
11557
67
87
1141
11859
8
6
1200
11940
36
90
1163
11842
60
336
1130
11456
95
626
1029
10408
EKG study
11524-6 [3013512]
1.2e-01
1.2e+00
2.3e+00
—
2.1e+00
9.7e-01
5.1e-01
cases:4.36%
controls:3.88%
cases:6.37%
controls:2.10%
cases:2.81%
controls:0.28%
—
—
cases:2.75%
controls:0.34%
cases:6.39%
controls:2.51%
cases:11.57%
controls:7.27%
52
459
1141
11367
77
251
1131
11695
34
34
1174
11912
—
33
40
1166
11892
76
296
1114
11496
130
802
994
10232
Chloride [Moles/volume] in Blood
2069-3 [3018572]
—
2.3e+00
—
1.0e+50
2.5e+00
2.3e+00
7.8e-01
—
—
cases:0.58%
controls:0.06%
—
—
cases:0.75%
controls:0.00%
cases:0.50%
controls:0.04%
cases:0.67%
controls:0.07%
cases:0.89%
controls:0.41%
—
7
7
1201
11939
—
9
0
1199
11946
6
5
1193
11927
8
8
1182
11784
10
45
1114
10989
Anion gap in Blood by calculation
41276-7 [3039000]
—
2.3e+00
—
1.0e+50
2.5e+00
2.3e+00
7.8e-01
—
—
cases:0.58%
controls:0.06%
—
—
cases:0.75%
controls:0.00%
cases:0.50%
controls:0.04%
cases:0.67%
controls:0.07%
cases:0.89%
controls:0.41%
—
7
7
1201
11939
—
9
0
1199
11946
6
5
1193
11927
8
8
1182
11784
10
45
1114
10989
Cardiac arrhythmia, unspecified
I49.9 [45581778]
6.5e-01
1.8e+00
2.5e+00
—
—
1.6e+00
1.2e+00
cases:1.59%
controls:0.84%
cases:1.66%
controls:0.27%
cases:0.50%
controls:0.04%
—
—
—
—
cases:1.68%
controls:0.35%
cases:4.54%
controls:1.46%
19
99
1174
11727
20
32
1188
11914
6
5
1202
11941
—
—
20
41
1170
11751
51
161
1073
10873
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 [3044355]
1.2e+00
4.9e+00
—
—
—
2.1e+00
8.4e-01
cases:0.84%
controls:0.26%
cases:6.46%
controls:0.05%
—
—
—
—
—
—
cases:0.76%
controls:0.09%
cases:0.71%
controls:0.31%
10
31
1183
11795
78
6
1130
11940
—
—
—
9
11
1181
11781
8
34
1116
11000
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
5.2e-01
1.7e+00
2.3e+00
1.0e+50
2.4e+00
5.6e-01
6.5e-01
cases:3.77%
controls:2.27%
cases:5.88%
controls:1.16%
cases:0.75%
controls:0.08%
cases:0.99%
controls:0.00%
cases:1.50%
controls:0.14%
cases:2.02%
controls:1.16%
cases:8.01%
controls:4.33%
45
269
1148
11557
71
139
1137
11807
9
9
1199
11937
12
0
1196
11946
18
17
1181
11915
24
137
1166
11655
90
478
1034
10556
Cathetrisation of vein
TPH04 [2001309597]
6.8e-01
1.4e+00
1.8e+00
1.0e+50
1.7e+00
1.9e+00
1.1e+00
cases:3.60%
controls:1.86%
cases:3.81%
controls:0.94%
cases:0.50%
controls:0.08%
cases:1.24%
controls:0.00%
cases:0.83%
controls:0.16%
cases:4.71%
controls:0.74%
cases:7.74%
controls:2.76%
43
220
1150
11606
46
112
1162
11834
6
10
1202
11936
15
0
1193
11946
10
19
1189
11913
56
87
1134
11705
87
304
1037
10730
Carotid artery syndrome (hemispheric)
G45.1 [45576586]
1.2e+00
3.9e+00
—
—
—
2.8e+00
—
cases:0.59%
controls:0.17%
cases:2.07%
controls:0.04%
—
—
—
—
—
—
cases:0.84%
controls:0.05%
—
—
7
20
1186
11806
25
5
1183
11941
—
—
—
10
6
1180
11786
—
Chronic cardiac insufficiency
201 [2001600199]
2.2e+00
3.0e+00
—
—
—
—
1.4e+00
cases:1.26%
controls:0.14%
cases:0.99%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.25%
15
16
1178
11810
12
6
1196
11940
—
—
—
—
12
28
1112
11006
Protein C actual/normal in Platelet poor plasma by Coagulation assay
27819-2 [3020287]
1.5e+00
5.1e+00
—
—
1.0e+50
1.6e+00
8.4e-01
cases:1.01%
controls:0.22%
cases:7.78%
controls:0.05%
—
—
—
—
cases:1.08%
controls:0.00%
cases:0.42%
controls:0.08%
cases:0.71%
controls:0.31%
12
26
1181
11800
94
6
1114
11940
—
—
13
0
1186
11932
5
10
1185
11782
8
34
1116
11000
furosemide and potassium-sparing agents
C03EB01 [21601554]
1.2e+00
1.7e+00
—
—
2.3e+00
1.4e+00
9.9e-01
cases:1.26%
controls:0.36%
cases:1.41%
controls:0.26%
—
—
—
—
cases:0.58%
controls:0.06%
cases:0.84%
controls:0.21%
cases:0.80%
controls:0.30%
15
43
1178
11783
17
31
1191
11915
—
—
7
7
1192
11925
10
25
1180
11767
9
33
1115
11001
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
7.4e-02
1.2e+00
2.3e+00
1.0e+50
2.0e+00
1.1e+00
3.1e-01
cases:6.37%
controls:5.94%
cases:5.88%
controls:1.88%
cases:1.82%
controls:0.18%
cases:0.50%
controls:0.00%
cases:0.92%
controls:0.13%
cases:5.21%
controls:1.76%
cases:9.52%
controls:7.15%
76
703
1117
11123
71
225
1137
11721
22
22
1186
11924
6
0
1202
11946
11
15
1188
11917
62
208
1128
11584
107
789
1017
10245
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-7.8e-02
4.1e-01
1.5e+00
2.6e+00
1.2e+00
5.4e-01
3.3e-01
cases:8.47%
controls:9.09%
cases:10.18%
controls:6.97%
cases:7.78%
controls:1.79%
cases:1.08%
controls:0.08%
cases:5.75%
controls:1.78%
cases:10.92%
controls:6.67%
cases:19.93%
controls:15.15%
101
1075
1092
10751
123
833
1085
11113
94
214
1114
11732
13
10
1195
11936
69
212
1130
11720
130
787
1060
11005
224
1672
900
9362
Urgent procedure
ZXD05 [2001311386]
2.5e-01
1.1e+00
1.9e+00
1.0e+50
2.1e+00
7.9e-01
7.4e-01
cases:5.36%
controls:4.24%
cases:3.06%
controls:1.04%
cases:0.75%
controls:0.12%
cases:1.57%
controls:0.00%
cases:0.92%
controls:0.12%
cases:2.27%
controls:1.04%
cases:5.69%
controls:2.80%
64
501
1129
11325
37
124
1171
11822
9
14
1199
11932
19
0
1189
11946
11
14
1188
11918
27
123
1163
11669
64
309
1060
10725
ABO and Rh group [Type] in Blood
882-1 [3003694]
-1.5e-01
7.0e-01
3.9e+00
1.0e+50
—
2.0e+00
1.3e-01
cases:2.60%
controls:3.01%
cases:3.31%
controls:1.67%
cases:5.96%
controls:0.13%
cases:1.24%
controls:0.00%
—
—
cases:6.64%
controls:0.98%
cases:5.87%
controls:5.20%
31
356
1162
11470
40
199
1168
11747
72
16
1136
11930
15
0
1193
11946
—
79
116
1111
11676
66
574
1058
10460
Laboratory Visit
OMOP4822461 [32036]
6.0e-02
3.8e-01
1.3e+00
3.1e+00
1.2e+00
4.4e-01
1.5e-01
cases:34.12%
controls:32.78%
cases:40.07%
controls:31.44%
cases:28.64%
controls:9.71%
cases:14.24%
controls:0.71%
cases:26.11%
controls:9.40%
cases:44.20%
controls:33.75%
cases:58.36%
controls:54.56%
407
3876
786
7950
484
3756
724
8190
346
1160
862
10786
172
85
1036
11861
313
1122
886
10810
526
3980
664
7812
656
6020
468
5014
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
2.2e-01
2.8e+00
2.6e+00
—
—
—
1.0e+00
cases:1.09%
controls:0.88%
cases:4.14%
controls:0.25%
cases:0.58%
controls:0.04%
—
—
—
—
—
—
cases:2.22%
controls:0.82%
13
104
1180
11722
50
30
1158
11916
7
5
1201
11941
—
—
—
25
90
1099
10944
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
-2.0e-02
4.9e-01
1.0e+00
1.9e+00
1.9e+00
6.3e-01
4.3e-01
cases:6.54%
controls:6.66%
cases:6.62%
controls:4.15%
cases:2.57%
controls:0.94%
cases:0.58%
controls:0.08%
cases:5.34%
controls:0.80%
cases:7.98%
controls:4.40%
cases:17.17%
controls:11.89%
78
788
1115
11038
80
496
1128
11450
31
112
1177
11834
7
10
1201
11936
64
95
1135
11837
95
519
1095
11273
193
1312
931
9722
Oxygen saturation in Arterial blood
2708-6 [3016502]
5.4e-01
1.1e+00
—
1.0e+50
2.9e+00
1.7e+00
7.9e-01
cases:0.84%
controls:0.49%
cases:1.08%
controls:0.37%
—
—
cases:1.90%
controls:0.00%
cases:1.75%
controls:0.10%
cases:2.69%
controls:0.50%
cases:4.18%
controls:1.94%
10
58
1183
11768
13
44
1195
11902
—
23
0
1185
11946
21
12
1178
11920
32
59
1158
11733
47
214
1077
10820
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21668-9 [3015816]
1.3e+00
5.1e+00
—
—
—
—
1.1e+00
cases:0.92%
controls:0.25%
cases:7.28%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.28%
11
29
1182
11797
88
6
1120
11940
—
—
—
—
9
31
1115
11003
Heart disease other
K84 [2002000611]
—
2.1e+00
—
—
—
2.3e+00
1.9e+00
—
—
cases:0.50%
controls:0.06%
—
—
—
—
—
—
cases:0.67%
controls:0.07%
cases:1.16%
controls:0.17%
—
6
7
1202
11939
—
—
—
8
8
1182
11784
13
19
1111
11015
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
4.0e-01
1.1e+00
—
1.0e+50
2.8e+00
1.6e+00
7.8e-01
cases:1.01%
controls:0.68%
cases:1.57%
controls:0.51%
—
—
cases:1.90%
controls:0.00%
cases:1.83%
controls:0.11%
cases:2.94%
controls:0.61%
cases:4.54%
controls:2.14%
12
80
1181
11746
19
61
1189
11885
—
23
0
1185
11946
22
13
1177
11919
35
72
1155
11720
51
236
1073
10798
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
4.0e-01
1.1e+00
—
1.0e+50
2.8e+00
1.6e+00
7.8e-01
cases:1.01%
controls:0.68%
cases:1.57%
controls:0.51%
—
—
cases:1.90%
controls:0.00%
cases:1.83%
controls:0.11%
cases:2.94%
controls:0.61%
cases:4.54%
controls:2.14%
12
80
1181
11746
19
61
1189
11885
—
23
0
1185
11946
22
13
1177
11919
35
72
1155
11720
51
236
1073
10798
pH of Arterial blood
2744-1 [3019977]
4.1e-01
1.1e+00
—
1.0e+50
2.8e+00
1.6e+00
7.7e-01
cases:1.01%
controls:0.67%
cases:1.57%
controls:0.51%
—
—
cases:1.90%
controls:0.00%
cases:1.83%
controls:0.11%
cases:2.94%
controls:0.61%
cases:4.54%
controls:2.15%
12
79
1181
11747
19
61
1189
11885
—
23
0
1185
11946
22
13
1177
11919
35
72
1155
11720
51
237
1073
10797
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
1.5e-01
8.0e-01
1.8e+00
—
1.9e+00
1.1e+00
7.4e-01
cases:2.51%
controls:2.18%
cases:2.24%
controls:1.01%
cases:0.91%
controls:0.16%
—
—
cases:1.08%
controls:0.16%
cases:2.86%
controls:0.97%
cases:4.80%
controls:2.35%
30
258
1163
11568
27
121
1181
11825
11
19
1197
11927
—
13
19
1186
11913
34
114
1156
11678
54
259
1070
10775
Base excess in Arterial blood by calculation
1925-7 [3003396]
4.0e-01
1.1e+00
—
1.0e+50
2.8e+00
1.6e+00
7.8e-01
cases:1.01%
controls:0.68%
cases:1.57%
controls:0.52%
—
—
cases:1.90%
controls:0.00%
cases:1.83%
controls:0.11%
cases:2.94%
controls:0.62%
cases:4.54%
controls:2.13%
12
80
1181
11746
19
62
1189
11884
—
23
0
1185
11946
22
13
1177
11919
35
73
1155
11719
51
235
1073
10799
Thrombophilia screening test
314089003 [4195642]
1.5e+00
4.9e+00
—
—
1.0e+50
—
1.1e+00
cases:1.01%
controls:0.24%
cases:8.03%
controls:0.07%
—
—
—
—
cases:1.00%
controls:0.00%
—
—
cases:0.80%
controls:0.28%
12
28
1181
11798
97
8
1111
11938
—
—
12
0
1187
11932
—
9
31
1115
11003
Inpatient Visit
IP [9201]
8.4e-02
4.1e-01
1.3e+00
—
2.6e+00
1.8e+00
6.5e-01
cases:4.61%
controls:4.25%
cases:3.15%
controls:2.12%
cases:0.91%
controls:0.25%
—
—
cases:1.75%
controls:0.13%
cases:11.01%
controls:2.04%
cases:12.54%
controls:6.94%
55
503
1138
11323
38
253
1170
11693
11
30
1197
11916
—
21
16
1178
11916
131
240
1059
11552
141
766
983
10268
Ventricular premature depolarization
I49.3 [45538386]
1.1e+00
2.1e+00
—
1.0e+50
—
1.8e+00
1.3e+00
cases:1.26%
controls:0.43%
cases:1.32%
controls:0.16%
—
—
cases:0.41%
controls:0.00%
—
—
cases:1.26%
controls:0.21%
cases:2.67%
controls:0.75%
15
51
1178
11775
16
19
1192
11927
—
5
0
1203
11946
—
15
25
1175
11767
30
83
1094
10951
Presence of electronic cardiac devices
Z95.0 [45571406]
1.1e+00
1.3e+00
—
1.0e+50
1.7e+00
1.9e+00
1.9e+00
cases:1.26%
controls:0.41%
cases:1.16%
controls:0.32%
—
—
cases:0.83%
controls:0.00%
cases:0.42%
controls:0.08%
cases:1.93%
controls:0.29%
cases:4.36%
controls:0.67%
15
48
1178
11778
14
38
1194
11908
—
10
0
1198
11946
5
9
1194
11923
23
34
1167
11758
49
74
1075
10960
Respiratory and circulatory monitoring
WX700 [2001310817]
2.2e-01
8.0e-01
—
1.0e+50
3.0e+00
1.8e+00
7.0e-01
cases:2.51%
controls:2.04%
cases:1.90%
controls:0.86%
—
—
cases:3.89%
controls:0.00%
cases:0.83%
controls:0.04%
cases:3.70%
controls:0.65%
cases:3.56%
controls:1.79%
30
241
1163
11585
23
103
1185
11843
—
47
0
1161
11946
10
5
1189
11927
44
77
1146
11715
40
198
1084
10836
Chronic atrial fibrillation
I48.2 [45591467]
—
2.3e+00
—
—
—
1.7e+00
2.2e+00
—
—
cases:0.58%
controls:0.06%
—
—
—
—
—
—
cases:0.67%
controls:0.12%
cases:2.31%
controls:0.26%
—
7
7
1201
11939
—
—
—
8
14
1182
11778
26
29
1098
11005
Emergency Room and Inpatient Visit
ERIP [262]
2.2e-01
1.7e+00
2.0e+00
1.0e+50
1.8e+00
8.2e-01
2.8e-01
cases:2.01%
controls:1.62%
cases:7.04%
controls:1.39%
cases:1.24%
controls:0.18%
cases:2.07%
controls:0.00%
cases:1.25%
controls:0.22%
cases:4.03%
controls:1.82%
cases:9.34%
controls:7.23%
24
191
1169
11635
85
166
1123
11780
15
21
1193
11925
25
0
1183
11946
15
26
1184
11906
48
215
1142
11577
105
798
1019
10236
Atrial fibrillation/flutter
K78 [2002000605]
1.3e+00
1.5e+00
9.6e-01
—
1.1e+00
1.7e+00
1.7e+00
cases:1.84%
controls:0.52%
cases:1.66%
controls:0.36%
cases:0.41%
controls:0.16%
—
—
cases:0.42%
controls:0.14%
cases:1.85%
controls:0.36%
cases:4.36%
controls:0.85%
22
62
1171
11764
20
43
1188
11903
5
19
1203
11927
—
5
17
1194
11915
22
42
1168
11750
49
94
1075
10940
Lactate [Moles/volume] in Blood
32693-4 [3047181]
—
2.0e+00
—
1.0e+50
2.1e+00
1.9e+00
9.1e-01
—
—
cases:0.75%
controls:0.10%
—
—
cases:0.75%
controls:0.00%
cases:0.50%
controls:0.06%
cases:0.92%
controls:0.14%
cases:1.51%
controls:0.62%
—
9
12
1199
11934
—
9
0
1199
11946
6
7
1193
11925
11
16
1179
11776
17
68
1107
10966
Check up of cardiac pacemaker
XFP20 [2001303367]
1.1e+00
1.3e+00
—
1.0e+50
1.9e+00
1.9e+00
1.8e+00
cases:1.84%
controls:0.61%
cases:1.82%
controls:0.51%
—
—
cases:0.66%
controls:0.00%
cases:0.50%
controls:0.08%
cases:3.11%
controls:0.47%
cases:5.16%
controls:0.93%
22
72
1171
11754
22
61
1186
11885
—
8
0
1200
11946
6
9
1193
11923
37
55
1153
11737
58
103
1066
10931
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
351 [2001600312]
1.5e+00
1.8e+00
—
—
—
1.6e+00
1.0e+00
cases:2.18%
controls:0.47%
cases:1.74%
controls:0.28%
—
—
—
—
—
—
cases:1.26%
controls:0.25%
cases:2.85%
controls:1.04%
26
56
1167
11770
21
34
1187
11912
—
—
—
15
29
1175
11763
32
115
1092
10919
General anesthesia, balanced
WX408 [2001310808]
4.0e-01
3.8e-01
—
—
2.7e+00
2.3e+00
1.1e+00
cases:6.20%
controls:4.23%
cases:2.24%
controls:1.53%
—
—
—
—
cases:1.75%
controls:0.13%
cases:8.91%
controls:0.98%
cases:5.87%
controls:2.08%
74
500
1119
11326
27
183
1181
11763
—
—
21
15
1178
11917
106
116
1084
11676
66
229
1058
10805
More than one and less than three hours
ZXE10 [2001311401]
2.3e-01
8.5e-01
1.2e+00
1.0e+50
2.0e+00
2.0e+00
1.1e+00
cases:7.54%
controls:6.06%
cases:4.14%
controls:1.82%
cases:0.75%
controls:0.23%
cases:5.38%
controls:0.00%
cases:1.33%
controls:0.18%
cases:7.98%
controls:1.12%
cases:8.63%
controls:3.19%
90
717
1103
11109
50
217
1158
11729
9
27
1199
11919
65
0
1143
11946
16
22
1183
11910
95
132
1095
11660
97
352
1027
10682
Other specified special examinations
Z01.8 [45581003]
6.5e-01
1.2e+00
1.9e+00
—
1.9e+00
1.5e+00
6.3e-01
cases:4.27%
controls:2.28%
cases:2.90%
controls:0.89%
cases:0.75%
controls:0.11%
—
—
cases:0.50%
controls:0.08%
cases:3.11%
controls:0.70%
cases:6.14%
controls:3.35%
51
270
1142
11556
35
106
1173
11840
9
13
1199
11933
—
6
9
1193
11923
37
83
1153
11709
69
370
1055
10664
Chest pain, unspecified
R07.4 [45558450]
7.8e-01
1.3e+00
1.2e+00
—
1.8e+00
1.4e+00
6.7e-01
cases:5.70%
controls:2.71%
cases:3.64%
controls:0.99%
cases:0.41%
controls:0.13%
—
—
cases:0.83%
controls:0.14%
cases:3.70%
controls:0.98%
cases:7.38%
controls:3.92%
68
320
1125
11506
44
118
1164
11828
5
15
1203
11931
—
10
17
1189
11915
44
115
1146
11677
83
433
1041
10601
Intubation
WX704 [2001310820]
9.6e-01
4.4e-01
—
1.0e+50
2.8e+00
2.1e+00
7.2e-01
cases:1.59%
controls:0.62%
cases:0.41%
controls:0.27%
—
—
cases:1.66%
controls:0.00%
cases:0.67%
controls:0.04%
cases:1.85%
controls:0.22%
cases:1.87%
controls:0.92%
19
73
1174
11753
5
32
1203
11914
—
20
0
1188
11946
8
5
1191
11927
22
26
1168
11766
21
101
1103
10933
Presence of prosthetic heart valve
Z95.2 [45542495]
—
—
—
—
—
3.5e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.04%
cases:2.22%
controls:0.24%
—
—
—
—
—
17
5
1173
11787
25
26
1099
11008
Intravenous general anesthesia
WX404 [2001310807]
-6.2e-02
7.9e-01
—
—
1.8e+00
1.8e+00
1.4e+00
cases:3.35%
controls:3.56%
cases:2.98%
controls:1.38%
—
—
—
—
cases:1.08%
controls:0.18%
cases:5.21%
controls:0.87%
cases:5.87%
controls:1.53%
40
421
1153
11405
36
165
1172
11781
—
—
13
22
1186
11910
62
103
1128
11689
66
169
1058
10865
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
8.1e-01
6.5e-01
—
1.0e+50
3.2e+00
1.8e+00
7.8e-01
cases:0.59%
controls:0.26%
cases:0.50%
controls:0.26%
—
—
cases:1.16%
controls:0.00%
cases:1.17%
controls:0.05%
cases:1.93%
controls:0.32%
cases:2.58%
controls:1.20%
7
31
1186
11795
6
31
1202
11915
—
14
0
1194
11946
14
6
1185
11926
23
38
1167
11754
29
132
1095
10902
Sick sinus syndrome
I49.5 [45562354]
1.0e+00
1.6e+00
-1.0e+50
1.0e+50
—
2.2e+00
1.8e+00
cases:0.67%
controls:0.25%
cases:0.75%
controls:0.15%
cases:0.00%
controls:0.04%
cases:0.50%
controls:0.00%
—
—
cases:1.01%
controls:0.11%
cases:2.76%
controls:0.45%
8
29
1185
11797
9
18
1199
11928
0
5
1208
11941
6
0
1202
11946
—
12
13
1178
11779
31
50
1093
10984
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
290 [2001600222]
1.3e+00
1.8e+00
—
—
—
1.6e+00
1.0e+00
cases:2.26%
controls:0.63%
cases:1.82%
controls:0.32%
—
—
—
—
—
—
cases:1.51%
controls:0.32%
cases:3.29%
controls:1.20%
27
75
1166
11751
22
38
1186
11908
—
—
—
18
38
1172
11754
37
132
1087
10902
Catheterisation of right atrium or ventricle
TFC00 [2001303396]
1.9e+00
3.7e+00
1.0e+50
1.0e+50
1.0e+50
—
—
cases:0.84%
controls:0.13%
cases:2.07%
controls:0.05%
cases:0.50%
controls:0.00%
cases:1.08%
controls:0.00%
cases:0.42%
controls:0.00%
—
—
—
—
10
15
1183
11811
25
6
1183
11940
6
0
1202
11946
13
0
1195
11946
5
0
1194
11932
—
—
Neck artery ultrasound examination with Doppler method
PA6DE [2001308705]
4.0e-01
3.4e+00
—
—
—
2.2e+00
7.4e-01
cases:0.50%
controls:0.34%
cases:1.74%
controls:0.06%
—
—
—
—
—
—
cases:0.84%
controls:0.09%
cases:0.62%
controls:0.30%
6
40
1187
11786
21
7
1187
11939
—
—
—
10
11
1180
11781
7
33
1117
11001
Thoracic aortic aneurysm, without mention of rupture
I71.2 [45601082]
1.6e+00
—
—
1.0e+50
—
2.1e+00
1.8e+00
cases:0.84%
controls:0.17%
—
—
—
—
cases:0.91%
controls:0.00%
—
—
cases:1.01%
controls:0.12%
cases:2.05%
controls:0.34%
10
20
1183
11806
—
—
11
0
1197
11946
—
12
14
1178
11778
23
38
1101
10996
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
6.9e-01
6.2e-01
—
1.0e+50
3.2e+00
1.6e+00
7.2e-01
cases:0.50%
controls:0.25%
cases:0.50%
controls:0.27%
—
—
cases:1.16%
controls:0.00%
cases:1.17%
controls:0.05%
cases:1.60%
controls:0.32%
cases:2.49%
controls:1.22%
6
30
1187
11796
6
32
1202
11914
—
14
0
1194
11946
14
6
1185
11926
19
38
1171
11754
28
135
1096
10899
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.2e-01
8.5e-01
9.6e-01
2.1e+00
1.0e+00
2.9e-01
2.2e-01
cases:19.78%
controls:17.99%
cases:21.85%
controls:10.64%
cases:3.64%
controls:1.42%
cases:0.50%
controls:0.06%
cases:3.50%
controls:1.31%
cases:15.13%
controls:11.75%
cases:36.03%
controls:31.11%
236
2128
957
9698
264
1271
944
10675
44
170
1164
11776
6
7
1202
11939
42
156
1157
11776
180
1386
1010
10406
405
3433
719
7601
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.2e-02
2.6e-01
1.1e+00
2.4e+00
1.3e+00
3.7e-01
2.9e-01
cases:13.16%
controls:12.57%
cases:11.09%
controls:8.75%
cases:5.13%
controls:1.75%
cases:1.24%
controls:0.12%
cases:5.92%
controls:1.64%
cases:12.52%
controls:9.01%
cases:26.96%
controls:21.68%
157
1487
1036
10339
134
1045
1074
10901
62
209
1146
11737
15
14
1193
11932
71
196
1128
11736
149
1063
1041
10729
303
2392
821
8642
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4.7e-01
1.4e-01
1.7e+00
—
1.9e+00
1.1e+00
7.5e-01
cases:2.10%
controls:1.32%
cases:1.16%
controls:1.01%
cases:0.83%
controls:0.15%
—
—
cases:0.92%
controls:0.14%
cases:2.61%
controls:0.86%
cases:4.98%
controls:2.41%
25
156
1168
11670
14
121
1194
11825
10
18
1198
11928
—
11
17
1188
11915
31
102
1159
11690
56
266
1068
10768
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
4.8e-01
1.4e+00
—
1.0e+50
2.4e+00
1.6e+00
3.7e-01
cases:0.67%
controls:0.41%
cases:0.99%
controls:0.25%
—
—
cases:0.99%
controls:0.00%
cases:0.92%
controls:0.08%
cases:1.76%
controls:0.35%
cases:1.69%
controls:1.18%
8
49
1185
11777
12
30
1196
11916
—
12
0
1196
11946
11
10
1188
11922
21
41
1169
11751
19
130
1105
10904
Electrophysiological investigation
TFP34 [2001303229]
1.0e+00
1.8e+00
—
—
—
2.9e+00
2.4e+00
cases:0.84%
controls:0.30%
cases:0.58%
controls:0.10%
—
—
—
—
—
—
cases:1.09%
controls:0.06%
cases:1.16%
controls:0.11%
10
35
1183
11791
7
12
1201
11934
—
—
—
13
7
1177
11785
13
12
1111
11022
Heart failure
I50 [45581779]
1.9e+00
2.1e+00
—
—
—
1.6e+00
1.3e+00
cases:1.34%
controls:0.20%
cases:0.66%
controls:0.08%
—
—
—
—
—
—
cases:0.42%
controls:0.08%
cases:1.51%
controls:0.41%
16
24
1177
11802
8
10
1200
11936
—
—
—
5
10
1185
11782
17
45
1107
10989
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
5.8e-02
5.5e-01
1.1e+00
2.2e+00
9.4e-01
2.5e-01
2.3e-01
cases:23.89%
controls:22.86%
cases:27.81%
controls:18.14%
cases:9.19%
controls:3.38%
cases:1.99%
controls:0.23%
cases:8.17%
controls:3.37%
cases:23.45%
controls:19.32%
cases:47.15%
controls:41.37%
285
2703
908
9123
336
2167
872
9779
111
404
1097
11542
24
27
1184
11919
98
402
1101
11530
279
2278
911
9514
530
4565
594
6469
Office Visit
OMOP4822458 [581477]
6.1e-02
1.1e+00
1.4e+00
—
2.0e+00
8.0e-01
2.4e-01
cases:10.06%
controls:9.52%
cases:9.60%
controls:3.57%
cases:1.99%
controls:0.50%
—
—
cases:3.42%
controls:0.49%
cases:6.72%
controls:3.14%
cases:8.81%
controls:7.06%
120
1126
1073
10700
116
427
1092
11519
24
60
1184
11886
—
41
58
1158
11874
80
370
1110
11422
99
779
1025
10255
Pediatric Medicine
37 [38004477]
-1.1e-01
-4.6e-02
1.3e-01
3.9e+00
8.1e-01
4.7e-01
3.5e-01
cases:6.20%
controls:6.87%
cases:4.72%
controls:4.93%
cases:1.41%
controls:1.24%
cases:4.80%
controls:0.10%
cases:2.67%
controls:1.21%
cases:6.13%
controls:3.91%
cases:7.83%
controls:5.65%
74
813
1119
11013
57
589
1151
11357
17
148
1191
11798
58
12
1150
11934
32
144
1167
11788
73
461
1117
11331
88
623
1036
10411
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
9.6e-02
8.3e-01
1.0e+00
2.2e+00
8.6e-01
2.9e-01
2.0e-01
cases:20.12%
controls:18.62%
cases:23.34%
controls:11.68%
cases:4.14%
controls:1.49%
cases:0.58%
controls:0.07%
cases:3.42%
controls:1.48%
cases:16.72%
controls:13.10%
cases:39.95%
controls:35.25%
240
2202
953
9624
282
1395
926
10551
50
178
1158
11768
7
8
1201
11938
41
177
1158
11755
199
1545
991
10247
449
3889
675
7145
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
5.7e-01
1.1e+00
—
1.0e+50
2.8e+00
1.6e+00
6.7e-01
cases:0.84%
controls:0.47%
cases:0.99%
controls:0.34%
—
—
cases:1.90%
controls:0.00%
cases:1.67%
controls:0.10%
cases:2.44%
controls:0.51%
cases:3.56%
controls:1.85%
10
56
1183
11770
12
41
1196
11905
—
23
0
1185
11946
20
12
1179
11920
29
60
1161
11732
40
204
1084
10830
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
9.8e-02
9.3e-01
—
—
1.6e+00
1.7e+00
8.5e-01
cases:1.26%
controls:1.14%
cases:1.57%
controls:0.63%
—
—
—
—
cases:1.00%
controls:0.20%
cases:4.03%
controls:0.79%
cases:4.36%
controls:1.90%
15
135
1178
11691
19
75
1189
11871
—
—
12
24
1187
11908
48
93
1142
11699
49
210
1075
10824
Dilated cardiomyopathy
I42.0 [45586581]
1.1e+00
1.6e+00
—
—
1.9e+00
2.0e+00
1.4e+00
cases:1.01%
controls:0.32%
cases:1.16%
controls:0.23%
—
—
—
—
cases:0.50%
controls:0.08%
cases:1.51%
controls:0.21%
cases:1.51%
controls:0.37%
12
38
1181
11788
14
27
1194
11919
—
—
6
9
1193
11923
18
25
1172
11767
17
41
1107
10993
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.2e-01
8.1e-01
1.0e+00
2.3e+00
8.6e-01
2.6e-01
2.0e-01
cases:20.70%
controls:18.87%
cases:23.51%
controls:12.04%
cases:4.14%
controls:1.53%
cases:0.58%
controls:0.06%
cases:3.59%
controls:1.54%
cases:16.81%
controls:13.47%
cases:40.57%
controls:35.78%
247
2231
946
9595
284
1438
924
10508
50
183
1158
11763
7
7
1201
11939
43
184
1156
11748
200
1588
990
10204
456
3948
668
7086
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.1e-01
7.5e-01
1.1e+00
2.2e+00
7.7e-01
2.3e-01
2.1e-01
cases:21.29%
controls:19.52%
cases:24.25%
controls:13.18%
cases:4.55%
controls:1.62%
cases:0.66%
controls:0.08%
cases:3.50%
controls:1.65%
cases:17.98%
controls:14.78%
cases:42.44%
controls:37.32%
254
2308
939
9518
293
1575
915
10371
55
193
1153
11753
8
9
1200
11937
42
197
1157
11735
214
1743
976
10049
477
4118
647
6916
Differential panel, method unspecified - Blood
69738-3 [42870588]
-7.3e-02
5.5e-01
2.1e+00
—
1.5e+00
5.5e-01
3.4e-01
cases:4.53%
controls:4.85%
cases:6.71%
controls:3.98%
cases:5.88%
controls:0.80%
—
—
cases:4.00%
controls:0.94%
cases:6.89%
controls:4.09%
cases:12.01%
controls:8.89%
54
574
1139
11252
81
475
1127
11471
71
95
1137
11851
—
48
112
1151
11820
82
482
1108
11310
135
981
989
10053
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
5.4e-01
1.6e+00
—
—
—
2.0e+00
1.3e+00
cases:0.42%
controls:0.25%
cases:0.83%
controls:0.17%
—
—
—
—
—
—
cases:0.84%
controls:0.11%
cases:1.25%
controls:0.34%
5
29
1188
11797
10
20
1198
11926
—
—
—
10
13
1180
11779
14
37
1110
10997
Electroanatomical mapping
TFP35 [2001303230]
1.4e+00
2.6e+00
—
—
—
—
2.3e+00
cases:0.42%
controls:0.10%
cases:0.58%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.05%
5
12
1188
11814
7
5
1201
11941
—
—
—
—
6
6
1118
11028
Ablation treatment of atrial fibrillation
TFP46 [2001303239]
2.3e+00
2.6e+00
—
—
—
—
—
cases:1.01%
controls:0.10%
cases:0.66%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
12
12
1181
11814
8
6
1200
11940
—
—
—
—
—
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.9e-01
6.9e-01
6.8e-01
—
2.1e+00
1.3e+00
8.1e-01
cases:2.18%
controls:1.80%
cases:2.57%
controls:1.30%
cases:0.58%
controls:0.29%
—
—
cases:2.59%
controls:0.32%
cases:4.20%
controls:1.24%
cases:7.03%
controls:3.24%
26
213
1167
11613
31
155
1177
11791
7
35
1201
11911
—
31
38
1168
11894
50
146
1140
11646
79
358
1045
10676
Hyperlipidaemia, unspecified
E78.5 [45537986]
4.4e-01
1.4e+00
1.6e+00
1.0e+50
2.1e+00
1.3e+00
5.3e-01
cases:1.26%
controls:0.81%
cases:1.49%
controls:0.39%
cases:0.41%
controls:0.08%
cases:0.66%
controls:0.00%
cases:0.50%
controls:0.06%
cases:1.26%
controls:0.34%
cases:2.40%
controls:1.42%
15
96
1178
11730
18
46
1190
11900
5
10
1203
11936
8
0
1200
11946
6
7
1193
11925
15
40
1175
11752
27
157
1097
10877
Monocytes [#/volume] in Blood
26484-6 [3001604]
-1.1e-01
5.3e-01
1.9e+00
—
1.5e+00
5.8e-01
3.3e-01
cases:7.12%
controls:7.86%
cases:9.44%
controls:5.78%
cases:7.37%
controls:1.21%
—
—
cases:5.09%
controls:1.19%
cases:9.92%
controls:5.78%
cases:17.97%
controls:13.56%
85
930
1108
10896
114
690
1094
11256
89
145
1119
11801
—
61
142
1138
11790
118
682
1072
11110
202
1496
922
9538
Basophils [#/volume] in Blood
26444-0 [3006315]
-8.7e-02
5.4e-01
1.9e+00
—
1.5e+00
5.8e-01
3.3e-01
cases:7.29%
controls:7.91%
cases:9.52%
controls:5.78%
cases:7.37%
controls:1.21%
—
—
cases:5.09%
controls:1.20%
cases:9.92%
controls:5.79%
cases:17.97%
controls:13.58%
87
935
1106
10891
115
691
1093
11255
89
145
1119
11801
—
61
143
1138
11789
118
683
1072
11109
202
1498
922
9536
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
1.6e-01
7.8e-01
8.9e-01
2.1e+00
7.9e-01
2.3e-01
2.7e-01
cases:20.37%
controls:17.94%
cases:22.27%
controls:11.62%
cases:3.56%
controls:1.50%
cases:0.66%
controls:0.08%
cases:3.50%
controls:1.63%
cases:14.54%
controls:11.96%
cases:37.90%
controls:31.77%
243
2121
950
9705
269
1388
939
10558
43
179
1165
11767
8
10
1200
11936
42
194
1157
11738
173
1410
1017
10382
426
3506
698
7528
Basophils/Leukocytes in Blood
30180-4 [3022096]
-6.6e-02
5.6e-01
1.9e+00
—
1.4e+00
5.2e-01
3.3e-01
cases:7.21%
controls:7.66%
cases:9.35%
controls:5.56%
cases:7.37%
controls:1.16%
—
—
cases:4.75%
controls:1.18%
cases:8.91%
controls:5.47%
cases:16.46%
controls:12.45%
86
906
1107
10920
113
664
1095
11282
89
138
1119
11808
—
57
141
1142
11791
106
645
1084
11147
185
1374
939
9660
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-8.3e-02
5.3e-01
1.9e+00
—
1.5e+00
5.6e-01
3.1e-01
cases:7.63%
controls:8.24%
cases:9.85%
controls:6.02%
cases:7.37%
controls:1.21%
—
—
cases:5.09%
controls:1.22%
cases:10.00%
controls:5.94%
cases:18.15%
controls:14.00%
91
974
1102
10852
119
719
1089
11227
89
145
1119
11801
—
61
145
1138
11787
119
701
1071
11091
204
1545
920
9489
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
7.8e-01
6.2e-01
—
1.0e+50
3.2e+00
1.6e+00
7.0e-01
cases:0.59%
controls:0.27%
cases:0.50%
controls:0.27%
—
—
cases:1.16%
controls:0.00%
cases:1.17%
controls:0.05%
cases:1.60%
controls:0.33%
cases:2.40%
controls:1.21%
7
32
1186
11794
6
32
1202
11914
—
14
0
1194
11946
14
6
1185
11926
19
39
1171
11753
27
133
1097
10901
Migraine with aura [classical migraine]
G43.1 [45562086]
8.3e-01
1.7e+00
—
1.0e+50
2.1e+00
1.8e+00
1.2e+00
cases:1.42%
controls:0.63%
cases:2.07%
controls:0.38%
—
—
cases:0.41%
controls:0.00%
cases:0.42%
controls:0.05%
cases:1.93%
controls:0.33%
cases:3.20%
controls:0.96%
17
74
1176
11752
25
45
1183
11901
—
5
0
1203
11946
5
6
1194
11926
23
39
1167
11753
36
106
1088
10928
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-7.2e-02
5.6e-01
1.9e+00
—
1.4e+00
5.1e-01
3.1e-01
cases:7.21%
controls:7.70%
cases:9.35%
controls:5.58%
cases:7.37%
controls:1.16%
—
—
cases:4.75%
controls:1.18%
cases:8.82%
controls:5.47%
cases:16.28%
controls:12.51%
86
911
1107
10915
113
666
1095
11280
89
138
1119
11808
—
57
141
1142
11791
105
645
1085
11147
183
1380
941
9654
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-8.5e-02
5.5e-01
1.9e+00
—
1.4e+00
5.1e-01
3.1e-01
cases:7.12%
controls:7.71%
cases:9.27%
controls:5.59%
cases:7.37%
controls:1.16%
—
—
cases:4.75%
controls:1.18%
cases:8.82%
controls:5.47%
cases:16.37%
controls:12.52%
85
912
1108
10914
112
668
1096
11278
89
138
1119
11808
—
57
141
1142
11791
105
645
1085
11147
184
1382
940
9652
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.7e-02
9.8e-01
—
1.0e+50
—
2.9e+00
1.8e+00
cases:0.67%
controls:0.66%
cases:0.91%
controls:0.34%
—
—
cases:1.16%
controls:0.00%
—
—
cases:3.45%
controls:0.19%
cases:2.67%
controls:0.47%
8
78
1185
11748
11
41
1197
11905
—
14
0
1194
11946
—
41
22
1149
11770
30
52
1094
10982
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-1.3e-01
5.2e-01
1.8e+00
—
1.8e+00
5.9e-01
3.0e-01
cases:4.53%
controls:5.14%
cases:4.72%
controls:2.86%
cases:2.32%
controls:0.39%
—
—
cases:2.59%
controls:0.44%
cases:4.79%
controls:2.72%
cases:11.30%
controls:8.66%
54
608
1139
11218
57
342
1151
11604
28
47
1180
11899
—
31
52
1168
11880
57
321
1133
11471
127
955
997
10079
amoxicillin; oral, parenteral
J01CA04 [21602823]
3.5e-01
7.5e-01
9.6e-01
—
9.0e-01
9.5e-01
7.7e-01
cases:31.01%
controls:24.03%
cases:14.16%
controls:7.22%
cases:1.82%
controls:0.70%
—
—
cases:2.00%
controls:0.82%
cases:16.89%
controls:7.28%
cases:36.57%
controls:21.04%
370
2842
823
8984
171
862
1037
11084
22
84
1186
11862
—
24
98
1175
11834
201
859
989
10933
411
2322
713
8712
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 [2001700354]
1.8e-01
6.9e-01
1.1e+00
—
1.8e+00
1.1e+00
4.1e-01
cases:6.12%
controls:5.17%
cases:3.97%
controls:2.03%
cases:1.57%
controls:0.54%
—
—
cases:2.34%
controls:0.39%
cases:5.29%
controls:1.81%
cases:7.38%
controls:5.04%
73
611
1120
11215
48
243
1160
11703
19
64
1189
11882
—
28
47
1171
11885
63
213
1127
11579
83
556
1041
10478
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-8.9e-02
5.4e-01
1.8e+00
—
1.5e+00
5.6e-01
3.0e-01
cases:7.71%
controls:8.37%
cases:9.93%
controls:6.06%
cases:7.37%
controls:1.31%
—
—
cases:5.25%
controls:1.27%
cases:10.00%
controls:5.97%
cases:18.24%
controls:14.16%
92
990
1101
10836
120
724
1088
11222
89
157
1119
11789
—
63
152
1136
11780
119
704
1071
11088
205
1562
919
9472
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
1.5e+00
3.1e+00
1.0e+50
1.0e+50
—
1.3e+00
6.3e-01
cases:1.84%
controls:0.41%
cases:3.73%
controls:0.18%
cases:0.41%
controls:0.00%
cases:0.75%
controls:0.00%
—
—
cases:0.84%
controls:0.22%
cases:1.16%
controls:0.62%
22
48
1171
11778
45
21
1163
11925
5
0
1203
11946
9
0
1199
11946
—
10
26
1180
11766
13
68
1111
10966
Case Management Agency
251B00000X [38004193]
2.3e-02
2.7e-01
5.5e-01
2.8e+00
6.0e-01
3.5e-01
1.5e-01
cases:55.91%
controls:55.35%
cases:54.55%
controls:47.71%
cases:28.15%
controls:18.43%
cases:15.40%
controls:1.05%
cases:29.02%
controls:18.40%
cases:59.50%
controls:50.81%
cases:76.16%
controls:73.35%
667
6546
526
5280
659
5700
549
6246
340
2202
868
9744
186
125
1022
11821
348
2195
851
9737
708
5992
482
5800
856
8093
268
2941
Aortic (valve) stenosis with insufficiency
I35.2 [45562346]
1.2e+00
2.2e+00
—
1.0e+50
—
2.4e+00
1.3e+00
cases:0.50%
controls:0.15%
cases:0.58%
controls:0.07%
—
—
cases:0.58%
controls:0.00%
—
—
cases:0.67%
controls:0.06%
cases:0.89%
controls:0.24%
6
18
1187
11808
7
8
1201
11938
—
7
0
1201
11946
—
8
7
1182
11785
10
27
1114
11007
Electrocardiogram with exercise test
46136006 [4261794]
1.1e+00
1.9e+00
—
1.0e+50
—
1.4e+00
1.6e+00
cases:2.93%
controls:0.98%
cases:1.99%
controls:0.30%
—
—
cases:1.08%
controls:0.00%
—
—
cases:0.76%
controls:0.20%
cases:3.74%
controls:0.82%
35
116
1158
11710
24
36
1184
11910
—
13
0
1195
11946
—
9
23
1181
11769
42
90
1082
10944
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
2.3e-01
1.0e+00
1.5e+00
—
2.2e+00
1.3e+00
6.1e-01
cases:1.42%
controls:1.13%
cases:1.66%
controls:0.59%
cases:0.58%
controls:0.13%
—
—
cases:0.58%
controls:0.07%
cases:2.02%
controls:0.55%
cases:2.94%
controls:1.61%
17
134
1176
11692
20
71
1188
11875
7
15
1201
11931
—
7
8
1192
11924
24
65
1166
11727
33
178
1091
10856
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.1e-01
6.8e-01
1.5e+00
2.1e+00
1.3e+00
5.7e-01
4.3e-01
cases:5.95%
controls:5.38%
cases:7.28%
controls:3.82%
cases:2.98%
controls:0.66%
cases:0.41%
controls:0.05%
cases:2.67%
controls:0.74%
cases:6.55%
controls:3.82%
cases:14.86%
controls:10.22%
71
636
1122
11190
88
456
1120
11490
36
79
1172
11867
5
6
1203
11940
32
88
1167
11844
78
451
1112
11341
167
1128
957
9906
Subjective visual disturbances
H53.1 [45557467]
6.2e-01
1.8e+00
—
—
—
2.7e+00
4.3e-01
cases:0.67%
controls:0.36%
cases:0.83%
controls:0.13%
—
—
—
—
—
—
cases:1.34%
controls:0.09%
cases:1.07%
controls:0.70%
8
43
1185
11783
10
16
1198
11930
—
—
—
16
11
1174
11781
12
77
1112
10957
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
4.7e-01
5.7e-01
—
—
2.5e+00
1.4e+00
5.4e-01
cases:1.42%
controls:0.90%
cases:1.16%
controls:0.66%
—
—
—
—
cases:1.50%
controls:0.13%
cases:3.45%
controls:0.83%
cases:4.36%
controls:2.59%
17
106
1176
11720
14
79
1194
11867
—
—
18
15
1181
11917
41
98
1149
11694
49
286
1075
10748
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
5.1e-01
8.1e-01
1.2e+00
—
2.0e+00
1.0e+00
6.4e-01
cases:2.26%
controls:1.37%
cases:2.32%
controls:1.05%
cases:0.58%
controls:0.17%
—
—
cases:1.08%
controls:0.15%
cases:2.94%
controls:1.05%
cases:5.96%
controls:3.24%
27
162
1166
11664
28
125
1180
11821
7
20
1201
11926
—
13
18
1186
11914
35
124
1155
11668
67
357
1057
10677
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-4.6e-02
5.3e-01
1.9e+00
—
1.5e+00
5.1e-01
2.8e-01
cases:7.38%
controls:7.69%
cases:9.02%
controls:5.52%
cases:7.20%
controls:1.10%
—
—
cases:4.34%
controls:1.02%
cases:8.66%
controls:5.37%
cases:16.19%
controls:12.79%
88
910
1105
10916
109
659
1099
11287
87
132
1121
11814
—
52
122
1147
11810
103
633
1087
11159
182
1411
942
9623
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
3.3e-01
7.8e-01
1.1e+00
—
2.0e+00
1.0e+00
6.9e-01
cases:1.76%
controls:1.28%
cases:2.15%
controls:1.00%
cases:0.50%
controls:0.17%
—
—
cases:1.00%
controls:0.14%
cases:2.77%
controls:1.01%
cases:5.69%
controls:2.95%
21
151
1172
11675
26
119
1182
11827
6
20
1202
11926
—
12
17
1187
11915
33
119
1157
11673
64
325
1060
10709
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.2e-02
7.5e-01
7.1e-01
—
1.7e+00
1.2e+00
7.7e-01
cases:1.26%
controls:1.24%
cases:2.24%
controls:1.07%
cases:0.58%
controls:0.28%
—
—
cases:1.83%
controls:0.34%
cases:3.28%
controls:1.00%
cases:4.54%
controls:2.16%
15
147
1178
11679
27
128
1181
11818
7
34
1201
11912
—
22
40
1177
11892
39
118
1151
11674
51
238
1073
10796
Very extensive MRI examination of heart with high intesity magnet
FM1DG [2001303301]
1.9e+00
—
—
1.0e+50
—
—
2.5e+00
cases:0.75%
controls:0.11%
—
—
—
—
cases:0.83%
controls:0.00%
—
—
—
—
cases:1.07%
controls:0.09%
9
13
1184
11813
—
—
10
0
1198
11946
—
—
12
10
1112
11024
Hypertensive heart disease without (congestive) heart failure
I11.9 [45576863]
1.5e+00
1.8e+00
—
—
—
—
1.1e+00
cases:1.09%
controls:0.25%
cases:0.66%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.38%
13
30
1180
11796
8
13
1200
11933
—
—
—
—
13
42
1111
10992
Coronary angiography
AN1 [2000200163]
5.7e-01
2.3e+00
—
—
—
2.0e+00
2.7e-01
cases:2.18%
controls:1.24%
cases:2.81%
controls:0.28%
—
—
—
—
—
—
cases:1.43%
controls:0.19%
cases:0.98%
controls:0.75%
26
147
1167
11679
34
33
1174
11913
—
—
—
17
22
1173
11770
11
83
1113
10951
Pharmacy visit
OMOP4822462 [581458]
1.0e-01
5.0e-01
6.3e-01
8.7e-01
7.5e-01
8.8e-01
7.4e-01
cases:91.03%
controls:90.17%
cases:86.59%
controls:79.67%
cases:55.05%
controls:39.46%
cases:5.46%
controls:2.37%
cases:57.88%
controls:39.44%
cases:90.50%
controls:79.80%
cases:97.15%
controls:94.19%
1086
10663
107
1163
1046
9517
162
2429
665
4714
543
7232
66
283
1142
11663
694
4706
505
7226
1077
9410
113
2382
1092
10393
32
641
atorvastatin; oral
C10AA05 [21601860]
-1.9e-02
8.9e-01
8.5e-01
—
1.1e+00
8.9e-01
6.3e-01
cases:6.87%
controls:6.99%
cases:13.16%
controls:5.87%
cases:3.64%
controls:1.59%
—
—
cases:4.67%
controls:1.60%
cases:14.29%
controls:6.39%
cases:17.62%
controls:10.20%
82
827
1111
10999
159
701
1049
11245
44
190
1164
11756
—
56
191
1143
11741
170
754
1020
11038
198
1125
926
9909
More than five and less than seven hours
ZXE30 [2001311411]
3.4e-01
7.1e-01
—
1.0e+50
—
2.6e+00
1.7e+00
cases:0.84%
controls:0.60%
cases:0.58%
controls:0.28%
—
—
cases:2.48%
controls:0.00%
—
—
cases:1.51%
controls:0.11%
cases:1.07%
controls:0.19%
10
71
1183
11755
7
34
1201
11912
—
30
0
1178
11946
—
18
13
1172
11779
12
21
1112
11013
potassium chloride; oral
A12BA01 [21600877]
7.8e-01
1.2e+00
1.2e+00
—
1.2e+00
1.4e+00
9.2e-01
cases:2.18%
controls:1.01%
cases:2.15%
controls:0.67%
cases:0.41%
controls:0.13%
—
—
cases:0.67%
controls:0.19%
cases:2.69%
controls:0.69%
cases:4.09%
controls:1.68%
26
120
1167
11706
26
80
1182
11866
5
15
1203
11931
—
8
23
1191
11909
32
81
1158
11711
46
185
1078
10849
Gas panel - Arterial blood
24336-0 [3019060]
3.5e-01
1.1e+00
—
1.0e+50
2.7e+00
1.6e+00
6.7e-01
cases:0.59%
controls:0.41%
cases:0.83%
controls:0.27%
—
—
cases:0.99%
controls:0.00%
cases:1.08%
controls:0.08%
cases:1.43%
controls:0.30%
cases:2.05%
controls:1.06%
7
49
1186
11777
10
32
1198
11914
—
12
0
1196
11946
13
9
1186
11923
17
35
1173
11757
23
117
1101
10917
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
1.3e-01
4.3e-01
8.1e-01
2.0e+00
7.3e-01
2.2e-01
2.5e-01
cases:15.67%
controls:13.98%
cases:12.58%
controls:8.57%
cases:2.48%
controls:1.12%
cases:0.50%
controls:0.07%
cases:2.42%
controls:1.18%
cases:10.67%
controls:8.75%
cases:29.72%
controls:24.76%
187
1653
1006
10173
152
1024
1056
10922
30
134
1178
11812
6
8
1202
11938
29
141
1170
11791
127
1032
1063
10760
334
2732
790
8302
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
-5.3e-02
6.6e-01
6.3e-01
2.6e+00
9.6e-01
2.1e-01
2.0e-01
cases:10.73%
controls:11.25%
cases:12.00%
controls:6.61%
cases:1.82%
controls:0.98%
cases:0.66%
controls:0.05%
cases:2.67%
controls:1.04%
cases:7.98%
controls:6.59%
cases:21.62%
controls:18.41%
128
1330
1065
10496
145
790
1063
11156
22
117
1186
11829
8
6
1200
11940
32
124
1167
11808
95
777
1095
11015
243
2031
881
9003
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
—
1.7e+00
—
1.0e+50
2.6e+00
1.5e+00
4.0e-01
—
—
cases:0.58%
controls:0.11%
—
—
cases:0.75%
controls:0.00%
cases:0.58%
controls:0.04%
cases:0.92%
controls:0.20%
cases:1.07%
controls:0.72%
—
7
13
1201
11933
—
9
0
1199
11946
7
5
1192
11927
11
24
1179
11768
12
79
1112
10955
Homocysteine [Moles/volume] in Serum or Plasma
13965-9 [3016724]
1.8e+00
4.1e+00
—
—
—
—
—
cases:0.59%
controls:0.10%
cases:3.89%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
7
12
1186
11814
47
8
1161
11938
—
—
—
—
—
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
4.9e-01
7.4e-01
1.3e+00
—
1.8e+00
9.5e-01
5.8e-01
cases:2.43%
controls:1.51%
cases:2.32%
controls:1.12%
cases:0.66%
controls:0.18%
—
—
cases:0.92%
controls:0.15%
cases:2.94%
controls:1.16%
cases:6.41%
controls:3.70%
29
178
1164
11648
28
134
1180
11812
8
22
1200
11924
—
11
18
1188
11914
35
137
1155
11655
72
408
1052
10626
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
8.3e-02
7.0e-01
7.8e-01
2.6e+00
6.3e-01
1.1e-01
1.4e-01
cases:15.67%
controls:14.61%
cases:19.95%
controls:10.98%
cases:3.31%
controls:1.55%
cases:0.66%
controls:0.05%
cases:2.75%
controls:1.49%
cases:13.45%
controls:12.25%
cases:35.05%
controls:32.02%
187
1728
1006
10098
241
1312
967
10634
40
185
1168
11761
8
6
1200
11940
33
178
1166
11754
160
1444
1030
10348
394
3533
730
7501
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
-9.6e-02
4.1e-01
5.3e-01
2.4e+00
9.2e-01
3.3e-01
2.9e-01
cases:9.64%
controls:10.51%
cases:8.20%
controls:5.58%
cases:1.66%
controls:0.98%
cases:0.66%
controls:0.06%
cases:2.17%
controls:0.87%
cases:7.48%
controls:5.50%
cases:20.64%
controls:16.29%
115
1243
1078
10583
99
667
1109
11279
20
117
1188
11829
8
7
1200
11939
26
104
1173
11828
89
649
1101
11143
232
1797
892
9237
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.0e+00
5.8e-01
1.7e+00
—
2.2e+00
7.4e-01
7.8e-01
cases:1.34%
controls:0.50%
cases:0.91%
controls:0.51%
cases:0.41%
controls:0.08%
—
—
cases:0.58%
controls:0.07%
cases:1.01%
controls:0.48%
cases:4.00%
controls:1.87%
16
59
1177
11767
11
61
1197
11885
5
9
1203
11937
—
7
8
1192
11924
12
57
1178
11735
45
206
1079
10828
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
-1.6e-01
1.3e+00
—
—
2.6e+00
2.6e-01
4.5e-01
cases:0.67%
controls:0.79%
cases:1.66%
controls:0.45%
—
—
—
—
cases:0.58%
controls:0.04%
cases:0.67%
controls:0.52%
cases:2.05%
controls:1.31%
8
93
1185
11733
20
54
1188
11892
—
—
7
5
1192
11927
8
61
1182
11731
23
145
1101
10889
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
-3.5e-01
1.1e+00
—
—
2.9e+00
5.3e-01
2.8e-01
cases:1.09%
controls:1.54%
cases:2.65%
controls:0.94%
—
—
—
—
cases:0.75%
controls:0.04%
cases:1.26%
controls:0.75%
cases:3.83%
controls:2.91%
13
182
1180
11644
32
112
1176
11834
—
—
9
5
1190
11927
15
88
1175
11704
43
321
1081
10713
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
3.5e-01
7.9e-01
—
—
2.5e+00
1.4e+00
5.7e-01
cases:1.01%
controls:0.71%
cases:1.32%
controls:0.60%
—
—
—
—
cases:1.08%
controls:0.09%
cases:2.02%
controls:0.50%
cases:3.38%
controls:1.94%
12
84
1181
11742
16
72
1192
11874
—
—
13
11
1186
11921
24
59
1166
11733
38
214
1086
10820
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.7e-01
4.6e-01
9.1e-01
—
2.3e+00
1.1e+00
5.3e-01
cases:2.85%
controls:2.43%
cases:2.65%
controls:1.69%
cases:0.58%
controls:0.23%
—
—
cases:1.50%
controls:0.16%
cases:4.71%
controls:1.67%
cases:9.61%
controls:5.86%
34
287
1159
11539
32
202
1176
11744
7
28
1201
11918
—
18
19
1181
11913
56
197
1134
11595
108
647
1016
10387
Adjustment and management of cardiac devices
Z45.0 [45595515]
1.0e+00
1.3e+00
—
—
—
2.1e+00
1.8e+00
cases:0.75%
controls:0.28%
cases:0.75%
controls:0.20%
—
—
—
—
—
—
cases:1.18%
controls:0.15%
cases:2.31%
controls:0.40%
9
33
1184
11793
9
24
1199
11922
—
—
—
14
18
1176
11774
26
44
1098
10990
More than three and less than five hours
ZXE20 [2001311408]
1.8e-01
7.0e-01
—
1.0e+50
—
2.5e+00
1.3e+00
cases:2.18%
controls:1.83%
cases:0.91%
controls:0.45%
—
—
cases:3.48%
controls:0.00%
—
—
cases:3.03%
controls:0.26%
cases:2.67%
controls:0.71%
26
216
1167
11610
11
54
1197
11892
—
42
0
1166
11946
—
36
31
1154
11761
30
78
1094
10956
Presence of aortocoronary bypass graft
Z95.1 [45556881]
—
—
—
—
—
2.3e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.08%
cases:1.51%
controls:0.34%
—
—
—
—
—
9
9
1181
11783
17
37
1107
10997
Social worker
Z2446 [2001311559]
-1.6e-01
9.6e-01
—
—
—
1.6e+00
1.3e+00
cases:1.17%
controls:1.38%
cases:1.32%
controls:0.51%
—
—
—
—
—
—
cases:0.84%
controls:0.18%
cases:1.42%
controls:0.41%
14
163
1179
11663
16
61
1192
11885
—
—
—
10
21
1180
11771
16
45
1108
10989
Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
75515-7 [46235128]
1.2e+00
3.8e+00
—
—
—
—
—
cases:0.42%
controls:0.13%
cases:2.15%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
5
15
1188
11811
26
6
1182
11940
—
—
—
—
—
Cardiac murmur, unspecified
R01.1 [45548943]
1.5e+00
3.7e+00
—
—
—
—
-1.0e+50
cases:0.50%
controls:0.12%
cases:1.74%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
6
14
1187
11812
21
5
1187
11941
—
—
—
—
0
19
1124
11015
Fractional oxyhemoglobin in Venous blood
2716-9 [3019230]
—
—
—
1.0e+50
—
2.5e+00
1.3e+00
—
—
—
—
—
—
cases:0.41%
controls:0.00%
—
—
cases:1.18%
controls:0.10%
cases:1.69%
controls:0.49%
—
—
—
5
0
1203
11946
—
14
12
1176
11780
19
54
1105
10980
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.6e-01
5.5e-01
6.9e-01
—
1.7e+00
9.1e-01
5.2e-01
cases:7.63%
controls:6.58%
cases:4.14%
controls:2.44%
cases:0.99%
controls:0.50%
—
—
cases:2.75%
controls:0.50%
cases:5.46%
controls:2.26%
cases:9.88%
controls:6.10%
91
778
1102
11048
50
291
1158
11655
12
60
1196
11886
—
33
60
1166
11872
65
267
1125
11525
111
673
1013
10361
Evaluation of communicative skills
R1260 [2001310179]
—
3.7e+00
—
—
—
—
—
—
—
cases:1.66%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
20
5
1188
11941
—
—
—
—
—
Extensive CT of neck arteries
PA6BD [2001308697]
6.9e-01
3.7e+00
—
—
—
—
—
cases:0.50%
controls:0.25%
cases:2.57%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
6
30
1187
11796
31
8
1177
11938
—
—
—
—
—
Bacteria identified in Blood by Culture
600-7 [3023368]
-2.1e-01
6.0e-01
1.2e+00
—
2.3e+00
8.0e-01
5.9e-01
cases:1.93%
controls:2.38%
cases:2.73%
controls:1.52%
cases:0.83%
controls:0.26%
—
—
cases:1.92%
controls:0.20%
cases:3.11%
controls:1.42%
cases:8.36%
controls:4.79%
23
281
1170
11545
33
182
1175
11764
10
31
1198
11915
—
23
24
1176
11908
37
168
1153
11624
94
529
1030
10505
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
2.9e-02
2.8e-01
5.4e-01
—
1.6e+00
1.3e+00
6.8e-01
cases:0.92%
controls:0.90%
cases:1.49%
controls:1.13%
cases:0.41%
controls:0.24%
—
—
cases:1.25%
controls:0.24%
cases:3.28%
controls:0.93%
cases:3.74%
controls:1.93%
11
106
1182
11720
18
135
1190
11811
5
29
1203
11917
—
15
29
1184
11903
39
110
1151
11682
42
213
1082
10821
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
7.5e-01
2.0e+00
—
—
—
1.6e+00
8.0e-01
cases:0.92%
controls:0.44%
cases:1.41%
controls:0.19%
—
—
—
—
—
—
cases:0.76%
controls:0.15%
cases:0.98%
controls:0.44%
11
52
1182
11774
17
23
1191
11923
—
—
—
9
18
1181
11774
11
49
1113
10985
Digoxin [Moles/volume] in Serum or Plasma
14698-5 [3027456]
—
—
—
—
—
2.1e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.08%
cases:1.60%
controls:0.35%
—
—
—
—
—
8
10
1182
11782
18
39
1106
10995
Supraventricular tachycardia
I47.1 [45567178]
6.7e-01
1.9e+00
—
1.0e+50
—
1.7e+00
9.2e-01
cases:0.84%
controls:0.43%
cases:1.08%
controls:0.16%
—
—
cases:1.32%
controls:0.00%
—
—
cases:0.67%
controls:0.13%
cases:1.25%
controls:0.50%
10
51
1183
11775
13
19
1195
11927
—
16
0
1192
11946
—
8
15
1182
11777
14
55
1110
10979
Bacteria identified in Isolate by Culture
43409-2 [3042936]
-2.0e-01
2.6e-01
—
—
2.5e+00
1.0e+00
3.2e-01
cases:1.26%
controls:1.54%
cases:1.08%
controls:0.83%
—
—
—
—
cases:1.17%
controls:0.10%
cases:1.93%
controls:0.70%
cases:3.65%
controls:2.66%
15
182
1178
11644
13
99
1195
11847
—
—
14
12
1185
11920
23
83
1167
11709
41
294
1083
10740
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
8.0e-02
1.0e+00
—
—
1.8e+00
7.3e-01
6.3e-01
cases:1.09%
controls:1.01%
cases:1.99%
controls:0.71%
—
—
—
—
cases:0.67%
controls:0.11%
cases:1.43%
controls:0.70%
cases:5.52%
controls:3.03%
13
119
1180
11707
24
85
1184
11861
—
—
8
13
1191
11919
17
82
1173
11710
62
334
1062
10700
Paraesthesia of skin
R20.2 [45568120]
6.2e-01
1.8e+00
—
—
—
1.6e+00
6.8e-01
cases:0.67%
controls:0.36%
cases:0.75%
controls:0.13%
—
—
—
—
—
—
cases:0.76%
controls:0.15%
cases:1.33%
controls:0.68%
8
43
1185
11783
9
15
1199
11931
—
—
—
9
18
1181
11774
15
75
1109
10959
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
7.9e-02
1.0e+00
9.1e-01
—
1.1e+00
2.3e-01
3.0e-01
cases:11.32%
controls:10.54%
cases:14.07%
controls:5.70%
cases:1.57%
controls:0.64%
—
—
cases:2.34%
controls:0.79%
cases:7.39%
controls:5.96%
cases:23.84%
controls:18.87%
135
1247
1058
10579
170
681
1038
11265
19
76
1189
11870
—
28
94
1171
11838
88
703
1102
11089
268
2082
856
8952
Palpitations
R00.2 [45558446]
1.6e-01
1.6e+00
—
—
—
1.7e+00
3.7e-01
cases:0.59%
controls:0.50%
cases:0.83%
controls:0.17%
—
—
—
—
—
—
cases:0.67%
controls:0.13%
cases:1.51%
controls:1.05%
7
59
1186
11767
10
20
1198
11926
—
—
—
8
15
1182
11777
17
116
1107
10918
verapamil; oral, parenteral
C08DA01 [21601767]
7.3e-01
1.4e+00
—
—
—
1.8e+00
1.5e+00
cases:0.75%
controls:0.36%
cases:0.75%
controls:0.18%
—
—
—
—
—
—
cases:0.67%
controls:0.11%
cases:1.42%
controls:0.34%
9
43
1184
11783
9
22
1199
11924
—
—
—
8
13
1182
11779
16
37
1108
10997
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.7e-02
1.1e+00
—
—
2.2e+00
8.4e-01
4.9e-01
cases:0.67%
controls:0.66%
cases:1.57%
controls:0.54%
—
—
—
—
cases:0.58%
controls:0.07%
cases:1.18%
controls:0.51%
cases:3.65%
controls:2.26%
8
78
1185
11748
19
64
1189
11882
—
—
7
8
1192
11924
14
60
1176
11732
41
249
1083
10785
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
208G00000X [38004023]
2.2e-01
-1.0e+50
—
1.0e+50
—
3.2e+00
—
cases:0.42%
controls:0.34%
cases:0.00%
controls:0.07%
—
—
cases:0.83%
controls:0.00%
—
—
cases:1.93%
controls:0.08%
—
—
5
40
1188
11786
0
8
1208
11938
—
10
0
1198
11946
—
23
9
1167
11783
—
Puncture of pleura with ultrasound guidance
GA4YT [2001303531]
—
—
—
—
1.0e+50
3.2e+00
1.4e+00
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.00%
cases:1.26%
controls:0.05%
cases:0.44%
controls:0.11%
—
—
—
—
6
0
1193
11932
15
6
1175
11786
5
12
1119
11022
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
4.4e-01
1.5e+00
—
1.0e+50
—
1.7e+00
9.6e-01
cases:0.67%
controls:0.43%
cases:0.75%
controls:0.16%
—
—
cases:0.41%
controls:0.00%
—
—
cases:0.76%
controls:0.14%
cases:1.25%
controls:0.48%
8
51
1185
11775
9
19
1199
11927
—
5
0
1203
11946
—
9
17
1181
11775
14
53
1110
10981
Telehealth
OMOP5556618 [722455]
6.8e-02
3.9e-01
6.0e-01
—
1.2e+00
6.6e-01
3.3e-01
cases:23.13%
controls:21.94%
cases:14.32%
controls:10.17%
cases:3.31%
controls:1.85%
—
—
cases:4.84%
controls:1.48%
cases:16.64%
controls:9.38%
cases:26.42%
controls:20.46%
276
2595
917
9231
173
1215
1035
10731
40
221
1168
11725
—
58
177
1141
11755
198
1106
992
10686
297
2258
827
8776
Cardiac arrhythmia NOS
K80 [2002000607]
8.2e-01
2.1e+00
—
—
—
9.8e-01
1.0e+00
cases:1.26%
controls:0.56%
cases:0.83%
controls:0.10%
—
—
—
—
—
—
cases:0.67%
controls:0.25%
cases:2.05%
controls:0.74%
15
66
1178
11760
10
12
1198
11934
—
—
—
8
30
1182
11762
23
82
1101
10952
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-3.6e-02
4.8e-01
7.2e-01
—
1.4e+00
7.8e-01
5.1e-01
cases:5.70%
controls:5.89%
cases:7.28%
controls:4.65%
cases:1.82%
controls:0.90%
—
—
cases:3.50%
controls:0.93%
cases:8.49%
controls:4.06%
cases:15.93%
controls:10.22%
68
697
1125
11129
88
556
1120
11390
22
107
1186
11839
—
42
111
1157
11821
101
479
1089
11313
179
1128
945
9906
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
7.9e-01
9.4e-01
—
—
—
1.9e+00
1.2e+00
cases:0.84%
controls:0.38%
cases:0.58%
controls:0.23%
—
—
—
—
—
—
cases:1.18%
controls:0.17%
cases:1.96%
controls:0.62%
10
45
1183
11781
7
27
1201
11919
—
—
—
14
20
1176
11772
22
68
1102
10966
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
-2.2e-01
5.5e-01
—
—
2.1e+00
1.1e+00
-8.9e-02
cases:1.26%
controls:1.56%
cases:1.24%
controls:0.72%
—
—
—
—
cases:0.58%
controls:0.08%
cases:1.51%
controls:0.53%
cases:2.40%
controls:2.62%
15
184
1178
11642
15
86
1193
11860
—
—
7
9
1192
11923
18
63
1172
11729
27
289
1097
10745
Supine thorax X-ray examination
GD1QA [2001303648]
4.4e-01
2.1e+00
—
1.0e+50
—
9.8e-01
2.6e-01
cases:1.68%
controls:1.08%
cases:3.64%
controls:0.46%
—
—
cases:0.58%
controls:0.00%
—
—
cases:1.26%
controls:0.47%
cases:2.40%
controls:1.87%
20
128
1173
11698
44
55
1164
11891
—
7
0
1201
11946
—
15
56
1175
11736
27
206
1097
10828
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.9e-01
5.8e-01
—
—
2.1e+00
9.3e-01
5.7e-01
cases:1.26%
controls:1.04%
cases:1.08%
controls:0.60%
—
—
—
—
cases:0.50%
controls:0.06%
cases:1.43%
controls:0.57%
cases:3.02%
controls:1.74%
15
123
1178
11703
13
72
1195
11874
—
—
6
7
1193
11925
17
67
1173
11725
34
192
1090
10842
dipyridamole; oral, parenteral
B01AC07 [21600992]
1.3e+00
1.7e+00
—
—
—
1.2e+00
9.0e-01
cases:1.01%
controls:0.27%
cases:0.83%
controls:0.15%
—
—
—
—
—
—
cases:0.50%
controls:0.15%
cases:0.53%
controls:0.22%
12
32
1181
11794
10
18
1198
11928
—
—
—
6
18
1184
11774
6
24
1118
11010
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-1.4e-01
5.0e-01
7.1e-01
—
1.4e+00
6.9e-01
4.2e-01
cases:5.70%
controls:6.49%
cases:8.03%
controls:5.04%
cases:1.90%
controls:0.95%
—
—
cases:3.84%
controls:0.99%
cases:8.66%
controls:4.54%
cases:16.99%
controls:11.81%
68
768
1125
11058
97
602
1111
11344
23
113
1185
11833
—
46
118
1153
11814
103
535
1087
11257
191
1303
933
9731
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
5.4e-01
1.2e+00
—
—
—
1.8e+00
2.4e-01
cases:1.17%
controls:0.68%
cases:1.16%
controls:0.35%
—
—
—
—
—
—
cases:1.51%
controls:0.25%
cases:1.07%
controls:0.84%
14
81
1179
11745
14
42
1194
11904
—
—
—
18
30
1172
11762
12
93
1112
10941
Heart valve disease NOS
K83 [2002000610]
-1.0e+50
—
—
—
—
—
3.0e+00
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.05%
0
5
1193
11821
—
—
—
—
—
10
5
1114
11029
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
-1.7e-01
1.1e+00
—
—
1.9e+00
8.8e-01
4.5e-01
cases:0.59%
controls:0.69%
cases:1.66%
controls:0.56%
—
—
—
—
cases:0.58%
controls:0.09%
cases:1.18%
controls:0.49%
cases:3.38%
controls:2.18%
7
82
1186
11744
20
67
1188
11879
—
—
7
11
1192
11921
14
58
1176
11734
38
240
1086
10794
Choriogonadotropin [Presence] in Serum or Plasma
2118-8 [3003191]
—
9.4e-01
—
—
—
1.9e+00
1.0e+00
—
—
cases:0.58%
controls:0.23%
—
—
—
—
—
—
cases:0.84%
controls:0.13%
cases:1.42%
controls:0.52%
—
7
27
1201
11919
—
—
—
10
15
1180
11777
16
57
1108
10977
Epistaxis
R04.0 [45606791]
6.3e-01
1.7e+00
—
—
—
1.7e+00
1.2e+00
cases:0.84%
controls:0.45%
cases:0.50%
controls:0.09%
—
—
—
—
—
—
cases:0.76%
controls:0.14%
cases:2.40%
controls:0.74%
10
53
1183
11773
6
11
1202
11935
—
—
—
9
16
1181
11776
27
82
1097
10952
Angiography of the heart and coronary arteries
81 [2002100125]
—
—
—
1.0e+50
—
2.9e+00
1.4e+00
—
—
—
—
—
—
cases:0.75%
controls:0.00%
—
—
cases:0.92%
controls:0.05%
cases:0.44%
controls:0.11%
—
—
—
9
0
1199
11946
—
11
6
1179
11786
5
12
1119
11022
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
—
2.9e+00
—
—
—
—
9.5e-01
—
—
cases:0.75%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.17%
—
9
5
1199
11941
—
—
—
—
5
19
1119
11015
Limited MRI examination of neck vasculature with high intensity magnet
PA6AG [2001308695]
—
2.9e+00
—
—
—
—
—
—
—
cases:0.75%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
9
5
1199
11941
—
—
—
—
—
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
—
2.9e+00
—
—
—
—
1.0e+00
—
—
cases:0.75%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.16%
—
9
5
1199
11941
—
—
—
—
5
18
1119
11016
X-ray examination of the lungs in one projection
GD1PA [2001303645]
-1.2e-01
1.4e+00
—
1.0e+50
—
1.5e+00
6.9e-01
cases:0.84%
controls:0.95%
cases:1.41%
controls:0.37%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.01%
controls:0.22%
cases:2.05%
controls:1.03%
10
112
1183
11714
17
44
1191
11902
—
6
0
1202
11946
—
12
26
1178
11766
23
114
1101
10920
Oxygen saturation in Venous blood
2711-0 [3024928]
—
1.4e+00
—
—
—
1.7e+00
1.1e+00
—
—
cases:0.41%
controls:0.10%
—
—
—
—
—
—
cases:0.67%
controls:0.12%
cases:1.87%
controls:0.61%
—
5
12
1203
11934
—
—
—
8
14
1182
11778
21
67
1103
10967
Other medical or dental certificate
WZA90 [2001310883]
1.5e-01
7.1e-01
2.0e+00
—
—
8.5e-01
4.6e-01
cases:3.35%
controls:2.89%
cases:1.74%
controls:0.86%
cases:0.50%
controls:0.07%
—
—
—
—
cases:1.85%
controls:0.80%
cases:4.72%
controls:3.02%
40
342
1153
11484
21
103
1187
11843
6
8
1202
11938
—
—
22
94
1168
11698
53
333
1071
10701
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
—
1.3e+00
—
—
—
1.5e+00
9.0e-01
—
—
cases:0.91%
controls:0.24%
—
—
—
—
—
—
cases:0.76%
controls:0.17%
cases:1.07%
controls:0.44%
—
11
29
1197
11917
—
—
—
9
20
1181
11772
12
48
1112
10986
Syncope and collapse
R55 [45568141]
1.8e-01
1.5e+00
—
1.0e+50
—
1.3e+00
5.5e-01
cases:1.09%
controls:0.91%
cases:1.49%
controls:0.34%
—
—
cases:0.58%
controls:0.00%
—
—
cases:1.09%
controls:0.29%
cases:2.05%
controls:1.19%
13
108
1180
11718
18
41
1190
11905
—
7
0
1201
11946
—
13
34
1177
11758
23
131
1101
10903
Gas panel - Venous blood
24339-4 [3000991]
-2.9e-02
4.2e-01
—
—
1.6e+00
1.2e+00
5.6e-01
cases:1.26%
controls:1.29%
cases:1.82%
controls:1.21%
—
—
—
—
cases:1.00%
controls:0.20%
cases:2.69%
controls:0.83%
cases:3.91%
controls:2.28%
15
153
1178
11673
22
144
1186
11802
—
—
12
24
1187
11908
32
98
1158
11694
44
252
1080
10782
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
-3.2e-01
1.3e+00
—
—
—
8.4e-01
1.5e+00
cases:0.50%
controls:0.69%
cases:1.66%
controls:0.48%
—
—
—
—
—
—
cases:0.59%
controls:0.25%
cases:1.16%
controls:0.25%
6
82
1187
11744
20
57
1188
11889
—
—
—
7
30
1183
11762
13
28
1111
11006
candesartan; oral
C09CA06 [21601829]
4.9e-01
6.6e-01
9.9e-01
-1.0e+50
7.7e-01
6.1e-01
2.9e-01
cases:5.95%
controls:3.73%
cases:5.88%
controls:3.12%
cases:2.40%
controls:0.90%
cases:0.00%
controls:0.04%
cases:1.75%
controls:0.82%
cases:6.39%
controls:3.57%
cases:7.65%
controls:5.82%
71
441
1122
11385
71
373
1137
11573
29
108
1179
11838
0
5
1208
11941
21
98
1178
11834
76
421
1114
11371
86
642
1038
10392
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.0e-01
3.2e-01
4.5e-01
-1.0e+50
1.4e+00
5.4e-01
4.6e-01
cases:30.26%
controls:26.25%
cases:18.29%
controls:14.03%
cases:3.64%
controls:2.35%
cases:0.00%
controls:0.09%
cases:8.26%
controls:2.22%
cases:22.27%
controls:14.32%
cases:46.26%
controls:35.10%
361
3104
832
8722
221
1676
987
10270
44
281
1164
11665
0
11
1208
11935
99
265
1100
11667
265
1689
925
10103
520
3873
604
7161
Old myocardial infarction
I25.2 [45601025]
7.9e-01
1.1e+00
—
1.0e+50
—
1.7e+00
9.7e-01
cases:1.09%
controls:0.50%
cases:0.66%
controls:0.22%
—
—
cases:0.75%
controls:0.00%
—
—
cases:1.34%
controls:0.25%
cases:1.51%
controls:0.58%
13
59
1180
11767
8
26
1200
11920
—
9
0
1199
11946
—
16
29
1174
11763
17
64
1107
10970
pH of Venous blood
2746-6 [3012544]
-7.0e-02
5.1e-01
1.1e+00
—
1.7e+00
1.0e+00
2.9e-01
cases:1.34%
controls:1.44%
cases:2.07%
controls:1.25%
cases:0.58%
controls:0.19%
—
—
cases:0.83%
controls:0.16%
cases:2.61%
controls:0.98%
cases:3.83%
controls:2.90%
16
170
1177
11656
25
149
1183
11797
7
23
1201
11923
—
10
19
1189
11913
31
115
1159
11677
43
320
1081
10714
Stress, not elsewhere classified
Z73.3 [45542455]
—
2.6e+00
—
—
—
—
—
—
—
cases:0.58%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
7
5
1201
11941
—
—
—
—
—
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
-1.0e+50
-1.0e+50
—
—
—
—
2.6e+00
cases:0.00%
controls:0.09%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.05%
0
11
1193
11815
0
7
1208
11939
—
—
—
—
7
5
1117
11029
Left ventricular failure
I50.1 [45543181]
5.3e-01
1.5e+00
—
1.0e+50
—
1.3e+00
1.2e+00
cases:0.50%
controls:0.30%
cases:0.83%
controls:0.19%
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.67%
controls:0.18%
cases:1.60%
controls:0.51%
6
35
1187
11791
10
23
1198
11923
—
6
0
1202
11946
—
8
21
1182
11771
18
56
1106
10978
Morphology [Interpretation] in Blood Narrative
18314-5 [3000093]
—
—
—
—
—
-1.0e+50
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.98%
controls:0.07%
—
—
—
—
—
0
6
1190
11786
11
8
1113
11026
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
-1.0e-03
4.9e-01
1.3e+00
—
1.9e+00
2.5e-01
7.0e-01
cases:1.09%
controls:1.09%
cases:1.41%
controls:0.87%
cases:0.41%
controls:0.12%
—
—
cases:1.00%
controls:0.15%
cases:0.92%
controls:0.72%
cases:3.29%
controls:1.66%
13
129
1180
11697
17
104
1191
11842
5
14
1203
11932
—
12
18
1187
11914
11
85
1179
11707
37
183
1087
10851
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
-3.0e-01
5.3e-01
—
—
2.6e+00
3.6e-01
2.5e-01
cases:1.51%
controls:2.03%
cases:1.66%
controls:0.98%
—
—
—
—
cases:0.67%
controls:0.05%
cases:1.18%
controls:0.82%
cases:4.18%
controls:3.30%
18
240
1175
11586
20
117
1188
11829
—
—
8
6
1191
11926
14
97
1176
11695
47
364
1077
10670

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
755
2886
4.18
164.77
6.4
3.3
1320.46
1048.63
ng/l
0.72
674
2404
592
1934
4.34
160.01
3.8
3.4
30.82
29.62
s
4.17
581
1889
1006
4886
4.09
151.07
30.3
11.1
1.48
1.18
inr
38.76
876
4058
314
707
5.30
133.59
3.7
3.5
225.11
178.34
ng/l
0.74
279
634
162
181
9.83
133.20
1.1
1.2
—
—
—
0
0
275
626
5.11
114.59
3.5
4.8
21.33
21.52
s
0.23
234
589
148
229
7.00
91.99
1.3
1.3
4.31
4.59
u/ml
0.09
77
108
516
2121
3.14
90.01
4.4
3.7
1203.08
446.10
ng/l
2.01
414
1460
688
3319
2.93
89.93
6.5
5.6
80.66
91.27
%
20.31
681
3262
750
3989
2.71
78.40
2.8
2.7
—
—
—
0
0
929
5713
2.58
68.85
3.3
3.0
—
—
estimate
—
0
0
59
39
15.59
67.15
1.2
1.4
28.17
28.36
s
0.05
59
39
104
161
6.81
64.28
2.6
2.4
—
—
—
0
0
242
807
3.35
57.63
2.2
2.3
16.80
7.05
ug/l
4.47
217
711
311
1284
2.77
50.37
9.3
11.3
7.59
7.53
mmol/l
0.06
306
1243
429
2092
2.44
49.12
7.1
6.1
0.82
0.82
mmol/l
0.38
415
1997
178
555
3.48
46.75
4.8
5.6
3.06
3.28
g/l
1.31
172
537
601
3505
2.16
44.00
2.8
2.3
230.60
234.71
u/l
0.03
575
3361
39
28
14.17
42.27
3.6
8.9
4.97
5.14
kpa
0.23
39
28
1039
7583
2.14
40.54
9.5
6.0
6.20
6.47
mmol/l
6.40
1006
7150
275
1244
2.46
35.99
17.9
9.7
0.86
0.73
mmol/l
0.24
251
1036
273
1254
2.42
34.44
18.0
9.7
7.42
7.41
ph
1.23
124
668
183
726
2.71
31.19
22.5
12.1
0.64
0.66
%
0.30
183
721
187
751
2.68
31.11
22.0
11.8
1.23
1.28
%
0.35
187
744
319
1633
2.19
30.87
17.6
11.0
—
—
—
0
0
622
4076
1.87
29.67
4.9
3.4
56.15
57.21
ng/l
0.02
432
2594
824
5917
1.84
29.07
14.2
9.1
1.20
1.22
mmol/l
8.71
789
5531
47
74
6.48
28.46
1.1
1.1
1.07
1.05
ratio
0.53
42
65
307
1632
2.09
26.58
19.0
13.8
25.21
24.63
mmol/l
3.63
307
1626
32
7
46.31
26.46
2.6
5.1
98.78
97.29
g/l
—
32
7
461
2882
1.85
24.54
3.2
2.4
1.15
1.26
mg/l
0.35
344
2194
743
5384
1.73
23.50
6.2
6.0
36.45
36.55
g/l
0.18
702
5093
1430
12738
2.94
23.42
27.4
16.7
139.50
139.59
mmol/l
0.84
1424
12485
1430
12751
2.92
23.11
27.6
16.8
3.97
3.96
mmol/l
1.80
1423
12462
705
5082
1.70
22.35
7.5
8.5
—
—
—
0
0
839
6342
1.70
22.24
9.1
7.2
16.53
13.72
umol/l
2.39
798
6033
324
1864
1.92
22.02
3.6
2.9
21.23
22.77
%
1.45
306
1768
343
2034
1.87
21.15
3.5
2.8
2.43
2.40
g/l
0.46
321
1912
850
6507
1.67
20.95
12.3
9.2
1.21
1.22
mmol/l
5.80
774
5770
361
2187
1.84
20.75
3.6
2.8
12.78
13.68
umol/l
1.63
339
2067
58
153
3.87
19.37
3.1
3.3
0.78
0.83
nmol/l
0.23
46
128
471
3137
1.71
19.32
4.8
4.4
—
—
—
0
0
312
1864
1.83
18.53
6.8
7.9
7.37
7.37
ph
0.12
207
1167
64
189
3.47
18.13
8.4
6.7
11.60
11.39
mg/l
0.10
55
176
254
1433
1.91
18.01
7.3
8.5
24.17
23.76
mmol/l
1.61
254
1425
305
1827
1.82
17.90
6.8
7.8
1.56
1.39
mmol/l
0.44
272
1536
937
7525
1.62
17.65
7.5
8.1
1.85
2.09
e9/l
6.48
826
6569
920
7374
1.61
17.31
7.6
8.1
0.04
0.04
e9/l
1.06
793
6265
920
7376
1.61
17.27
7.5
8.1
0.58
0.57
e9/l
0.27
791
6267
224
1230
1.95
17.17
10.7
8.1
—
—
—
0
0
334
2079
1.76
17.15
9.7
8.5
1.20
1.16
mmol/l
1.32
324
1952
111
472
2.44
16.21
2.5
2.2
1.18
1.45
g/l
2.45
94
422
262
1544
1.83
16.08
10.2
7.7
7.42
7.41
ph
1.44
227
1252
559
4043
1.59
15.88
1.5
1.6
—
—
—
0
0
1419
12960
2.32
15.39
21.6
14.5
24.10
22.71
mg/l
1.01
1222
10322
932
7602
1.56
15.34
8.0
8.6
0.18
0.20
e9/l
3.04
819
6579
503
3592
1.58
14.86
5.6
3.2
—
0.70
—
0
10
854
6866
1.54
14.73
7.9
8.3
0.66
0.67
%
0.43
821
6517
140
693
2.11
14.23
4.9
6.6
1.19
1.23
%
0.26
140
688
873
7091
1.52
14.06
7.8
8.2
28.25
30.89
%
10.11
844
6796
852
6888
1.52
14.01
7.9
8.4
8.98
8.61
%
3.55
819
6540
36
85
4.28
13.98
2.1
1.4
71358.18
29301.81
e6/l
0.43
22
42
860
6972
1.52
13.91
7.6
8.1
56.46
54.13
%
6.96
835
6719
850
6877
1.52
13.86
7.9
8.3
2.84
2.99
%
1.11
817
6526
1446
13414
2.45
13.34
25.5
17.3
72.59
70.65
umol/l
1.21
1441
13256
486
3530
1.54
12.95
3.0
2.6
3.09
2.69
mg/l
2.34
437
3094
37
95
3.94
12.88
2.1
1.3
1430.68
1905.49
e6/l
0.38
25
61
961
8075
1.49
12.34
10.0
10.9
3.89
3.90
e9/l
0.08
839
6932
1428
13259
2.15
11.77
19.0
12.1
—
—
—
0
0
267
1733
1.64
11.32
2.7
2.0
—
—
—
0
0
582
4485
1.47
11.28
4.3
3.9
33.30
32.48
u/l
0.10
555
4274
800
6578
1.44
10.83
11.9
12.1
0.00
0.00
e9/l
0.02
632
5257
221
1382
1.69
10.78
3.5
3.3
0.20
0.21
g/l
0.99
216
1312
252
1633
1.64
10.71
5.0
4.7
8.46
7.26
umol/l
0.51
232
1397
134
727
1.91
10.52
11.0
15.1
1.24
1.21
mg/l
0.19
129
693
32
88
3.67
10.16
5.4
4.9
113.15
73.84
mg/l
0.85
27
76
1074
9382
1.47
10.16
9.5
7.8
89.95
89.17
u/l
0.13
1034
8918
31
84
3.72
10.05
2.1
1.4
—
—
—
0
0
86
405
2.18
9.95
3.9
2.4
702.27
407.84
ug/l
0.44
81
378
242
1589
1.61
9.70
3.5
4.7
1.91
1.66
%
2.27
225
1466
569
4462
1.43
9.65
6.8
7.5
—
—
—
0
0
153
892
1.78
9.55
2.1
3.1
64.99
66.61
g/l
1.43
142
835
34
103
3.33
9.36
46.8
46.4
7.50
6.74
ug/l
1.17
34
93
97
495
2.01
9.11
1.1
1.3
—
—
—
0
0
462
3524
1.43
8.99
4.7
4.2
7.40
7.40
ph
0.14
348
2484
18
20
9.03
8.99
1.1
1.1
—
—
—
0
0
812
6831
1.39
8.89
4.2
3.4
101.75
96.46
ug/l
0.34
770
6478
105
562
1.92
8.60
1.1
1.6
—
12.91
—
0
15
61
283
2.19
7.39
1.7
1.9
—
—
—
0
0
61
283
2.19
7.39
1.7
1.9
—
—
—
0
0
28
90
3.13
7.07
2.3
1.7
—
—
—
0
0
182
1203
1.57
7.02
3.2
3.8
76.62
68.81
e9/l
1.54
126
816
60
283
2.15
6.99
1.7
1.9
—
—
—
0
0
60
283
2.15
6.99
1.7
1.9
—
—
—
0
0
63
304
2.10
6.93
7.3
7.8
1.18
1.31
mmol/l
0.59
58
265
233
1636
1.49
6.80
1.8
1.7
1137.50
1191.41
nmol/l
0.39
178
1238
24
75
3.21
6.36
4.6
3.4
—
—
—
0
0
100
583
1.75
6.28
1.8
2.0
—
—
—
0
0
134
847
1.63
6.23
3.3
3.4
4.44
4.75
pmol/l
2.58
123
774
50
230
2.20
6.23
6.7
5.0
1.64
2.34
mmol/l
1.66
31
143
515
4209
1.33
6.05
3.4
3.4
2.36
2.37
mmol/l
0.72
469
3868
471
3803
1.33
6.01
3.0
2.8
62.30
81.13
u/l
0.43
443
3553
470
3862
1.30
5.15
4.1
3.7
0.46
0.36
e6/l
0.48
360
2793
524
4376
1.29
5.05
4.3
3.8
222.82
63.02
e6/l
0.43
415
3297
68
379
1.82
5.02
4.0
3.7
7.17
3.78
index
0.47
42
211
602
5137
1.27
4.83
5.1
4.5
47.98
81.24
e6/l
1.22
438
3479
103
652
1.61
4.81
1.8
2.4
—
—
—
0
0
95
592
1.63
4.73
1.5
1.9
4.02
7.54
iu/ml
1.61
21
117
211
1564
1.39
4.56
1.8
1.5
—
—
—
0
0
262
2012
1.35
4.55
1.4
1.4
693.62
482.64
titre
0.80
47
394
69
400
1.75
4.50
1.4
1.3
—
—
—
0
0
929
8384
1.26
4.49
5.1
4.5
201.00
2318.25
e6/l
1.96
19
107
311
2456
1.32
4.47
3.0
3.3
0.97
0.98
e6/l
0.02
169
1278
48
249
1.94
4.44
3.3
2.9
16.77
16.67
%
0.09
48
242
31
136
2.29
4.40
2.2
2.3
0.96
0.90
%
0.24
21
84
364
2950
1.30
4.32
3.7
3.0
4.99
6.30
e6/l
1.31
340
2664
31
138
2.26
4.26
2.4
2.5
31.65
32.51
pg
0.38
31
138
360
2927
1.29
4.15
3.8
3.2
346.04
329.18
umol/l
2.00
317
2630
445
3726
1.26
4.03
4.1
3.6
—
1.69
estimate
—
0
14
1234
11587
1.31
4.00
26.2
18.5
13.58
13.43
%
3.56
1226
11455
438
3670
1.26
3.93
3.1
3.0
—
—
—
0
0
216
1648
1.35
3.90
2.1
1.7
—
—
—
0
0
1266
11947
1.31
3.83
6.0
5.2
1.96
1.89
mu/l
1.34
1207
11236
26
114
2.29
3.73
5.3
4.8
1.19
0.72
index
1.57
26
114
82
526
1.58
3.68
1.4
1.7
1.12
1.18
g/l
1.35
76
504
147
1063
1.41
3.68
6.4
5.8
79.07
72.02
ng/l
0.72
131
981
172
1279
1.38
3.66
2.5
2.5
38.05
77.68
u/l
0.52
151
1063
48
268
1.80
3.60
5.9
4.4
—
—
—
0
0
19
75
2.54
3.42
1.8
1.5
31.64
37.17
%
0.22
11
52
382
3196
1.25
3.41
1.8
1.6
20.03
20.38
nmol/l
0.19
338
2754
275
2216
1.28
3.36
2.6
2.7
2.42
2.44
mmol/l
1.84
240
1978
50
290
1.74
3.33
4.6
4.6
91.55
90.87
%
0.29
50
279
1472
14305
1.70
3.30
32.6
22.0
4.49
4.54
e12/l
3.73
1449
13911
1472
14305
1.70
3.30
32.5
22.0
29.97
29.91
pg
0.56
1467
14186
1472
14306
1.70
3.29
35.4
22.7
39.85
40.84
%
1.75
1467
14180
30
148
2.03
3.26
1.2
1.1
—
—
—
0
0
1472
14309
1.69
3.24
32.6
22.1
6.76
6.77
e9/l
0.10
1450
13907
398
3364
1.24
3.22
3.5
3.7
—
0.05
—
0
22
1471
14298
1.68
3.22
32.6
22.1
246.64
259.61
e9/l
11.98
1452
13950
24
109
2.21
3.21
1.7
1.7
61.88
53.70
%
0.55
17
79
1471
14301
1.67
3.18
32.5
22.0
89.91
89.55
fl
1.89
1466
14183
641
5690
1.21
3.17
3.4
3.4
6.24
6.22
ph
0.13
322
3114
56
340
1.66
3.17
1.9
2.1
10.77
10.51
g/l
0.13
50
313
46
267
1.73
3.08
5.9
3.8
3.86
3.86
mmol/l
0.05
46
262
285
2337
1.26
3.01
3.3
3.4
3.12
2.61
e6/l
0.30
143
1165
77
513
1.52
2.98
1.5
1.7
0.22
0.23
g/l
0.58
72
493
9
21
4.28
2.97
2.1
1.6
38.58
22.19
g/l
—
9
15
65
421
1.56
2.86
2.5
2.0
0.68
1.96
ug/l
1.07
59
376
1164
10981
1.23
2.85
5.8
5.7
37.51
38.45
mmol/mol
4.05
1109
10426
28
143
1.96
2.80
2.3
3.3
—
—
—
0
0
62
400
1.56
2.79
1.2
1.2
—
—
—
0
0
212
1694
1.28
2.77
1.2
1.3
—
—
—
0
0
63
413
1.54
2.65
1.3
1.3
3.52
10.12
u/ml
0.90
14
49
51
318
1.61
2.65
2.6
2.5
—
—
—
0
0
1100
10347
1.20
2.64
5.0
4.3
14.91
14.59
pmol/l
4.19
1032
9605
63
414
1.53
2.63
1.3
1.3
2.10
4.69
u/ml
—
9
31
36
205
1.76
2.61
1.9
1.6
—
—
—
0
0
934
8672
1.18
2.55
4.3
3.8
49.99
43.51
u/l
1.19
904
8290
8
20
3.99
2.55
2.1
2.1
—
—
—
0
0
17
74
2.30
2.54
1.1
1.1
231.83
213.10
iu/ml
0.12
17
74
22
107
2.06
2.53
1.2
1.1
—
—
—
0
0
140
1071
1.33
2.53
5.0
5.5
0.07
0.14
%
0.59
41
285
36
592
0.59
2.51
1.0
1.2
2.64
3.17
u/ml
0.11
25
409
160
1251
1.30
2.48
1.3
1.4
143.79
289.83
u/ml
2.51
151
1176
99
721
1.39
2.45
1.2
1.2
—
—
—
0
0
22
109
2.02
2.42
36.4
39.2
148.29
140.16
ug/l
0.16
17
99
762
6986
1.17
2.35
4.0
3.8
20.99
5.95
estimate
0.50
130
1373
1187
11287
1.20
2.33
5.1
4.5
5.70
5.80
mmol/l
2.48
1113
10474
82
584
1.42
2.32
4.3
6.1
278.91
315.74
mg/l
0.23
56
355
307
2610
1.21
2.30
4.0
3.1
550.21
539.97
mosm/kgh2o
0.34
282
2298
562
5050
1.17
2.21
2.3
2.0
98.45
96.75
pmol/l
0.38
316
2671
51
334
1.53
2.20
5.6
3.9
1.19
1.36
mmol/l
1.40
51
326
135
1051
1.30
2.18
4.4
5.0
0.74
0.60
%
0.40
48
333
107
1381
0.75
2.15
1.7
1.7
—
—
—
0
0
45
674
0.65
2.13
1.1
1.2
5.26
3.03
u/ml
0.27
27
467
27
151
1.79
2.12
1.4
1.3
—
—
—
0
0
58
395
1.48
2.10
2.2
1.9
4.39
4.36
iu/l
0.01
20
161
139
1094
1.29
2.08
4.9
5.2
1.04
0.89
%
0.26
49
350
134
1050
1.29
2.08
5.0
5.2
0.22
0.10
%
0.71
43
304
512
4590
1.16
2.05
2.1
2.0
—
—
—
0
0
41
619
0.65
2.03
1.0
1.2
2.49
5.56
u/ml
1.36
27
442
40
606
0.65
2.02
1.0
1.2
1.35
0.98
u/ml
0.18
23
389
9
32
2.80
1.98
2.7
2.1
—
—
—
0
0
124
973
1.29
1.92
5.4
4.3
7.34
7.35
ph
0.23
93
703
12
52
2.30
1.85
1.6
1.2
—
—
—
0
0
12
52
2.30
1.85
1.6
1.2
—
—
—
0
0
12
52
2.30
1.85
1.6
1.2
—
—
—
0
0
48
324
1.49
1.85
4.4
4.1
8.51
9.44
umol/l
0.15
34
259
5
12
4.15
1.81
1.8
1.3
—
—
—
0
0
407
3616
1.16
1.81
4.1
3.9
0.00
0.01
estimate
1.28
118
1287
39
253
1.55
1.80
1.4
2.3
77.38
69.48
mmol/l
0.35
29
221
178
1470
1.23
1.80
1.2
1.3
—
—
—
0
0
747
6927
1.14
1.79
4.0
3.8
0.00
0.00
estimate
0.50
124
1360
104
1309
0.77
1.77
1.3
1.3
—
—
—
0
0
199
1666
1.21
1.76
2.4
3.2
3.99
4.99
e9/l
1.64
175
1483
24
394
0.60
1.74
1.0
1.1
0.02
0.68
u/ml
1.02
13
195
32
200
1.60
1.74
2.2
1.6
503.18
338.55
mu/l
0.90
25
163
26
416
0.61
1.70
1.1
1.1
4.28
9.91
u/ml
1.34
14
245
28
440
0.63
1.70
1.1
1.1
1.50
7.35
u/ml
5.81
17
280
755
7028
1.13
1.66
4.0
3.8
0.00
0.24
estimate
0.54
120
1299
20
111
1.80
1.65
1.4
2.1
—
—
—
0
0
425
3812
1.15
1.65
1.5
1.7
2.02
2.06
g/l
0.18
270
2230
10
42
2.37
1.61
3.4
3.4
39.56
30.50
mg/l
—
5
21
123
989
1.26
1.60
3.2
4.5
18.25
15.36
ug/l
0.07
100
800
24
143
1.68
1.58
1.4
3.5
—
—
—
0
0
58
421
1.38
1.56
1.5
1.4
282.79
309.40
ug/g
0.40
33
251
18
99
1.82
1.54
1.2
1.1
—
—
—
0
0
158
1312
1.22
1.54
3.5
3.5
10.11
9.93
g/l
0.17
149
1240
276
2410
1.17
1.53
1.4
1.3
17.32
27.04
iu/ml
3.22
77
676
57
417
1.37
1.47
2.8
3.5
126.38
3340.08
u/ml
0.75
49
357
45
316
1.43
1.47
1.7
1.8
30.77
21.62
ng/l
0.46
45
316
45
317
1.42
1.45
3.4
2.6
135.97
130.72
g/l
0.82
37
257
1144
10981
1.14
1.43
4.6
4.0
1.18
1.27
mmol/l
5.54
1080
10280
6
22
2.72
1.42
1.2
1.3
—
—
—
0
0
6
23
2.60
1.35
2.0
3.2
—
—
—
0
0
6
23
2.60
1.35
1.5
1.8
—
—
—
0
0
30
198
1.52
1.34
1.1
1.7
—
—
—
0
0
1208
11662
1.14
1.29
5.3
4.7
4.33
4.65
mmol/l
23.59
1156
11054
168
1933
0.85
1.26
1.7
1.8
—
—
—
0
0
9
44
2.04
1.25
1.1
1.5
66.87
79.16
nmol/24h
—
9
44
49
364
1.35
1.19
1.4
3.1
—
—
—
0
0
1215
11754
1.13
1.17
5.9
5.2
2.52
2.75
mmol/l
16.88
1154
11101
70
550
1.28
1.16
2.3
2.5
—
—
—
0
0
117
974
1.21
1.16
2.2
2.4
17.89
19.54
au/ml
0.09
11
104
1367
13340
1.18
1.13
14.5
11.6
25.72
26.21
u/l
0.51
1346
13022
15
244
0.61
1.12
1.1
1.6
10.29
16.50
u/ml
—
6
153
549
5105
1.11
1.12
1.8
1.9
1.27
1.36
mmol/l
2.02
469
4452
38
275
1.38
1.10
1.9
3.5
1.57
2.16
ratio
0.93
23
154
10
51
1.95
1.09
1.3
1.4
172.30
170.73
mmol/24h
—
10
51
33
235
1.40
1.06
8.6
4.7
8.01
7.76
pmol/l
0.08
33
235
18
113
1.59
1.03
1.2
1.2
0.43
0.56
ratio
4.08
13
63
30
211
1.42
1.03
2.6
2.5
24.32
19.32
iu/ml
—
5
15
19
121
1.57
1.03
1.6
1.8
—
—
—
0
0
34
245
1.39
1.02
4.1
3.8
4.12
4.11
e9/l
0.01
34
245
544
5079
1.10
1.01
3.7
3.6
4.83
0.03
estimate
0.49
104
1126
27
377
0.71
1.01
4.5
2.2
0.72
0.74
nmol/l
0.08
21
327
1196
11596
1.11
0.98
5.2
4.6
1.41
1.46
mmol/l
3.51
1140
10933
247
2214
1.13
0.98
1.4
1.3
10.08
9.27
u/ml
0.06
91
809
9
49
1.83
0.98
1.2
1.3
—
—
—
0
0
28
197
1.42
0.97
1.4
1.2
—
—
—
0
0
341
3117
1.11
0.96
3.8
3.7
1.02
1.51
kg/l
0.50
215
2061
108
912
1.19
0.95
1.2
1.2
—
—
—
0
0
34
249
1.36
0.95
1.2
1.1
—
—
—
0
0
73
597
1.23
0.90
2.3
2.1
0.00
1.21
estimate
0.51
18
210
17
252
0.67
0.89
1.0
1.5
1.62
3.55
u/ml
0.74
11
166
102
866
1.18
0.86
4.8
4.4
1.23
1.23
mmol/l
0.30
96
751
49
385
1.27
0.86
1.5
3.0
10.13
9.70
e6/l
0.02
39
284
13
79
1.64
0.86
1.0
1.1
—
—
—
0
0
40
306
1.31
0.86
2.1
3.7
30.47
48.29
mg/l
0.85
32
258
40
306
1.31
0.86
2.1
3.7
48.60
61.82
mg/l
0.27
32
257
122
1053
1.16
0.85
1.8
2.0
1.05
1.15
g/l
0.65
117
994
76
899
0.83
0.83
1.6
1.6
1204.59
984.39
mu/l
0.93
59
781
465
4899
0.92
0.83
2.9
2.9
—
—
—
0
0
13
80
1.62
0.82
1.0
1.0
—
—
—
0
0
49
390
1.26
0.79
1.5
3.0
165.55
796.61
e6/l
1.02
40
297
13
198
0.65
0.79
1.0
1.2
0.75
2.36
u/ml
—
8
113
42
525
0.79
0.78
1.1
1.1
0.64
0.67
ratio
—
7
56
5
96
0.52
0.78
1.0
1.1
—
1.32
nmol/l
—
0
19
56
454
1.23
0.78
2.3
1.9
—
—
—
0
0
27
198
1.36
0.77
1.0
1.2
58.83
24.01
u/l
0.72
22
174
45
557
0.80
0.77
1.1
1.1
1.47
1.52
g/l
0.64
45
557
8
131
0.60
0.73
1.9
2.3
—
—
—
0
0
47
574
0.81
0.73
1.2
1.2
0.82
0.90
g/l
1.63
47
574
365
3397
1.09
0.72
3.6
3.6
55.37
49.75
mg/l
0.16
231
2242
7
39
1.79
0.72
3.4
2.9
0.60
0.62
mmol/l
—
7
39
81
937
0.85
0.72
1.8
1.9
—
—
—
0
0
132
1165
1.14
0.71
2.1
2.1
0.00
0.02
estimate
0.78
22
264
154
1373
1.13
0.70
1.7
1.5
—
—
—
0
0
103
894
1.15
0.70
1.3
1.3
14.18
45.79
au/ml
—
9
56
28
211
1.32
0.69
1.5
1.4
22.25
20.03
u/l
0.14
20
179
7
42
1.66
0.68
1.1
1.2
—
—
—
0
0
125
1104
1.14
0.67
1.3
1.3
121.51
138.96
u/ml
0.20
46
409
105
1181
0.87
0.65
1.7
1.6
3.00
3.47
mmol/l
3.51
76
807
27
205
1.31
0.65
1.5
1.8
3.62
5.02
mmol/24h
1.35
22
184
13
86
1.51
0.64
2.2
2.2
—
—
—
0
0
141
1553
0.89
0.64
2.0
1.9
3.34
3.53
ratio
0.81
110
1181
51
605
0.83
0.62
1.1
1.1
—
—
—
0
0
41
497
0.81
0.62
1.5
1.5
78.92
61.35
ug/l
1.32
33
426
8
49
1.62
0.61
1.6
1.7
—
—
—
0
0
35
278
1.26
0.61
1.1
1.2
—
—
—
0
0
8
50
1.59
0.61
2.5
2.3
27.50
29.20
%
—
8
50
52
432
1.20
0.61
2.3
1.9
114.86
121.55
au/ml
0.18
22
157
18
130
1.38
0.59
1.2
1.2
100.06
114.80
pmol/l
0.66
18
130
0
22
0.00
0.59
0.0
1.4
—
72.50
—
0
22
77
875
0.87
0.57
1.8
2.0
—
—
—
0
0
16
114
1.40
0.57
1.3
1.8
—
—
—
0
0
328
3073
1.08
0.56
5.1
5.1
—
—
—
0
0
367
3454
1.07
0.56
4.2
4.2
11.21
8.29
mg/mmol
0.36
231
2217
20
149
1.34
0.56
1.3
1.3
—
—
—
0
0
443
4198
1.07
0.55
1.5
1.6
0.87
2.56
u/ml
5.94
110
1007
65
558
1.16
0.54
1.4
1.2
—
—
—
0
0
9
60
1.49
0.54
1.2
1.2
—
5.60
—
0
5
6
38
1.57
0.54
2.0
3.2
—
—
—
0
0
88
774
1.14
0.53
1.9
2.3
8869.44
5066.66
u/l
0.43
29
285
9
61
1.47
0.53
1.7
2.0
103.72
105.97
ng/l
—
9
61
35
285
1.22
0.51
1.8
1.6
16810.74
12419.50
e6/l
0.32
27
208
154
1403
1.10
0.51
1.3
1.4
—
—
—
0
0
26
206
1.26
0.49
1.4
1.4
—
—
—
0
0
84
935
0.89
0.48
1.8
2.0
—
—
—
0
0
7
46
1.51
0.48
2.3
2.3
—
—
—
0
0
31
374
0.82
0.48
1.6
1.5
—
—
—
0
0
30
244
1.23
0.46
3.1
3.7
1175.24
1444.89
e6/l
0.95
25
193
443
4224
1.06
0.46
3.7
3.8
7.45
7.89
mmol/l
1.15
381
3706
85
941
0.89
0.46
1.9
2.0
—
—
—
0
0
7
50
1.39
0.44
1.4
1.6
—
—
—
0
0
90
991
0.90
0.44
2.3
2.3
6.15
6.13
ph
0.08
52
649
32
381
0.83
0.44
1.6
1.5
—
—
—
0
0
85
937
0.90
0.43
1.8
2.0
—
—
—
0
0
20
156
1.28
0.43
1.3
1.3
—
—
—
0
0
73
646
1.13
0.43
1.1
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
5.6
—
8.25
—
0
15
15
113
1.32
0.41
1.5
1.2
—
—
—
0
0
24
291
0.82
0.40
1.5
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
50
435
1.15
0.39
1.2
1.1
6.12
14.11
au/ml
1.03
11
79
12
88
1.36
0.38
1.2
2.4
—
—
—
0
0
9
66
1.36
0.38
1.4
2.2
—
—
—
0
0
56
492
1.14
0.38
1.4
1.2
—
—
—
0
0
29
241
1.20
0.38
1.1
1.1
—
—
—
0
0
10
71
1.40
0.38
1.0
1.2
1060.00
558.33
titre
—
5
12
5
36
1.38
0.38
2.8
2.0
—
—
—
0
0
31
362
0.85
0.37
1.5
1.5
1.30
1.28
mm
0.06
22
262
199
1866
1.07
0.36
1.7
1.6
—
—
—
0
0
10
134
0.74
0.36
1.1
1.3
4.62
5.25
u/ml
—
10
127
338
3223
1.05
0.36
1.9
2.1
—
—
—
0
0
6
41
1.46
0.36
1.3
1.2
—
—
—
0
0
10
72
1.38
0.35
4.8
3.4
109.82
121.52
ug/l
—
10
72
165
1539
1.07
0.35
3.5
2.4
341.37
360.89
nmol/l
0.52
156
1461
19
232
0.81
0.35
1.0
1.0
19.37
19.42
mmol/l
0.02
19
224
9
123
0.73
0.35
1.0
1.1
337.33
287.83
mg/l
—
9
113
11
81
1.35
0.35
1.0
1.2
—
—
—
0
0
6
43
1.39
0.35
1.0
1.0
—
—
—
0
0
39
440
0.88
0.31
2.2
2.4
—
—
—
0
0
19
228
0.83
0.31
1.0
1.0
-2.11
-2.24
mmol/l
—
8
49
19
228
0.83
0.31
1.0
1.0
—
—
—
0
0
25
292
0.85
0.31
1.2
1.1
2.37
4.48
eliau/ml
0.72
11
112
21
174
1.20
0.30
6.2
3.8
1.73
1.68
umol/l
0.14
21
168
7
56
1.24
0.29
1.9
2.4
15.44
17.95
umol/l
—
7
56
107
993
1.08
0.28
1.8
1.5
—
—
—
0
0
8
63
1.26
0.27
1.3
1.2
—
—
—
0
0
10
76
1.31
0.27
1.2
1.1
1446.80
1436.70
miu/ml
—
10
76
32
279
1.14
0.26
1.4
1.4
82.36
138.86
pmol/l
0.70
32
272
22
186
1.18
0.26
1.2
1.3
—
—
—
0
0
19
223
0.84
0.26
1.1
1.1
8.46
15.56
u/ml
—
8
57
15
122
1.22
0.25
1.6
2.5
1.05
1.31
g/24h
—
6
80
12
95
1.26
0.25
2.8
3.5
1035.75
898.37
u/ml
0.15
12
95
49
443
1.10
0.24
1.1
1.1
2.91
7.18
eliau/ml
—
7
75
158
1644
0.95
0.23
1.3
1.2
—
—
—
0
0
27
235
1.14
0.23
1.1
1.2
—
—
—
0
0
18
210
0.85
0.23
1.6
1.8
—
—
—
0
0
38
339
1.12
0.23
15.3
9.1
—
—
—
0
0
5
37
1.34
0.23
1.4
1.3
—
—
—
0
0
5
38
1.31
0.23
1.0
1.7
6.52
239398.25
nmol/l
—
5
33
107
1003
1.06
0.23
5.0
3.9
—
—
—
0
0
44
398
1.10
0.22
4.2
3.2
55.50
55.68
%
0.03
44
398
233
2235
1.04
0.21
1.5
1.7
453.51
33264144.44
pmol/l
2.40
195
1915
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
3.18
—
0
5
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
39
351
1.11
0.21
1.2
1.2
—
—
—
0
0
8
102
0.78
0.21
2.5
2.1
119.38
123.83
ng/l
—
8
88
156
1617
0.95
0.21
2.9
2.9
0.79
0.72
ug/l
0.20
97
923
101
949
1.06
0.21
1.8
1.8
22.57
20.89
iu/l
0.19
78
717
46
419
1.09
0.20
1.3
1.2
—
—
—
0
0
22
191
1.15
0.20
2.5
4.3
9772.40
1644.07
u/ml
0.39
22
180
12
98
1.22
0.20
3.1
2.6
42.57
42.85
%
—
7
50
27
239
1.12
0.19
4.0
4.3
—
—
—
0
0
6
52
1.15
0.19
4.8
2.5
512.67
513.15
min
—
6
39
6
52
1.15
0.19
1.5
1.7
0.00
0.06
estimate
—
6
52
11
90
1.22
0.18
1.1
1.1
—
—
—
0
0
273
2642
1.03
0.17
1.7
1.7
—
—
—
0
0
24
213
1.12
0.17
3.3
3.8
367.58
536.72
e6/l
1.62
19
158
24
213
1.12
0.17
3.4
3.8
312.89
202.43
e6/l
0.67
19
163
8
71
1.12
0.16
2.6
3.4
7.73
10.73
mg/l
—
8
61
45
417
1.07
0.15
1.3
1.2
—
—
—
0
0
10
83
1.20
0.14
1.2
1.4
78.10
74.98
umol/l
—
10
83
273
2652
1.03
0.14
4.5
4.7
1.61
2.05
ug/l
1.56
241
2430
621
6094
1.02
0.14
3.3
2.9
76.17
74.29
nmol/l
0.90
569
5634
38
351
1.08
0.13
5.7
4.4
25.44
22.84
nmol/l
0.44
38
343
16
142
1.12
0.11
1.1
1.1
—
—
—
0
0
24
219
1.09
0.11
1.7
3.1
—
—
—
0
0
17
187
0.90
0.11
1.3
1.5
—
—
—
0
0
85
876
0.96
0.11
1.8
1.6
—
—
—
0
0
10
114
0.87
0.10
1.1
1.0
—
—
—
0
0
75
717
1.04
0.10
1.9
2.0
8.60
7.51
u/l
0.29
46
475
12
105
1.14
0.10
3.3
2.7
—
—
—
0
0
26
240
1.08
0.10
1.8
4.0
—
—
—
0
0
55
570
0.96
0.09
2.9
3.2
1.02
1.02
ratio
0.25
48
524
10
113
0.88
0.09
1.1
1.1
—
—
—
0
0
14
154
0.90
0.09
1.0
1.3
3.51
23.68
u/ml
—
8
120
17
154
1.10
0.09
7.3
4.1
23.35
26.56
umol/l
1.48
17
149
55
524
1.04
0.09
1.9
1.7
277.37
211.36
u/ml
0.83
41
267
26
242
1.07
0.08
1.0
1.1
12.78
7.10
iu/ml
—
6
43
38
396
0.95
0.08
1.1
1.2
—
—
—
0
0
8
73
1.09
0.07
1.3
1.4
—
—
—
0
0
13
142
0.91
0.07
1.1
1.3
—
—
—
0
0
7
84
0.83
0.07
1.0
1.1
27.31
37.20
iu/ml
—
7
84
9
84
1.06
0.07
1.4
1.2
173.80
166.24
pmol/l
—
9
84
224
2256
0.98
0.07
2.1
3.0
114.24
106.75
ug/g
0.14
169
1845
48
495
0.96
0.07
1.7
1.7
34.73
9.44
u/ml
—
6
122
50
515
0.96
0.07
1.7
1.9
—
—
—
0
0
125
1218
1.02
0.06
1.5
1.5
—
—
—
0
0
14
151
0.92
0.06
1.3
1.4
—
—
nmol/l
—
0
0
119
1160
1.02
0.06
2.4
2.4
10.71
12.09
nmol/l
1.10
109
1057
68
658
1.03
0.05
1.6
1.7
0.22
0.31
mg/l
0.58
25
300
10
109
0.91
0.04
1.0
1.1
—
—
—
0
0
20
209
0.95
0.04
1.7
1.6
—
—
—
0
0
24
249
0.96
0.04
2.1
2.0
—
9.33
—
0
6
69
699
0.98
0.03
1.8
1.7
—
—
—
0
0
42
428
0.97
0.03
1.6
1.5
66.67
90.00
titre
—
6
50
376
3717
1.01
0.02
3.5
3.1
0.96
0.03
estimate
0.78
106
1112
14
147
0.95
0.02
1.4
1.2
—
—
—
0
0
17
176
0.96
0.01
2.8
4.2
0.39
0.38
e9/l
0.02
12
113
22
225
0.97
0.01
1.1
1.1
—
—
—
0
0
28
284
0.98
0.00
1.3
1.7
0.61
0.77
g/l
0.52
22
240
18
173
1.03
0.00
1.3
1.4
0.68
0.58
nmol/l
0.59
18
165
14
138
1.01
0.00
1.0
1.1
—
—
—
0
0
22
220
0.99
0.00
3.0
2.3
126.08
104.33
ug/min
0.09
12
141
31
307
1.00
0.00
1.8
1.5
0.54
0.36
nmol/l
0.25
25
243
13
124
1.04
0.00
2.3
2.3
15.14
30.08
mg/l
—
7
84
57
569
0.99
0.00
1.4
1.3
253.55
234.20
miu/ml
0.14
27
266
10
94
1.06
0.00
3.9
2.7
73.70
56.23
umol/l
—
10
86
0
8
0.00
0.00
0.0
2.5
—
178.50
—
0
8
6
65
0.92
-0.00
1.3
1.4
—
86.00
%
—
0
10
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
6
62
0.96
-0.00
1.0
1.3
126.83
144.36
nmol/l
—
6
62
6
69
0.86
-0.00
1.3
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
217.00
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
516.50
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
89
1.00
-0.00
9.6
12.2
0.77
0.60
mmol/l
—
9
83
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
342.78
—
0
9
8
79
1.01
-0.00
1.0
1.2
20.38
8.62
mm/h
—
8
79
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.04
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
11.54
—
0
9

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_ASD and mortality.

Females

Parameter HR [95% CI] p-value
Q17_ASD 1.807 [1.57, 2.09] < 0.001
Birth year 0.999 [0.99, 1.01] 0.845

During the follow-up period (1.1.1998 — 31.12.2019), 451 out of 5990 females with Q17_ASD died.

Males

Parameter HR [95% CI] p-value
Q17_ASD 1.752 [1.5, 2.04] < 0.001
Birth year 0.987 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 363 out of 4494 males with Q17_ASD died.

Mortality risk

Mortality risk for people of age

years, who have Q17_ASD.

N-year risk Females Males
1 0.2% 0.337%
5 1.099% 2.003%
10 2.988% 5.23%
15 5.839% 9.857%
20 10.621% 15.809%

Relationships between endpoints

↥

Index endpoint: Q17_ASD – Atrial septal defect

GWS hits: 4

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data